Microorganisms and methods for the production of oxygenated compounds from hexoses

Engineered recombinant microorganisms convert hexose feedstocks into pentose-5-phosphate intermediates to produce MEG or glycolic acid, addressing yield and cost issues in existing production methods by optimizing the pentose phosphate pathway, resulting in efficient and cost-effective production.

US20240392329A1Inactive Publication Date: 2024-11-28BRASKEM SA
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
US18/737619
Authority / Receiving Office
US · United States
Patent Type
Applications(United States)
Current Assignee / Owner
Priority Date
2019-02-20
Filing Date
2024-06-07
Publication Date
2024-11-28
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Current methods for producing monoethylene glycol (MEG) and glycolic acid from hexose feedstocks face challenges such as low yield potential, ATP shortage, excess NADH, and reliance on expensive and impure xylose feedstocks, as well as glucose-induced inhibition of xylose utilization.

Method used

Recombinant microorganisms are engineered to convert hexose feedstocks into pentose-5-phosphate intermediates, such as D-xylulose-5-phosphate, which are then used to produce MEG or glycolic acid through pathways that bypass glycolysis, optimizing flux into the pentose phosphate pathway and connecting intermediates with known production routes to enhance yield and reduce impurities.

Benefits of technology

This approach achieves a lossless conversion of hexose to pentose intermediates, addressing ATP shortages and excess NADH, and provides a cost-effective and efficient production of MEG or glycolic acid with improved yield potential, overcoming the limitations of existing methods.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure US20240392329A1-D00000_ABST
    Figure US20240392329A1-D00000_ABST
Patent Text Reader

Abstract

The present application relates to recombinant microorganisms useful in the biosynthesis of monoethylene glycol (MEG), or optionally MEG and one or more co-product, from one or more hexose feedstock. The present application also relates to recombinant microorganisms useful in the biosynthesis of glycolic acid (GA), or optionally GA and one or more co-product, from one or more hexose feedstock. The present application relates to recombinant microorganisms useful in the biosynthesis of xylitol, or optionally xylitol and one or more co-product, from one or more hexose feedstock. Also provided are methods of producing MEG (or GA or xylitol), or optionally MEG (or GA or xylitol) and one or more co-product, from one or more hexose feedstock using the recombinant microorganisms, as well as compositions comprising the recombinant microorganisms and / or the products MEG (or GA or xylitol), or optionally MEG (or GA or xylitol) and one or more co-product.
Need to check novelty before this filing date? Find Prior Art

Description

CROSS-REFERENCE TO RELATED APPLICATIONS

[0001] This application is a continuation of U.S. application Ser. No. 16 / 796,417 filed Feb. 20, 2020, which claims priority to U.S. Provisional Application No. 62 / 808,247 filed Feb. 20, 2019, entitled “MICROORGANISMS AND METHODS FOR THE PRODUCTION OF OXYGENATED COMPOUNDS FROM HEXOSES”, the entire disclosures of which are incorporated by reference herein.TECHNICAL FIELD

[0002] This application relates to recombinant microorganisms useSful in the biosynthesis of monoethylene glycol or monoethylene glycol and one or more co-product from one or more hexose feedstock. This application additionally relates to recombinant microorganisms useful in the biosynthesis of glycolic acid or glycolic acid and one or more co-product from one or more hexose feedstock. The application further relates to methods of producing monoethylene glycol or monoethylene glycol and one or more co-product from one or more hexose feedstock using the recombinant microorganisms, as well as methods of producing glycolic acid or glycolic acid and one or more co-product from one or more hexose feedstock using the recombinant microorganisms. The application further relates to compositions comprising one or more of these compounds and / or the recombinant microorganisms.STATEMENT REGARDING SEQUENCE LISTING

[0003] The Sequence Listing associated with this application is provided in XML format in lieu of a paper copy, and is hereby incorporated by reference into the specification. The name of the XML file containing the Sequence Listing is 127125-5006-US01 Sequence Listing.xml. The text file is about 452,323 bytes, was created on Aug. 9, 2024, and is being submitted electronically via Patent Center.BACKGROUND

[0004] A large number of chemical compounds are currently derived from petrochemicals. Compounds such as monoethylene glycol (MEG), glycolic acid, acetone, isopropanol (IPA), propene, serine, glycine, monoethanolamine, and ethylenediamine are valuable as raw material in the production of products like polyethylene terephthalate (PET) resins (from MEG), plastic polypropylene (from propene), polyglycolic acid and other biocompatible copolymers (from glycolic acid) and polyurethane fibers (from ethylenediamine). Alkenes (such as ethylene, propylene, different butenes, and pentenes, for example) are used in the plastics industry, fuels, and in other areas of the chemical industry. For example, isobutene is a small, highly reactive molecule that is used extensively as a platform chemical to manufacture a wide variety of products including fuel additives, rubber and rubber additives, and specialty chemicals.

[0005] However, the compounds are currently produced from precursors that originate from fossil fuels, which contribute to climate change. To develop more environmentally friendly processes for the production of MEG, researchers have engineered microorganisms with biosynthetic pathways to produce MEG. However, these pathways are challenging to implement, with loss of product yield, redox balance and excess biomass formation being some major obstacles to overcome.

[0006] Thus there exists a need for improved biosynthesis pathways for the production of MEG and other chemical compounds useful in industrial and pharmaceutical applications.SUMMARY OF THE DISCLOSURE

[0007] The present application relates to recombinant microorganisms having one or more biosynthesis pathways for the production of monoethylene glycol (MEG) or glycolic acid (GA), or optionally, MEG (or GA) and one or more co-product from one or more hexose feedstock.

[0008] The recombinant microorganisms and methods of the present disclosure combine the advantages of glucose based, fermentative MEG production and xylose based, fermentative MEG production. In some embodiments, the recombinant microorganisms and methods of the present disclosure combine the advantages of xylose degradation biochemistry for high yielding MEG (or GA), or optionally, MEG (or GA) and one or more co-product, formation with the advantages of readily available pure hexose sugar feedstocks.

[0009] In some embodiments, the recombinant microorganisms and methods of the present disclosure solves the problem of xylose feedstock availability. In some embodiments, the recombinant microorganisms and methods of the present disclosure solves the problem of non-affordable xylose feedstock price. In some embodiments, the recombinant microorganisms and methods of the present disclosure solves the problem of xylose feedstock impurities. In some embodiments, the recombinant microorganisms and methods of the present disclosure solves the problem of inefficient xylose uptake by a microorganism. In some embodiments, the recombinant microorganisms and methods of the present disclosure solves the problem of glucose induced inhibition of xylose utilization. In some embodiments, the recombinant microorganisms and methods of the present disclosure solves the problem of a shortage of ATP in MEG (or GA) production pathways. In some embodiments, the recombinant microorganisms and methods of the present disclosure solves the problem of excess NADH in MEG (or GA) production pathways. In some embodiments, the recombinant microorganisms and methods of the present disclosure solves the problem of low overall product yield potential.

[0010] In some embodiments, the recombinant microorganisms and methods of the present disclosure provide a lossless conversion of one or more hexose feedstock to one or more pentose-5-phosphate intermediate. In some embodiments, the one or more pentose-5-phosphate intermediate is used for the production of MEG (or GA), or optionally, MEG (or GA) and one or more co-product, by one or more xylose based fermentation methods. In some embodiments, glucose flux is funneled into the pentose phosphate pathway instead of the glycolysis pathway.

[0011] In one aspect, the present disclosure provides a recombinant microorganism comprising one or more biochemical pathway that produces monoethylene glycol (MEG) (or glycolic acid) from one or more hexose feedstock via one or more pentose-5-phosphate intermediate. In one embodiment, one or more co-product is co-produced with MEG (or glycolic acid). In another embodiment, the one or more pentose-5-phosphate intermediate is one or more of D-xylulose-5-phosphate, D-ribulose-5-phosphate or D-ribose-5-phosphate.

[0012] Therefore, in one embodiment, the application relates to a recombinant microorganism comprising one or more biochemical pathway comprising the expression of at least one enzyme having an activity that converts one or more hexose feedstock in a lossless conversion to one or more pentose-5-phosphate intermediate.

[0013] In some embodiments, the recombinant microorganism comprises the expression of at least one enzyme having transketolase activity. In some embodiments, the enzyme having transketolase activity is encoded by an amino acid sequence having at least 70% sequence identity, at least 80% sequence identity, or at least 90% sequence identity to tktA from E. coli. In other embodiments, the enzyme having transketolase activity is tktA from E. coli. In some embodiments, the enzyme having transketolase activity is encoded by an amino acid sequence having at least 70% sequence identity at least 80% sequence identity, or at least 90% sequence identity to tktB from E. coli. In other embodiments, the enzyme having transketolase activity is tktB from E. coli. In another embodiment, the one or more nucleic acid molecules encoding the enzyme having transketolase activity comprises an amino acid sequence selected from the group consisting of SEQ ID NOs: 148 and 150. In some embodiments, the one or more nucleic acid molecules encoding the enzyme having transketolase activity is tktA, or homolog thereof. In some embodiments, the one or more nucleic acid molecules encoding the enzyme having transketolase activity is tktB, or homolog thereof. In a further embodiment, the one or more nucleic acid molecule encoding the enzyme having transketolase activity is encoded by a nucleic acid sequence selected from the group consisting of SEQ ID NOs: 147 and 149.

[0014] In some embodiments, the recombinant microorganism comprises the expression of at least one enzyme having transaldolase activity. In some embodiments, the enzyme having transaldolase activity is encoded by an amino acid sequence having at least 70% sequence identity, at least 80% sequence identity, or at least 90% sequence identity to talA or talB from E. coli. In some embodiments, the enzyme having transaldolase activity is talA from E. coli. In other embodiments, the enzyme having transaldolase activity is talB from E. coli. In another embodiment, the one or more nucleic acid molecules encoding the enzyme having transaldolase activity comprises an amino acid sequence selected from the group consisting of SEQ ID NOs: 152 and 154. In a further embodiment, the one or more nucleic acid molecule encoding the enzyme having transaldolase activity is encoded by a nucleic acid sequence selected from the group consisting of SEQ ID NOs: 151 and 153.

[0015] In some embodiments, the recombinant microorganism comprises the expression of at least one enzyme having ribulose-5-phosphate 3-epimerase activity. In some embodiments, the enzyme having ribulose-5-phosphate 3-epimerase activity is encoded by an amino acid sequence having at least 70% sequence identity, at least 80% sequence identity, or at least 90% sequence identity to rpe from E. coli. In other embodiments, the enzyme having ribulose-5-phosphate 3-epimerase activity is rpe from E. coli. In another embodiment, the one or more nucleic acid molecules encoding the enzyme having ribulose-5-phosphate 3-epimerase activity comprise an amino acid sequence set forth in SEQ ID NO: 158. In a further embodiment, the one or more nucleic acid molecule encoding the enzyme having ribulose-5-phosphate 3-epimerase activity is encoded by a nucleic acid sequence set forth in SEQ ID NO: 157.

[0016] In some embodiments, the recombinant microorganism comprises the expression of at least one enzyme having ribose-5-phosphate isomerase activity. In some embodiments, the enzyme having ribose-5-phosphate isomerase activity is encoded by an amino acid sequence having at least 70% sequence identity, at least 80% sequence identity, or at least 90% sequence identity to rpiA from E. coli. In other embodiments, the enzyme having ribose-5-phosphate isomerase activity is rpiA from E. coli. In other embodiments, the enzyme having ribose-5-phosphate isomerase activity is encoded by an amino acid sequence having at least 70% sequence identity, at least 80% sequence identity, or at least 90% sequence identity to rpiB from E. coli. In other embodiments, the enzyme having ribose-5-phosphate isomerase activity is rpiB from E. coli. In another embodiment, the one or more nucleic acid molecules encoding enzyme having ribose-5-phosphate isomerase activity comprise an amino acid sequence set forth in SEQ ID NO: 156. In a further embodiment, the one or more nucleic acid molecule encoding the enzyme having ribose-5-phosphate isomerase activity is encoded by a nucleic acid sequence set forth in SEQ ID NO: 155.

[0017] In some embodiments, the recombinant microorganism comprises the expression of at least one enzyme having a transketolase activity, a transaldolase activity, a ribulose-5-phosphate 3-epimerase activity, and a ribose-5-phosphate isomerase activity. In other embodiments, the recombinant microorganism further comprises a deleted or diminished activity in one or more endogenous enzymes selected from glyceraldehyde 3-phosphate dehydrogenase, phosphoglycerate kinase and phosphoglycerate mutase. In some embodiments, the endogenous glyceraldehyde 3-phosphate dehydrogenase enzyme is gapA, the phosphoglycerate kinase is pgk and the phosphoglycerate mutase is gpmA and / or gpmM.

[0018] In some embodiments, the recombinant microorganism comprises the expression of at least one enzyme having fructose-6-phosphate phosphoketolase activity. In some embodiments, an enzyme having fructose-6-phosphate phosphoketolase activity is encoded by an amino acid sequence having at least 70% sequence identity, at least 80% sequence identity, or at least 90% sequence identity to an enzyme having fructose-6-phosphate phosphoketolase activity selected from the group consisting of Bifidobacterium dentium BDP_1006, Bifidobacterium lactis xfp, Lactobacillus paraplantarum xpkA and Bifidobacterium breve xfp. In a preferred embodiment, an enzyme having fructose-6-phosphate phosphoketolase activity is selected from the group consisting of Bifidobacterium dentium BDP_1006, Bifidobacterium lactis xfp, Lactobacillus paraplantarum xpkA and Bifidobacterium breve xfp. In another embodiment, the one or more nucleic acid molecules encoding the enzyme having fructose-6-phosphate phosphoketolase activity comprise an amino acid sequence selected from the group consisting of SEQ ID NOs: 212, 214, 216 and 218. In a further embodiment, the one or more nucleic acid molecule encoding the enzyme having fructose-6-phosphate phosphoketolase activity is encoded by a nucleic acid sequence selected from the group consisting of SEQ ID NOs: 211, 213, 215 and 217.

[0019] In some embodiments, the recombinant microorganism comprises the expression of at least one enzyme having phosphate acetyltransferase activity. In some embodiments, an enzyme having phosphate acetyltransferase activity is encoded by an amino acid sequence having at least 70% sequence identity, at least 80% sequence identity, or at least 90% sequence identity to an enzyme having phosphate acetyltransferase activity selected from E. coli pta and Clostridium acetobutylicum pta. In a preferred embodiment, an enzyme having phosphate acetyltransferase activity is selected from E. coli pta and Clostridium acetobutylicum pta. In another embodiment, the one or more nucleic acid molecules encoding the enzyme having phosphate acetyltransferase activity comprise an amino acid sequence selected from SEQ ID NOs: 220 and 222. In a further embodiment, the one or more nucleic acid molecule encoding the enzyme having phosphate acetyltransferase activity is encoded by a nucleic acid sequence selected from SEQ ID NOs: 219 and 221.

[0020] In some embodiments, the recombinant microorganism comprises the expression of at least one enzyme having a fructose-6-phosphate phosphoketolase activity, a phosphate acetyltransferase activity, a transketolase activity, a transaldolase activity, a ribulose-5-phosphate 3-epimerase activity, and a ribose-5-phosphate isomerase activity. In other embodiments, the recombinant microorganism further comprises a deleted or diminished activity in an endogenous 6-phosphofructokinase enzyme. In some embodiments, the endogenous 6-phosphofructokinase enzyme is pfkA and / or pfkB.

[0021] In another embodiment, the one or more pentose-5-phosphate intermediate produced in the lossless conversion of one or more hexose feedstock can be connected with any one of the known C2 MEG or glycolic acid production pathways by conversion of the one or more pentose-5-phosphate intermediate to one or more pentose and / or pentose-1-phosphate intermediate. In some embodiments, the recombinant microorganism comprises the expression of at least one enzyme having a pentose phosphatase activity, an arabitol phosphate dehydrogenase activity, and / or a phosphopentomutase activity. In some embodiments, the phosphopentomutase is (Pgm3). In some embodiments, the phosphopentosemutase is Pgm3 from Saccharomyces cerevisiae. In some embodiments, the phosphopentosemutase is encoded by an aminoacid sequence having at least 70% sequence identity, at least 80% sequence identity or at least 90% sequence identity to the Pgm3 from Saccharomyces cerevisiae.

[0022] In some embodiments, the recombinant microorganism comprises the expression of at least one enzyme having pentose phosphatase activity. In other embodiments, the at least one enzyme having pentose phosphatase activity is selected from one or more of an enzyme having D-pentose-5-phosphatase activity, an enzyme having D-xylulose-5-phosphatase activity, an enzyme having D-ribose-5-phosphatase activity, and an enzyme having D-ribulose-5-phosphatase activity. In some embodiments, the pentose phosphatase is encoded by an amino acid sequence having at least 70% sequence identity, at least 80% sequence identity, or at least 90% sequence identity to a D-pentose-5-phosphatase selected from the group consisting of E. coli phoA, E. coli yfbT and E. coli yidA. In some embodiments, the enzyme having D-xylulose-5-phosphatase activity is encoded by an amino acid sequence having at least 70% sequence identity, at least 80% sequence identity, or at least 90% sequence identity to Bacillus subtilis araL. In some embodiments, the enzyme having D-ribose-5-phosphatase activity is encoded by an amino acid sequence having at least 70% sequence identity, at least 80% sequence identity, or at least 90% sequence identity to an enzyme having D-ribose-5-phosphatase activity selected from the group consisting of Arabidopsis thaliana SGPP, Pseudomonas fluorescens PFLU_2693, and E. coli ybiV. In some embodiments, the enzyme having D-ribulose-5-phosphatase activity is encoded by an amino acid sequence having at least 70% sequence identity, at least 80% sequence identity, or at least 90% sequence identity to Plasmodium falciparum PF10_0325. In some embodiments, the one or more nucleic acid molecules encoding the enzyme having D-pentose-5-phosphatase activity is selected from the group consisting of SEQ ID NOs: 159, 161, 163, 165, 167, 169, 171 and 173. In another embodiment, the one or more nucleic acid molecules encoding the enzyme having D-pentose-5-phosphatase activity comprise an amino acid sequence selected from the group consisting of SEQ ID NOs: 160, 162, 164, 166, 168, 170, 172 and 174.

[0023] In some embodiments, the recombinant microorganism comprises the expression of at least one enzyme having arabitol phosphate dehydrogenase activity. In some embodiments, the enzyme having arabitol phosphate dehydrogenase activity is selected from one or more of an enzyme having D-arabitol 1-phosphate 4-dehydrogenase activity, an enzyme having D-arabitol 5-phosphate 2-dehydrogenase activity, an enzyme having D-arabitol 1-phosphate 2-dehydrogenase activity and an enzyme having D-arabitol 5-phosphate 4-dehydrogenase activity.

[0024] In some embodiments, an enzyme having D-arabitol 1-phosphate 4-dehydrogenase activity is encoded by an amino acid sequence having at least 70% sequence identity, at least 80% sequence identity, or at least 90% sequence identity to APDH from Enterococcus avium. In a preferred embodiment, an enzyme having D-arabitol 1-phosphate 4-dehydrogenase activity is APDH from Enterococcus avium. In some embodiments, the one or more nucleic acid molecules encoding an enzyme having D-arabitol 1-phosphate 4-dehydrogenase activity is set forth in SEQ ID NO: 175. In another embodiment, the one or more nucleic acid molecules encoding an enzyme having D-arabitol 1-phosphate 4-dehydrogenase activity comprise an amino acid sequence set forth in SEQ ID NO: 176.

[0025] In some embodiments, an enzyme having D-arabitol 5-phosphate 2-dehydrogenase activity is encoded by an amino acid sequence having at least 70% sequence identity, at least 80% sequence identity, or at least 90% sequence identity to APDH from Enterococcus avium. In a preferred embodiment, an enzyme having D-arabitol 5-phosphate 2-dehydrogenase activity is APDH from Enterococcus avium. In some embodiments, the one or more nucleic acid molecules encoding an enzyme having D-arabitol 5-phosphate 2-dehydrogenase activity is set forth in SEQ ID NO: 175. In another embodiment, the one or more nucleic acid molecules encoding an enzyme having D-arabitol 5-phosphate 2-dehydrogenase activity comprise an amino acid sequence set forth in SEQ ID NO: 176.

[0026] In some embodiments, an enzyme having D-arabitol 1-phosphate 2-dehydrogenase activity is encoded by an amino acid sequence having at least 70% sequence identity, at least 80% sequence identity, or at least 90% sequence identity to an enzyme having D-arabitol 1-phosphate 2-dehydrogenase activity selected from the group consisting of Candida albicans ARD1, Candida tropicalis ARD1, Scheffersomyces stipitis ARDH, Bacillus subtilis egsA (araM), Aeropyrum pernix egsA, E. coli gpsA and Saccharomyces cerevisiae GPD1. In a preferred embodiment, an enzyme having D-arabitol 1-phosphate 2-dehydrogenase activity is selected from the group consisting of Candida albicans ARD1, Candida tropicalis ARD1, Scheffersomyces stipitis ARDH, Bacillus subtilis egsA (araM), Aeropyrum pernix egsA, E. coli gpsA and Saccharomyces cerevisiae GPD1. In some embodiments, the one or more nucleic acid molecules encoding an enzyme having D-arabitol 1-phosphate 2-dehydrogenase activity is selected from the group consisting of SEQ ID NOS: 177, 179, 181, 189, 191, 193 and 195. In another embodiment, the one or more nucleic acid molecules encoding an enzyme having D-arabitol 1-phosphate 2-dehydrogenase activity comprise an amino acid sequence selected from the group consisting of SEQ ID NOs: 178, 180, 182, 190, 192, 194 and 196.

[0027] In some embodiments, an enzyme having D-arabitol 5-phosphate 4-dehydrogenase activity is encoded by an amino acid sequence having at least 70% sequence identity, at least 80% sequence identity, or at least 90% sequence identity to an enzyme having D-arabitol 5-phosphate 4-dehydrogenase activity selected from the group consisting of Pseudomonas fluorescens mtID, Klebsiella pneumoniae daID, Ralstonia solanacearum daID, Bacillus subtilis egsA (araM), Aeropyrum pernix egsA, E. coli gpsA and Saccharomyces cerevisiae GPD1. In a preferred embodiment, an enzyme having D-arabitol 5-phosphate 4-dehydrogenase activity is selected from the group consisting of Pseudomonas fluorescens mtID, Klebsiella pneumoniae daID, Ralstonia solanacearum daID, Bacillus subtilis egsA (araM), Aeropyrum pernix egsA, E. coli gpsA and Saccharomyces cerevisiae GPD1. In some embodiments, the one or more nucleic acid molecules encoding an enzyme having D-arabitol 5-phosphate 4-dehydrogenase activity is selected from the group consisting of SEQ ID NOS: 183, 185, 187, 189, 191, 193 and 195. In another embodiment, the one or more nucleic acid molecules encoding an enzyme having D-arabitol 5-phosphate 4-dehydrogenase activity comprise an amino acid sequence selected from the group consisting of SEQ ID NOs: 184, 186, 188, 190, 192, 194 and 196.

[0028] In some embodiments, the recombinant microorganism comprises the expression of at least one enzyme having phosphopentomutase activity. In some embodiments, an enzyme having phosphopentomutase activity is encoded by an amino acid sequence having at least 70% sequence identity, at least 80% sequence identity, or at least 90% sequence identity to an enzyme having phosphopentomutase activity selected from the group consisting of E. coli deoB, E. coli pgm, Bacillus subtilis pgcA, Lactococcus lactis pgmB, E. coli ycjU, Pseudomonas aeruginosa algC, and E. coli cpsG. In a preferred embodiment, an enzyme having phosphopentomutase activity is selected from the group consisting of E. coli deoB, E. coli pgm, Bacillus subtilis pgcA, Lactococcus lactis pgmB, E. coli ycjU, Pseudomonas aeruginosa algC, and E. coli cpsG. In some embodiments, the one or more nucleic acid molecules encoding an enzyme having phosphopentomutase activity is selected from the group consisting of SEQ ID NOs: 197, 199, 201, 203, 205, 207 and 209. In another embodiment, the one or more nucleic acid molecules encoding an enzyme having phosphopentomutase activity comprise an amino acid sequence selected from the group consisting of SEQ ID NOs: 198, 200, 202, 204, 206, 208 and 210.

[0029] In some embodiments of any of the recombinant microorganisms described above, the recombinant microorganism further comprises a diminished activity in one or more endogenous enzymes selected from glucose 6-phosphate-1-dehydrogenase, 6-phosphogluconolactonase, and 6-phosphogluconate dehydrogenase. In further embodiments, the glucose 6-phosphate-1-dehydrogenase is zwf, the 6-phosphogluconolactonase is pgl, and the 6-phosphogluconate dehydrogenase is gnd.

[0030] In some embodiments, the application provides for a recombinant microorganism that co-produces MEG (or glycolic acid) and one or more co-product selected from acetone, isopropanol, propene, isobutene and one or more serine pathway compounds. In some preferred embodiments, the one or more serine pathway compounds is selected from serine, glycine, monoethanolamine (MEA) and ethylenediamine (EDA).

[0031] In some embodiments, the one or more hexose feedstock is selected from glucose or oligomers of glucose thereof. In other embodiments, the oligomers of glucose are selected from fructose, sucrose, starch, cellobiose, maltose, lactose and cellulose.

[0032] In some embodiments, the expression of an enzyme having transketolase activity or an enzyme having fructose-6-phosphate phosphoketolase activity in the recombinant microorganism enables a lossless conversion of one or more hexose feedstock to one or more pentose-5-phosphate intermediate.

[0033] In some embodiments, the recombinant microorganism produces MEG or glycolic acid (GA) through the conversion of glycolaldehyde in a C2 pathway and through the conversion of dihydroxyacetone phosphate (DHAP) or pyruvate in a C3 pathway. In other embodiments, the glycolaldehyde is oxidized to glycolic acid by a glycolaldehyde dehydrogenase.

[0034] In some embodiments, the at least one enzyme for the production of MEG or GA through the conversion of DHAP or pyruvate in a C3 pathway are selected from at least one enzyme having an activity selected from a 3-phosphoglycerate dehydrogenase activity, a phosphoserine aminotransferase activity, a 3-phosphohydroxypyruvate phosphatase activity, a phosphoserine phosphatase activity, a serine transaminase activity, a hydroxypyruvate decarboxylase activity, a 3-phosphohydroxypyruvate reductase activity, a glycolaldehyde reductase activity, a glycolaldehyde dehydrogenase activity, a serine oxidoreductase (deaminating) or serine-pyruvate aminotransferase activity, a serine decarboxylase activity, an ethanolamine aminotransferase or ethanolamine oxidoreductase (deaminating) activity, a glycerate decarboxylase activity, a hydroxypyruvate reductase activity, a 3-phosphoglycerate phosphatase activity, a 2-phosphoglycerate phosphatase activity, a glycerate 3-kinase activity, and a glycerate 2-kinase activity.

[0035] In some embodiments, the recombinant microorganism produces MEG or glycolic acid (GA) through the conversion of glycolaldehyde in a C2 pathway and produces one or more co-product through the conversion of dihydroxyacetone phosphate (DHAP) or pyruvate in a C3 pathway. In other embodiments, the one or more co-product is selected from acetone, isopropanol, propene, isobutene and one or more serine pathway compounds. In some preferred embodiments, the one or more serine pathway compounds is selected from serine, glycine, monoethanolamine (MEA) and ethylenediamine (EDA).

[0036] In some embodiments, the at least one enzyme for the production of one or more co-product through the conversion of DHAP or pyruvate in a C3 pathway are selected from at least one enzyme having an activity selected from a thiolase or acetyl coenzyme A acetyltransferase activity, an acetyl-CoA:acetoacetate transferase or acetate:acetoacetyl-CoA hydrolase activity, and an acetoacetate decarboxylase activity, and the one or more co-product comprises acetone.

[0037] In some embodiments, the at least one enzyme for the production of one or more co-product through the conversion of DHAP or pyruvate in a C3 pathway are selected from at least one enzyme having an activity selected from a thiolase or acetyl coenzyme A acetyltransferase activity, an acetyl-CoA:acetoacetate transferase or acetate:acetoacetyl-CoA hydrolase activity, an acetoacetate decarboxylase activity, and a secondary alcohol dehydrogenase activity, and the one or more co-product comprises isopropanol.

[0038] In some embodiments, the at least one enzyme for the production of one or more co-product through the conversion of DHAP or pyruvate in a C3 pathway are selected from at least one enzyme having an activity selected from a thiolase or acetyl coenzyme A acetyltransferase activity, an acetyl-CoA:acetoacetate transferase or acetate:acetoacetyl-CoA hydrolase activity, an acetoacetate decarboxylase activity, a secondary alcohol dehydrogenase activity, and a dehydratase activity, and the one or more co-product comprises propene.

[0039] In some embodiments, the at least one enzyme for the production of one or more co-product through the conversion of DHAP or pyruvate in a C3 pathway are selected from at least one enzyme having an activity selected from a thiolase or acetyl coenzyme A acetyltransferase activity, an acetyl-CoA:acetoacetate transferase or acetate:acetoacetyl-CoA hydrolase activity, an acetoacetate decarboxylase activity, a 3-hydroxyisovalerate (3HIV) synthase activity, a hydroxymethylglutaryl-CoA synthase activity, a methylglutaconyl-CoA hydratase activity, a methylcrotonyl-CoA carboxylase activity, a methylcrotonyl-CoA hydratase activity, a 3-hydroxyisovaleryl-CoA thioesterase activity, a 3HIV kinase activity, a 3HIV-3-phosphate decarboxylase activity, and a 3HIV decarboxylase activity, and the one or more co-product comprises isobutene.

[0040] In some embodiments, the at least one enzyme for the production of one or more co-product through the conversion of DHAP or pyruvate in a C3 pathway are selected from at least one enzyme having an activity selected from a 3-phosphoglycerate dehydrogenase activity, a phosphoserine aminotransferase activity, a 3-phosphohydroxypyruvate phosphatase activity, a phosphoserine phosphatase activity, a serine oxidoreductase (deaminating) or serine-pyruvate aminotransferase activity, a hydroxypyruvate reductase activity, a 3-phosphoglycerate phosphatase activity, a 2-phosphoglycerate phosphatase activity, a glycerate 3-kinase activity, and a glycerate 2-kinase activity, and wherein the one or more co-product comprises L-serine.

[0041] In some embodiments, the at least one enzyme for the production of one or more co-product through the conversion of DHAP or pyruvate in a C3 pathway are selected from at least one enzyme having an activity selected from a serine hydroxymethyltransferase activity, a transferase activity, a formaldehyde dehydrogenase activity, a formate dehydrogenase activity, an activity associated with glycine cleavage system, a 3-phosphoglycerate dehydrogenase activity, a phosphoserine aminotransferase activity, a 3-phosphohydroxypyruvate phosphatase activity, a phosphoserine phosphatase activity, a serine transaminase activity, a hydroxypyruvate decarboxylase activity, a serine oxidoreductase (deaminating) activity, a serine decarboxylase activity, an ethanolamine aminotransferase or ethanolamine oxidoreductase (deaminating) activity, a hydroxypyruvate reductase activity, a 3-phosphoglycerate phosphatase activity, a 2-phosphoglycerate phosphatase activity, a glycerate 3-kinase activity, a glycerate 2-kinase activity, a glycolaldehyde dehydrogenase activity, a glycolate dehydrogenase activity, an alanine-glyoxylate aminotransferase activity, an alanine transaminase activity, an NAD(P)H dependent glutamate dehydrogenase activity, and wherein the one or more co-product comprises glycine. In another embodiment, the activity associated with glycine cleavage system comprise an enzyme or protein selected from a glycine decarboxylase (P protein), an aminomethyltransferase (T protein), a dihydrolipoamide dehydrogenase (L protein), and an H protein.

[0042] In some embodiments, the at least one enzyme for the production of one or more co-product through the conversion of DHAP or pyruvate in a C3 pathway are selected from at least one enzyme having an activity selected from a 3-phosphoglycerate dehydrogenase activity, a phosphoserine aminotransferase activity, a 3-phosphohydroxypyruvate phosphatase activity, a phosphoserine phosphatase activity, a transaminase activity, a hydroxypyruvate decarboxylase activity, a serine oxidoreductase (deaminating) or serine-pyruvate aminotransferase activity, a serine decarboxylase activity, a hydroxypyruvate reductase activity, a 3-phosphoglycerate phosphatase activity, a 2-phosphoglycerate phosphatase activity, a glycerate 3-kinase activity, a glycerate 2-kinase activity, an acetaldehyde dehydrogenase activity, and an ethanolamine ammonia lyase activity, and the one or more co-product comprises monoethanolamine (MEA).

[0043] In some embodiments, the at least one enzyme for the production of one or more co-product through the conversion of DHAP or pyruvate in a C3 pathway are selected from at least one enzyme having an activity selected from a serine dehydrogenase activity, a 2-aminomalonate semialdehyde decarboxylase activity, an aminoacetaldehyde transaminase activity, a 2-aminomalonate semialdehyde transaminase activity, a 2,3-diaminopropanoate decarboxylase activity, a serine decarboxylase activity, an ethanolamine dehydrogenase activity, a serine hydroxymethyltransferase activity, an aldehyde oxidase activity, an N-acetyl transferase or O-acetyl transferase activity, an N-acetylserine dehydrogenase activity, a transaminase activity, a deacetylase activity, a serine aminase activity, and a 2,3-diaminopropanoate ammonia lyase activity, and the one or more co-product comprises ethylenediamine (EDA).

[0044] In some embodiments, the at least one enzyme for the production of MEG or GA from glycolaldehyde in a C2 pathway are selected from at least one enzyme having an activity selected from a D-tagatose 3-epimerase activity, a D-ribulokinase activity, a D-ribulose-1-phosphate aldolase activity, a D-xylulose 1-kinase activity, a D-xylulose-1-phosphate aldolase activity, a xylose reductase or aldose reductase activity, a xylitol dehydrogenase activity, a xylose isomerase activity, a xylose dehydrogenase activity, a xylonolactonase activity, a xylonate dehydrogenase activity, a 2-keto-3-deoxy-D-pentonate aldolase activity, a glycolaldehyde reductase activity and a glycolaldehyde dehydrogenase activity. In some embodiments, the enzyme having D-xylulose-1-phosphate aldolase activity is aldoB. In some embodiments, the enzyme having D-ribulose-1-phosphate aldolase activity is fucA.

[0045] In some embodiments of any of the recombinant microorganisms described above, the recombinant microorganism further comprises one or more modifications to diminish or delete activity in a glycolaldehyde dehydrogenase, a lactate dehydrogenase, a xylose isomerase, a xylulose kinase or combination thereof.

[0046] In one embodiment, at least a portion of the excess NADH produced in the C3 pathway is used as a source of reducing equivalents in the C2 pathway. In another embodiment, at least a portion of the excess NADH produced in the C3 pathway is used to produce ATP.

[0047] In one embodiment, excess biomass formation is minimized and production of MEG (or glycolic acid) or MEG (or glycolic acid) and one or more co-products is maximized.

[0048] In another aspect, the application provides for a method of producing MEG or glycolic acid (GA) using a recombinant microorganism of any of the above embodiments, wherein the method comprises cultivating the recombinant microorganism in a culture medium containing one or more hexose feedstock providing a carbon source until the MEG or GA is produced. In some embodiments, one or more co-product is co-produced with MEG or GA. In further embodiments, the one or more co-product is selected from acetone, isopropanol, propene, isobutene and one or more serine pathway compound. In yet further embodiments, the one or more serine pathway compound is selected from serine, glycine, monoethanolamine (MEA) and ethylenediamine (EDA).

[0049] In yet another aspect, a method of producing a recombinant microorganism that produces or accumulates MEG or glycolic acid (GA) from one or more exogenous hexose feedstock via one or more pentose-5-phosphate intermediate, comprising: introducing into or expressing in the recombinant microorganism one or more enzyme for the conversion of the one or more hexose feedstock to the one or more pentose-5-phosphate intermediate; introducing into or expressing in the recombinant microorganism one or more enzyme for the conversion of the one or more pentose-5-phosphate intermediate to one or more pentose or pentose-1-phosphate intermediate; introducing into or expressing in the recombinant microorganism one or more C2 pathway comprising one or more enzyme for the production of MEG or GA from glycolaldehyde; and introducing into or expressing in the recombinant microorganism one or more C3 pathway comprising one or more enzyme for the production of MEG or GA derived from DHAP or pyruvate; and culturing the recombinant microorganism in a culture medium containing the one or more hexose feedstock to produce or accumulate MEG or GA, wherein glycolaldehyde and DHAP (or pyruvate) are intermediates produced in the C2 pathway, and wherein MEG or GA are produced in both the C2 and C3 pathways.

[0050] In some embodiments, the application provides for a method of producing a recombinant microorganism that produces or accumulates MEG or glycolic acid (GA) and one or more co-product from one or more exogenous hexose feedstock via one or more pentose-5-phosphate intermediate, comprising: introducing into or expressing in the recombinant microorganism one or more enzyme for the conversion of the one or more hexose feedstock to the one or more pentose-5-phosphate intermediate; introducing into or expressing in the recombinant microorganism one or more enzyme for the conversion of the one or more pentose-5-phosphate intermediate to one or more pentose or pentose-1-phosphate intermediate; introducing into or expressing in the recombinant microorganism one or more C2 pathway comprising one or more enzyme for the production of MEG or GA from glycolaldehyde; and introducing into or expressing in the recombinant microorganism one or more C3 pathway comprising one or more enzyme for the production of one or more co-product derived from DHAP or pyruvate; and culturing the recombinant microorganism in a culture medium containing the one or more hexose feedstock to produce or accumulate MEG or GA and one or more co-product, wherein glycolaldehyde and DHAP (or pyruvate) are intermediates produced in the C2 pathway, and wherein MEG or GA is produced in the one or more C2 pathway and the one or more co-product is produced in the one or more C3 pathway.BRIEF DESCRIPTION OF DRAWINGS

[0051] Illustrative embodiments of the disclosure are illustrated in the drawings, in which:

[0052] FIG. 1 illustrates lossless transformation of glucose to a pentose-phosphate. The symbol means enzymes to be potentially down regulated or inactivated / abolished, ie. respective gene potentially attenuated or deleted

[0053] FIG. 2 illustrates MEG and possible co-production pathways via D-xylulose-1-phosphate.

[0054] FIG. 3 illustrates MEG and possible co-production pathways via D-xylonate.

[0055] FIG. 4 illustrates MEG and possible co-production pathways via D-ribulose-1-phosphate.

[0056] FIG. 5 illustrates a scheme of options for connecting pentose phosphate pathway and MEG production pathways via pentose phosphatases (PP).

[0057] FIG. 6 illustrates a scheme for producing pentose-1-phosphates and derivatives from the pentose phosphate pathway via arabitol phosphate dehydrogenases (APD).

[0058] FIG. 7 illustrates the isomerization of pentose phosphates mediated by arabitol phosphate dehydrogenases (APD).

[0059] FIG. 8 illustrates a scheme for producing pentose-1-phosphates and derivatives from the pentose phosphate pathway via phosphopentomutases (PPM).

[0060] FIG. 9 illustrates lossless transformation of glucose to pentose phosphates and an acetyl-CoA. The symbol means enzymes to be potentially down regulated or inactivated / abolished, ie. respective gene potentially attenuated or deleted.

[0061] FIG. 10 illustrates an overview of the MEG and Ser, Gly, MEA, EDA co-production pathways.

[0062] FIG. 11 illustrates published EDA production pathways. From WO 2014 / 049382. Reaction F: direct L-serine amination via L-serine aminase. Reaction G: direct pyruvate amination via 2,3-diaminopropionate ammonia lyase.

[0063] FIG. 12 illustrates the biosynthesis pathway of xylitol from glucose with the use of phosphatase. The symbol means enzymes to be potentially down regulated or inactivated / abolished, ie. respective gene potentially attenuated or deleted.

[0064] FIG. 13 illustrates the biosynthesis pathway of xylitol from glucose with the use of arabitol-P dehydrogenase (ADP). The symbol means enzymes to be potentially down regulated or inactivated / abolished, ie. respective gene potentially attenuated or deleted.

[0065] FIG. 14 illustrates the biosynthesis pathway of xylitol from glucose with the use of phosphopentomutase (PPM). The symbol means enzymes to be potentially down regulated or inactivated / abolished, ie. respective gene potentially attenuated or deleted.

[0066] FIG. 15 is a scheme for an in vitro phosphoglucomutase assay on its natural substrate, glucose-1P.

[0067] FIG. 16 is a scheme for in vitro conversion of pentose to glycolic acid precursors through key pentose-5P intermediates acted on by phosphoglucomutase enzymes.

[0068] FIG. 17 is a scheme for in vivo screening of key enzyme candidates for facilitating conversion of pentose sugars to glycolic acid.

[0069] FIG. 18 is a scheme for in vitro conversion of pentose to glycolic acid precursors through key pentose-1P intermediates acted on by aldolase enzymes.DETAILED DESCRIPTIONDefinitions

[0070] The following definitions and abbreviations are to be used for the interpretation of the disclosure.

[0071] As used herein and in the appended claims, the singular forms “a,”“an,” and “the” include plural referents unless the context clearly dictates otherwise. Thus, for example, reference to “an enzyme” includes a plurality of such enzymes and reference to “the microorganism” includes reference to one or more microorganisms, and so forth.

[0072] As used herein, the terms “comprises,”“comprising,”“includes,”“including,”“has,”“having, “contains,”“containing,” or any other variation thereof, are intended to cover a non-exclusive inclusion. A composition, mixture, process, method, article, or apparatus that comprises a list of elements is not necessarily limited to only those elements but may include other elements not expressly listed or inherent to such composition, mixture, process, method, article, or apparatus. Further, unless expressly stated to the contrary, “or” refers to an inclusive “or” and not to an exclusive “or.”

[0073] The terms “about” and “around,” as used herein to modify a numerical value, indicate a close range surrounding that explicit value. If “X” were the value, “about X” or “around X” would indicate a value from 0.9X to 1.1X, or, in some embodiments, a value from 0.95X to 1.05X. Any reference to “about X” or “around X” specifically indicates at least the values X, 0.95X, 0.96X, 0.97X, 0.98X, 0.99X, 1.01X, 1.02X, 1.03X, 1.04X, and 1.05X. Thus, “about X” and “around X” are intended to teach and provide written description support for a claim limitation of, e.g., “0.98X.”

[0074] As used herein, the terms “microbial,”“microbial organism,” and “microorganism” include any organism that exists as a microscopic cell that is included within the domains of archaea, bacteria or eukarya, the latter including yeast and filamentous fungi, protozoa, algae, or higher Protista. Therefore, the term is intended to encompass prokaryotic or eukaryotic cells or organisms having a microscopic size and includes bacteria, archaea, and eubacteria of all species as well as eukaryotic microorganisms such as yeast and fungi. Also included are cell cultures of any species that can be cultured for the production of a chemical.

[0075] As described herein, in some embodiments, the recombinant microorganisms are prokaryotic microorganism. In some embodiments, the prokaryotic microorganisms are bacteria. “Bacteria”, or “eubacteria”, refers to a domain of prokaryotic organisms. Bacteria include at least eleven distinct groups as follows: (1) Gram-positive (gram+) bacteria, of which there are two major subdivisions: (1) high G+C group (Actinomycetes, Mycobacteria, Micrococcus, others) (2) low G+C group (Bacillus, Clostridia, Lactobacillus, Staphylococci, Streptococci, Mycoplasmas); (2) Proteobacteria, e.g., Purple photosynthetic+non-photosynthetic Gram-negative bacteria (includes most “common” Gram-negative bacteria); (3) Cyanobacteria, e.g., oxygenic phototrophs; (4) Spirochetes and related species; (5) Planctomyces; (6) Bacteroides, Flavobacteria; (7) Chlamydia; (8) Green sulfur bacteria; (9) Green non-sulfur bacteria (also anaerobic phototrophs); (10) Radioresistant micrococci and relatives; (11) Thermotoga and Thermosipho thermophiles.

[0076] “Gram-negative bacteria” include cocci, nonenteric rods, and enteric rods. The genera of Gram-negative bacteria include, for example, Neisseria, Spirillum, Pasteurella, Brucella, Yersinia, Francisella, Haemophilus, Bordetella, Escherichia, Salmonella, Shigella, Klebsiella, Proteus, Vibrio, Pseudomonas, Bacteroides, Acetobacter, Aerobacter, Agrobacterium, Azotobacter, Spirilla, Serratia, Vibrio, Rhizobium, Chlamydia, Rickettsia, Treponema, and Fusobacterium.

[0077] “Gram positive bacteria” include cocci, nonsporulating rods, and sporulating rods. The genera of gram positive bacteria include, for example, Actinomyces, Bacillus, Clostridium, Corynebacterium, Erysipelothrix, Lactobacillus, Listeria, Mycobacterium, Myxococcus, Nocardia, Staphylococcus, Streptococcus, and Streptomyces.

[0078] The term “recombinant microorganism” and “recombinant host cell” are used interchangeably herein and refer to microorganisms that have been genetically modified to express or to overexpress endogenous enzymes, to express heterologous enzymes, such as those included in a vector, in an integration construct, or which have an alteration in expression of an endogenous gene. By “alteration” it is meant that the expression of the gene, or level of a RNA molecule or equivalent RNA molecules encoding one or more polypeptides or polypeptide subunits, or activity of one or more polypeptides or polypeptide subunits is up regulated or down regulated, such that expression, level, or activity is greater than or less than that observed in the absence of the alteration. For example, the term “alter” can mean “inhibit,” but the use of the word “alter” is not limited to this definition. It is understood that the terms “recombinant microorganism” and “recombinant host cell” refer not only to the particular recombinant microorganism but to the progeny or potential progeny of such a microorganism. Because certain modifications may occur in succeeding generations due to either mutation or environmental influences, such progeny may not, in fact, be identical to the parent cell, but are still included within the scope of the term as used herein.

[0079] The term “expression” with respect to a gene sequence refers to transcription of the gene and, as appropriate, translation of the resulting mRNA transcript to a protein. Thus, as will be clear from the context, expression of a protein results from transcription and translation of the open reading frame sequence. The level of expression of a desired product in a host cell may be determined on the basis of either the amount of corresponding mRNA that is present in the cell, or the amount of the desired product encoded by the selected sequence. For example, mRNA transcribed from a selected sequence can be quantitated by qRT-PCR or by Northern hybridization (see Sambrook et al., Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press (1989)). Protein encoded by a selected sequence can be quantitated by various methods, e.g., by ELISA, by assaying for the biological activity of the protein, or by employing assays that are independent of such activity, such as western blotting or radioimmunoassay, using antibodies that recognize and bind the protein. See Sambrook et al., 1989, supra.

[0080] The term “polynucleotide” is used herein interchangeably with the term “nucleic acid” and refers to an organic polymer composed of two or more monomers including nucleotides, nucleosides or analogs thereof, including but not limited to single stranded or double stranded, sense or antisense deoxyribonucleic acid (DNA) of any length and, where appropriate, single stranded or double stranded, sense or antisense ribonucleic acid (RNA) of any length, including siRNA. The term “nucleotide” refers to any of several compounds that consist of a ribose or deoxyribose sugar joined to a purine or a pyrimidine base and to a phosphate group, and that are the basic structural units of nucleic acids. The term “nucleoside” refers to a compound (as guanosine or adenosine) that consists of a purine or pyrimidine base combined with deoxyribose or ribose and is found especially in nucleic acids. The term “nucleotide analog” or “nucleoside analog” refers, respectively, to a nucleotide or nucleoside in which one or more individual atoms have been replaced with a different atom or with a different functional group. Accordingly, the term polynucleotide includes nucleic acids of any length, DNA, RNA, analogs and fragments thereof. A polynucleotide of three or more nucleotides is also called nucleotidic oligomer or oligonucleotide.

[0081] It is understood that the polynucleotides described herein include “genes” and that the nucleic acid molecules described herein include “vectors” or “plasmids.” Accordingly, the term “gene”, also called a “structural gene” refers to a polynucleotide that codes for a particular sequence of amino acids, which comprise all or part of one or more proteins or enzymes, and may include regulatory (non-transcribed) DNA sequences, such as promoter sequences, which determine for example the conditions under which the gene is expressed. The transcribed region of the gene may include untranslated regions, including introns, 5′-untranslated region (UTR), and 3′-UTR, as well as the coding sequence.

[0082] The term “enzyme” as used herein refers to any substance that catalyzes or promotes one or more chemical or biochemical reactions, which usually includes enzymes totally or partially composed of a polypeptide or polypeptides, but can include enzymes composed of a different molecule including polynucleotides.

[0083] As used herein, the term “non-naturally occurring,” when used in reference to a microorganism organism or enzyme activity of the disclosure, is intended to mean that the microorganism organism or enzyme has at least one genetic alteration not normally found in a naturally occurring strain of the referenced species, including wild-type strains of the referenced species. Genetic alterations include, for example, modifications introducing expressible nucleic acids encoding metabolic polypeptides, other nucleic acid additions, nucleic acid deletions and / or other functional disruption of the microorganism's genetic material. Such modifications include, for example, coding regions and functional fragments thereof, for heterologous, homologous, or both heterologous and homologous polypeptides for the referenced species. Additional modifications include, for example, non-coding regulatory regions in which the modifications alter expression of a gene or operon. Exemplary non-naturally occurring microorganism or enzyme activity includes the hydroxylation activity described above.

[0084] The term “exogenous” as used herein with reference to various molecules, e.g., polynucleotides, polypeptides, enzymes, etc., refers to molecules that are not normally or naturally found in and / or produced by a given yeast, bacterium, organism, microorganism, or cell in nature.

[0085] On the other hand, the term “endogenous” or “native” as used herein with reference to various molecules, e.g., polynucleotides, polypeptides, enzymes, etc., refers to molecules that are normally or naturally found in and / or produced by a given yeast, bacterium, organism, microorganism, or cell in nature.

[0086] The term “heterologous” as used herein in the context of a modified host cell refers to various molecules, e.g., polynucleotides, polypeptides, enzymes, etc., wherein at least one of the following is true: (a) the molecule(s) is / are foreign (“exogenous”) to (i.e., not naturally found in) the host cell; (b) the molecule(s) is / are naturally found in (e.g., is “endogenous to”) a given host microorganism or host cell but is either produced in an unnatural location or in an unnatural amount in the cell; and / or (c) the molecule(s) differ(s) in nucleotide or amino acid sequence from the endogenous nucleotide or amino acid sequence(s) such that the molecule differing in nucleotide or amino acid sequence from the endogenous nucleotide or amino acid as found endogenously is produced in an unnatural (e.g., greater than naturally found) amount in the cell.

[0087] The term “homolog,” as used herein with respect to an original enzyme or gene of a first family or species, refers to distinct enzymes or genes of a second family or species which are determined by functional, structural, or genomic analyses to be an enzyme or gene of the second family or species which corresponds to the original enzyme or gene of the first family or species. Homologs most often have functional, structural, or genomic similarities. Techniques are known by which homologs of an enzyme or gene can readily be cloned using genetic probes and PCR. Identity of cloned sequences as homologs can be confirmed using functional assays and / or by genomic mapping of the genes.

[0088] A protein has “homology” or is “homologous” to a second protein if the amino acid sequence encoded by a gene has a similar amino acid sequence to that of the second gene. Alternatively, a protein has homology to a second protein if the two proteins have “similar” amino acid sequences. Thus, the term “homologous proteins” is intended to mean that the two proteins have similar amino acid sequences. In certain instances, the homology between two proteins is indicative of its shared ancestry, related by evolution. The terms “homologous sequences” or “homologs” are thought, believed, or known to be functionally related. A functional relationship may be indicated in any one of a number of ways, including, but not limited to: (a) degree of sequence identity and / or (b) the same or similar biological function. Preferably, both (a) and (b) are indicated. The degree of sequence identity may vary, but in one embodiment, is at least 50% (when using standard sequence alignment programs known in the art), at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least about 91%, at least about 92%, at least about 93%, at least about 94%, at least about 95%, at least about 96%, at least about 97%, at least about 98%, or at least 98.5%, or at least about 99%, or at least 99.5%, or at least 99.8%, or at least 99.9%. Homology can be determined using software programs readily available in the art, such as those discussed in Current Protocols in Molecular Biology (F. M. Ausubel et al., eds., 1987) Supplement 30, section 7.718, Table 7.71. Some alignment programs are MacVector (Oxford Molecular Ltd, Oxford, U.K.) and ALIGN Plus (Scientific and Educational Software, Pennsylvania). Other non-limiting alignment programs include Sequencher (Gene Codes, Ann Arbor, Michigan), AlignX, and Vector NTI (Invitrogen, Carlsbad, CA). A similar biological function may include, but is not limited to: catalyzing the same or similar enzymatic reaction; having the same or similar selectivity for a substrate or co-factor; having the same or similar stability; having the same or similar tolerance to various fermentation conditions (temperature, pH, etc.); and / or having the same or similar tolerance to various metabolic substrates, products, by-products, intermediates, etc. The degree of similarity in biological function may vary, but in one embodiment, is at least 1%, at least 2%, at least 3%, at least 4%, at least 5%, at least 6%, at least 7%, at least 8%, at least 9%, at least 10%, at least 20%, at least 30%, at least 40%, at least 50%, at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least about 91%, at least about 92%, at least about 93%, at least about 94%, at least about 95%, at least about 96%, at least about 97%, at least about 98%, or at least 98.5%, or at least about 99%, or at least 99.5%, or at least 99.8%, or at least 99.9%, according to one or more assays known to one skilled in the art to determine a given biological function.

[0089] The term “variant” refers to any polypeptide or enzyme described herein. A variant also encompasses one or more components of a multimer, multimers comprising an individual component, multimers comprising multiples of an individual component (e.g., multimers of a reference molecule), a chemical breakdown product, and a biological breakdown product. In particular, non-limiting embodiments, an enzyme may be a “variant” relative to a reference enzyme by virtue of alteration(s) in any part of the polypeptide sequence encoding the reference enzyme. A variant of a reference enzyme can have enzyme activity of at least 10%, at least 30%, at least 50%, at least 80%, at least 90%, at least 100%, at least 105%, at least 110%, at least 120%, at least 130% or more in a standard assay used to measure enzyme activity of a preparation of the reference enzyme. In some embodiments, a variant may also refer to polypeptides having at least 50%, at least 60%, at least 70%, at least 80%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% sequence identity to the full-length, or unprocessed enzymes of the present disclosure. In some embodiments, a variant may also refer to polypeptides having at least 50%, at least 60%, at least 70%, at least 80%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% sequence identity to the mature, or processed enzymes of the present disclosure.

[0090] The term “signal sequence” as used herein refers to an amino acid sequence that targets peptides and polypeptides to cellular locations or to the extracellular environment. Signal sequences are typically at the N-terminal portion of a polypeptide and are typically removed enzymatically. Polypeptides that have their signal sequences are referred to as being full-length and / or unprocessed. Polypeptides that have had their signal sequences removed are referred to as being mature and / or processed.

[0091] The term “yield potential” as used herein refers to a yield of a product from a biosynthetic pathway. In one embodiment, the yield potential may be expressed as a percent by weight of end product per weight of starting compound.

[0092] The term “thermodynamic maximum yield” as used herein refers to the maximum yield of a product obtained from fermentation of a given feedstock, such as glucose, based on the energetic value of the product compared to the feedstock. In a normal fermentation, without use of additional energy sources such as light, hydrogen gas or methane or electricity, for instance, the product cannot contain more energy than the feedstock. The thermodynamic maximum yield signifies a product yield at which all energy and mass from the feedstock is converted to the product. This yield can be calculated and is independent of a specific pathway. If a specific pathway towards a product has a lower yield than the thermodynamic maximum yield, then it loses mass and can most likely be improved upon or substituted with a more efficient pathway towards the product.

[0093] The term “redox balanced” refers to a set of reactions, which taken together produce as much redox cofactors as they consume. Designing metabolic pathways and engineering an organism such that the redox cofactors are balanced or close to being balanced usually results in a more efficient, higher yield production of the desired compounds. Redox reactions always occur together as two half-reactions happening simultaneously, one being an oxidation reaction and the other a reduction reaction. In redox processes, the reductant transfers electrons to the oxidant. Thus, in the reaction, the reductant or reducing agent loses electrons and is oxidized, and the oxidant or oxidizing agent gains electrons and is reduced. In one embodiment, the redox reactions take place in a biological system. Biological energy is frequently stored and released by means of redox reactions. Photosynthesis involves the reduction of carbon dioxide into sugars and the oxidation of water into molecular oxygen. The reverse reaction, respiration, oxidizes sugars to produce carbon dioxide and water. As intermediate steps, the reduced carbon compounds are used to reduce nicotinamide adenine dinucleotide (NAD+), which then contributes to the creation of a proton gradient, which drives the synthesis of adenosine triphosphate (ATP) and is maintained by the reduction of oxygen. The term redox state is often used to describe the balance of GSH / GSSG, NAD+ / NADH and NADP+ / NADPH in a biological system such as a cell or organ. The redox state is reflected in the balance of several sets of metabolites (e.g., lactate and pyruvate, beta-hydroxybutyrate, and acetoacetate), whose interconversion is dependent on these ratios. An abnormal redox state can develop in a variety of deleterious situations, such as hypoxia, shock, and sepsis.

[0094] The terms “C2 pathway”, “C2 branch pathway”, “C2 biochemical pathway” or “C2 stream” as used herein refers to a biochemical pathway wherein MEG can be produced via glycolaldehyde.

[0095] The terms “C3 pathway”, “C3 branch pathway”, “C3 biochemical pathway” or “C3 stream” as used herein refers to a biochemical pathway wherein MEG and / or one or more co-product such as acetone, isopropanol, propene, isobutene and / or serine pathway compounds can be produced via pyruvate, acetyl-CoA or dihydroxyacetonephosphate (DHAP).INTRODUCTION

[0096] This disclosure combines the advantages of xylose degradation biochemistry for high yielding MEG (or glycolic acid) or MEG (or glycolic acid) and co-product formation with the advantages of readily available pure hexose sugar feedstocks. It does so by providing a lossless conversion of the hexose glucose to the intermediate D-xylulose-5-phosphate, and further to the pentoses D-xylulose or D-ribulose, to be used as intermediates for the production of MEG (or glycolic acid) or MEG (or glycolic acid) and a co-product by any one of the previously described D-xylose based methods. Apart from glucose, other hexoses such as fructose or hexose oligosaccharides such as starch or sucrose or cellobiose can be used. In some embodiments, hexoses may be selected from D-allose, D-altrose, D-glucose, D-mannose, D-gulose, D-idose, D-galactose, D-talose, D-tagtose, D-sorbose, D-fructose, D-psicose, and other hexoses known in the art. In some embodiments, pentoses may be selected from D-xylose, D-ribose, D-arabinose, D-lyxose, D-xylulose, D-ribulose, and other pentoses known in the art. In some embodiments, the hexoses and pentoses may be selected from the levorotary or dextrorotary entatiomer of any of the hexoses and pentoses disclosed herein.

[0097] Compared to other glucose based MEG or glycolic acid production methods, the present methods solve the following problems: ATP shortage, if co-production is utilized; large NADH excess; low overall product yield potential.

[0098] Compared to other xylose based MEG or glycolic acid production methods, the present methods solve the following challenges and problems: a process depending on xylose (availability / market limitations, price, purity); glucose induced inhibition of xylose utilization.

[0099] Fermentative MEG production is described in WO2010 / 076324 (or US2011 / 0294178; Metabolic Explorer), which is herein incorporated in its entirety. This application suggested diol production via 2-ketoacid decarboxylation and reduction, including a serine biosynthesis based pathway to the intermediate hydroxypyruvate and further to ethyleneglycol. However, the disclosed pathway has a reduced total yield potential of 0.69 g_MEG / g_glucose, while the thermodynamic maximum yield for a glucose→MEG conversion is 0.82 g / g. This pathway is also not redox balanced and has a high excess of 2 mol NADH per mol of consumed glucose, all of which needs to be re-oxidized for the cell to be viable. In an aerobic fermentation, this NADH can be used to generate ATP, which however would be in high excess (2 NADH→6 ATP), leading to excess biomass formation during the production phase and therefore reduced product formation and yield.

[0100] Thus, the fermentative MEG production pathway disclosed in WO2010 / 076324 has an ATP shortage (−1ATP per MEG), excess NADH (+1 NADH per MEG), low yield potential (ymax=0.69 g_MEG / g_glucose) and is a challenging pathway that has not been demonstrated at high efficiency / productivity.

[0101] The disclosure of WO2011 / 130378A1 (or US2011 / 0312049; Genomatica) proposes an approach similar to WO2010 / 076324 to produce MEG from glucose via hydroxypyruvate, but also mentions pathway variations with alternative, but related key intermediates glycerate or ethanolamine.

[0102] The disclosure of WO2011 / 130378A1 has the same drawbacks as WO2010 / 076324, except for ATP shortage. ATP can be +0 or +1 per MEG, depending on utilized enzymes.

[0103] In the case of glycolic acid, the described pathways from glucose also go through 3-phosphoglycerate and serine pathway reactions, or via the glyoxylate shunt. In both cases, one CO2 is lost per glycolic acid, leading to a maximum yield (0.84 g / g) much lower than the thermodynamic maximum yield potential (1.7 g / g).

[0104] A demonstrated fermentative production of MEG from xylose (WO2013 / 126721), via ribulose-1-phosphate, has a high yield potential (0.82 g_MEG / g_xylose) which equals the thermodynamic maximum yield. It produces MEG via two different pathways which are active in parallel, a 2-carbon stream (via glycolaldehyde) and a 3-carbon stream (via dihydroxyacetonephosphate). The C2 stream is easy to implement, but the C3 stream is difficult to implement at high efficiency via metabolic engineering. The C3 stream utilizes the pathways presented in WO2010 / 076324 or WO2011 / 130378.

[0105] Assuming a typically ATP driven xylose import, the overall process is at least ATP neutral. Thus, some xylose and therefore yield will be lost in order to obtain some surplus ATP required for cell growth and maintenance.

[0106] However, the uptake of xylose is not as efficient and fast as that of glucose, the preferred carbon source of most microorganisms. Also, presence of glucose in the media usually inhibits utilization of other sugars such as xylose. For a more efficient process, the organism's regulation leading to this preferential consumption needs to be disrupted and the strain adapted towards xylose preference or sugar co-consumption.

[0107] The key challenge, however, is obtaining xylose as affordable and clean feedstock. Xylose as pure chemical is expensive and not available in bulk quantities. Xylose in hemicellulose hydrolysates is available in larger quantities and at potentially lower cost than glucose, but is accompanied by many impurities and substances that inhibit fermentations.

[0108] Therefore, the fermentative production of MEG (or glycolic acid) from xylose (WO2013 / 126721) poses a challenge with respect to using xylose as feedstock (availability, price, purity, inhibition of xylose utilization by glucose) and to using a C3 pathway, which has not been demonstrated at high efficiency / productivity. Moreover, there is an ATP shortage, +0ATP (or −1ATP if not using glycerate kinase), which is not sufficient for cell maintenance.

[0109] A further demonstrated fermentative production of MEG from xylose (Alkim et al., Microb Cell Fact (2015) 14:127), via xylulose-1-phosphate, is very similar to the route described by WO2013 / 126721. It has the same high yield potential (0.82 g / g), difficult to implement C3 stream for MEG production via DHAP, ATP shortage and feedstock challenges.

[0110] Another demonstrated fermentative production of MEG from xylose (WO2013 / 119020), via xylonate, shares similarities to the route described by WO2013 / 126721. It produces glycolaldehyde and pyruvate as key intermediates, allowing MEG production from glycolaldehyde with a yield potential of 0.41 g / g. This represents a high relative yield since it is achieved with only half the flux. However, no pathway to convert the remaining pyruvate to MEG is presented in WO2013 / 119020 or elsewhere. Currently, no realistic and efficient pathway is known to convert pyruvate to MEG. While pyruvate as a co-product itself would enable a redox neutral overall process (+0 NADH), it is not an economically interesting product and the process would lack 1 ATP (probably ˜2 ATP more for pyruvate export). Thus, ideally a pyruvate derived, economically interesting co-product at high yield is required that delivers surplus ATP. Therefore, the fermentative production of MEG from xylose (WO2013 / 119020), via xylonate, poses a challenge with respect to using xylose as feedstock (availability, price, purity, inhibition of xylose utilization by glucose), low absolute yield of MEG, ATP shortage (depending on co-product, it could be −1 to −3 ATP with pyruvate), and to requiring a pyruvate derived co-product with high yield potential and surplus ATP.

[0111] U.S. Application No. 62 / 305,814, U.S. Application No. 62 / 430,742 and U.S. Application No. 62 / 406,684, each of which is herein incorporated in its entirety, describe high yielding, easy to implement pathways for the co-production of MEG and compounds such as acetone, isopropanol (IPA), propene or isobutene and offer solutions to most of the challenges described for the above mentioned MEG production methods. They furthermore offer solutions for challenges encountered for previously described IPA or isobutene productions from glucose.

[0112] All currently known MEG (or glycolic acid) production methods using glucose as feedstock have low yield potential. This is an intrinsic drawback of the biochemistry of how glucose is degraded to MEG, with one decarboxylation occurring per produced MEG (or glycolic acid) molecule for all the proposed and known pathways. However, one decarboxylation per MEG is too much to achieve redox-neutral and therefore optimal yield.

[0113] All the presented MEG (or glycolic acid) production methods using xylose as feedstock have high or high relative yield potential, due to utilization of specific, beneficial xylose degradation biochemistry, leading to or close to an ideal 0.5 decarboxylation reactions per MEG molecule. However, all these methods share the challenges of using xylose as a feedstock, such as its market limitations and technical challenges from feedstock impurity.

[0114] The present disclosure combines the advantages of xylose degradation biochemistry for high yielding MEG (or glycolic acid), or optionally, MEG (or glycolic acid) and one or more co-product, formation with the advantages of readily available pure hexose sugar feedstocks. It does so by providing a lossless conversion of the hexose glucose to the intermediate D-xylulose-5-phosphate, and further to the pentoses D-xylulose or D-ribulose, to be used as intermediates for the production of MEG (or glycolic acid), or optionally, MEG (or glycolic acid) and one or more co-product, by any one of the previously described D-xylose based methods. Glycolic acid (GA) can be produced instead of MEG by oxidation of glycolaldehyde. Apart from glucose, other hexoses such as fructose or hexose oligosaccharides such as starch or sucrose can be used.

[0115] Compared to other glucose based MEG (or glycolic acid) production methods, the recombinant microorganisms and methods of the present disclosure solves: the problem of ATP shortage, if co-production is utilized; the problem of large NADH excess; the problem of low overall product yield potential.

[0116] Compared to other xylose based MEG (or glycolic acid) production methods, the recombinant microorganisms and methods of the present disclosure solves the challenges of a process depending on xylose (availability / market limitations, price, purity) and the problem of glucose induced inhibition of xylose utilization.

[0117] The present disclosure relates to the production of MEG, or optionally, MEG and one or more co-product, from a hexose, preferably in E. coli. Alternatively, glycolic acid (GA) can be produced instead of MEG by oxidation of glycolaldehyde.

[0118] If glucose is utilized by glycolysis, the standard degradation pathway of E. coli and most other organisms, it will be degraded via 3-phosphoglycerate, the common key intermediate for all glucose to MEG methods described so far. However, this 3-carbon compound is degraded to one 2-carbon compound (MEG), losing one CO2 per MEG, which is true for all described pathway variations, where NADH is in excess and means significant loss of yield potential (only 0.69 g_MEG per gram of sugar, vs 0.82 g_MEG thermodynamic maximum yield potential).Utilization of a Non-Oxidative Entry into Pentose Phosphate Pathway

[0119] In the present disclosure, glucose flux is funneled into the pentose phosphate pathway instead of the glycolysis pathway (FIG. 1). A transketolase, such as encoded by tktA or tktB from E. coli, is used as a non-oxidative entry into the pentose phosphate pathway to transform the glycolysis intermediates fructose-6-phosphate and glyceraldehyde-3-phosphate into D-xylulose-5-phosphate and D-erythrose-4-phosphate (FIG. 1). This produces the key intermediate D-xylulose-5-phosphate.

[0120] Alternatively, a fructose 6-phosphate phosphoketolase (Fpk) and a phosphate acetyltransferase (PTA) can be used as entry into the pentose phosphate pathway, making one erythrose-4-phosphate and one acetyl-CoA from fructose-6-phosphate (FIG. 9).Utilization of Pentose Phosphate Pathway for Full Conversion into Pentose Intermediates

[0121] For a lossless conversion of all hexose carbons into a pentose intermediate, D-erythrose-4-phosphate needs to be further processed. A transaldolase, such as encoded by talA or talB from E. coli, catalyzes the conversion of D-erythrose-4-phosphate and D-fructose-6-phosphate to generate D-seduheptulose-7-phosphate and D-glyceraldehyde-3-phosphate. These intermediates are further processed by a transketolase, such as encoded by tktA or tktB from E. coli, to generate D-ribose-5-phosphate and D-xylulose-5-phosphate. D-ribose-5-phosphate can be readily converted into D-ribulose-5-phosphate and further to D-xylulose-5-phosphate via ribose-5-phosphate isomerase (such as encoded by rpiA or rpiB in E. coli) and ribulose-5-phosphate 3-epimerase (such as encoded by rpe in E. coli), respectively. Thus, all glucose or fructose can be converted completely into D-xylulose-5-phosphate. The overall stoichiometry is:2.5 glucose+2.5 ATP+0.5 phosphate→2 D-xylulose-5-phosphate+D-ribose-5-phosphate

[0122] The bidirectional isomerase and epimerase reactions can of course also transform the two produced D-xylulose-5-phosphates and one D-ribose-5-phosphate molecule into three D-ribulose-5-phosphates. The overall net transformation depends lastly on which intermediate, D-xylulose-5-phosphate or D-ribulose-5-phosphate, is actually consumed by the following pathway.

[0123] In case of the alternative entry into the pentose phosphate pathway via Fpk (FIG. 9), the stoichiometry is:2 glucose+2 ATP+CoA→2 D-xylulose-5-phosphate+1 acetyl-CoAOptimization of Flux Towards Non-Oxidative Entry into Pentose Phosphate PathwayDeactivation of Oxidative Branch of Pentose Phosphate PathwayThe common pathway in E. coli, the oxidative entry into the pentose phosphate pathway via 6-phospho D-glucono-1,5-lactone and oxidative decarboxylation to D-ribulose-5-phosphate, should not be utilized, since it transforms the hexose glucose into a pentose with loss of one carbon (FIG. 1). It is advantageous to inhibit at least one or more enzymes catalyzing one or more appropriate reactions in the oxidative branch of the pentose phosphate pathway, namely glucose 6-phosphate-1-dehydrogenase, 6-phosphogluconolactonase, and 6-phosphogluconate dehydrogenase, by deleting one or more of the genes responsible For example, in E. coli, the genes are zwf (glucose 6-phosphate-1-dehydrogenase), pgl (6-phosphogluconolactonase), and gnd (6-phosphogluconate dehydrogenase).Downregulation of Glycolysis Downstream Reactions

[0125] The upper part of glycolysis is needed to transform 2.5 glucose or fructose into the key intermediates 2× fructose-6-phosphate and 1× glyceraldehyde-3-phosphate. To reduce or eliminate further flux through the lower part of glycolysis, i.e. the oxidative phosphorylation of glyceraldehyde-3-phosphate to 1,3-bisphospho D-glycerate an its subsequent conversion to 3-phospho-D-glycerate and 2-phospho-D-glycerate, activity of glyceraldehyde 3-phosphate dehydrogenase, phophoglycerate kinase and phosphoglycerate mutase, by gapA, pgk and gpmA / gpmM, respectively, in E. coli can be diminished.

[0126] However, if the alternative entry into the pentose phosphate pathway via fructose 6-phosphate phosphoketolase (Fpk) is utilized, then no glyceraldehyde 3-phosphate is needed and the appropriate 6-phosphofructokinase activity can be diminished or deleted (pfkA and / or pfkB genes in E. coli).Connecting Pentose-Phosphate Intermediates with MEG Production Routes

[0127] To connect the pentose phosphate pathway intermediate D-xylulose-5-phosphate with any one of the known MEG or glycolic acid production pathways, the D-xylulose-5-phosphate intermediate needs to be dephosphorylated by a pentose 5-phosphatase to generate D-xylulose (FIG. 2 and FIG. 5). Similarly, the D-ribulose-5-phosphate intermediate may be connected to any one of the known MEG or glycolic acid production pathways through dephosphorylation by a pentose 5-phosphatase to generate D-ribulose (FIG. 4 and FIG. 5).

[0128] In the case of a xylonate based pathway to MEG, the xylose isomerase function, such as XylA from E. coli, is further required to transform the generated D-xylulose into D-xylose (FIG. 3).Alternatives and Variations in Connecting Pentose-Phosphate Pathway with MEG Production Routes

[0129] In the case of a D-ribulose-1-phosphate based pathway, the D-xylulose-5-phosphate intermediate can be connected to the pentose phosphate pathway as described via D-xylulose formation, following epimerization and phosphorylation (dte and fucK mediated) (FIG. 4). Alternatively, D-ribulose-5-phosphate can be used as an entry point and degraded to D-ribulose by utilizing a D-ribulose 5-phosphatase. This way, the necessary isomerization reaction is performed at the level of RPE rather than DTE (FIG. 4).

[0130] In some embodiments, pentose-5-phosphates can be transformed into pentose-1-phosphates using two arabitol dehydrogenase reactions in a row (FIG. 6). Here, the 2-keto position of D-xylulose-5-phosphate or D-ribulose-5-phosphate is reduced, then the 4-hydroxy position is oxidized to a keto group, turning the pentose-5-phosphates into pentose-1-phosphates (FIG. 7).

[0131] In further embodiments, pentose-5-phosphates can be transformed directly into pentose-1-phosphates through the action of a pentose phosphomutase (also known as phosphopentomutase or PPM). Similar to a phosphoglucomutase or phosphomannomutase, it transfers the phosphate residue from the last to the 1-position of the phospho sugar.Hexose Utilization

[0132] The entry molecules of the pathway in the present disclosure are fructose-6-phosphate and glyceraldehyde-3-phosphate, both of which are obtained from normal glycolytic degradation of glucose or fructose in most organisms. If an organism has the ability to consume starch or sucrose or cellulose, for instance, via expression of a sucrose invertase, it will still generate glucose (and fructose), enabling it to utilize the methods of the present disclosure in the same way and to the same extent, yielding the same benefits.Monoethylene Glycol (MEG)

[0133] Monoethylene glycol (MEG) is an important raw material for industrial applications. A primary use of MEG is in the manufacture of polyethylene terephthalate (PET) resins, films and fibers. In addition, MEG is important in the production of antifreezes, coolants, aircraft anti-icer and deicers and solvents. MEG is also known as ethane-1,2-diol.

[0134] Ethylene glycol is also used as a medium for convective heat transfer in, for example, automobiles and liquid cooled computers.

[0135] Because of its high boiling point and affinity for water, ethylene glycol is a useful desiccant. Ethylene glycol is widely used to inhibit the formation of natural gas clathrates (hydrates) in long multiphase pipelines that convey natural gas from remote gas fields to a gas processing facility. Ethylene glycol can be recovered from the natural gas and reused as an inhibitor after purification treatment that removes water and inorganic salts.

[0136] Minor uses of ethylene glycol include in the manufacture of capacitors, as a chemical intermediate in the manufacture of 1,4-dioxane, and as an additive to prevent corrosion in liquid cooling systems for personal computers. Ethylene glycol is also used in the manufacture of some vaccines; as a minor ingredient in shoe polish, inks and dyes; as a rot and fungal treatment for wood; and as a preservative for biological specimens.Glycolic Acid

[0137] Glycolic acid is used in the textile industry as a dyeing and tanning agent, in food processing as a flavoring agent and as a preservative, and in the pharmaceutical industry as a skin care agent. It is also used in adhesives and plastics. Glycolic acid is often included into emulsion polymers, solvents and additives for ink and paint in order to improve flow properties and impart gloss. It is used in surface treatment products that increase the coefficient of friction on tile flooring.

[0138] Due to its excellent capability to penetrate skin, glycolic acid finds applications in skin care products to improve the skin's appearance and texture. It can be used as a chemical peel performed by a dermatologist in concentrations of 20 to 70% or at-home kits in lower concentrations between 10 and 20%. In addition to concentration, pH also plays a large part in determining the potency of glycolic acid in solution.

[0139] Glycolic acid can be synthesized in various ways. The predominant approach uses a catalyzed reaction of formaldehyde with synthesis gas (carbonylation of formaldehyde), for its low cost. It is also prepared by the reaction of chloroacetic acid with sodium hydroxide followed by re-acidification. Other methods, not noticeably in use, include hydrogenation of oxalic acid, and hydrolysis of the cyanohydrin derived from formaldehyde. Some of today's glycolic acids are formic acid-free. Glycolic acid can be isolated from natural sources, such as sugarcane, sugar beets, pineapple, cantaloupe and unripe grapes.

[0140] Glycolic acid is a useful intermediate for organic synthesis, in a range of reactions including: oxidation-reduction, esterification and long chain polymerization. It is used as a monomer in the preparation of polyglycolic acid and other biocompatible copolymers (e.g. PLGA). Commercially, important derivatives include the methyl (CAS #96-35-5) and ethyl (CAS #623-50-7) esters which are readily distillable. The butyl ester is a component of some varnishes, being desirable because it is nonvolatile and has good dissolving properties.Acetone

[0141] Acetone (also known as propanone) is an organic compound with the formula (CH3)2CO. It is a colorless, volatile, flammable liquid, and is the simplest ketone.

[0142] Acetone is miscible with water and serves as an important solvent, typically for cleaning purposes in the laboratory. Over 6.7 million tonnes are produced worldwide, mainly for use as a solvent and production of methyl methacrylate and bisphenol A. It is a common building block in organic chemistry. Familiar household uses of acetone are as the active ingredient in nail polish remover and as paint thinner.Isopropanol

[0143] Isopropyl alcohol (IUPAC name 2-propanol), also called isopropanol, is a compound with the chemical formula C3H6O or C3H7OH or CH3CHOHCH3. It is a colorless, flammable chemical compound with a strong odor. It is the simplest example of a secondary alcohol, where the alcohol carbon atom is attached to two other carbon atoms sometimes shown as (CH3)2CHOH. It is a structural isomer of propanol. It has a wide variety of industrial and household uses.

[0144] Propene, also known as propylene or methyl ethylene, is an unsaturated organic compound having the chemical formula C3H6. It has one double bond, and is the second simplest member of the alkene class of hydrocarbons.

[0145] Propene is produced from fossil fuels-petroleum, natural gas, and, to a much lesser extent, coal. Propene is a byproduct of oil refining and natural gas processing.Isobutene

[0146] Isobutene (also known as isobutylene or 2-methylpropene) is a hydrocarbon of industrial significance. It is a four-carbon branched alkene (olefin), one of the four isomers of butylene (butene). At standard temperature and pressure it is a colorless flammable gas.

[0147] Isobutene is used as an intermediate in the production of a variety of products. It is reacted with methanol and ethanol in the manufacture of the gasoline oxygenates methyl tert-butyl ether (MTBE) and ethyl tert-butyl ether (ETBE), respectively. Alkylation with butane produces isooctane, another fuel additive. Isobutene is also used in the production of methacrolein. Polymerization of isobutene produces butyl rubber (polyisobutene). Antioxidants such as butylated hydroxytoluene (BHT) and butylated hydroxyanisole (BHA) are produced by Friedel-Crafts alkylation of phenols using isobutene.

[0148] Polymer and chemical grade isobutene is typically obtained by dehydrating tertiary butyl alcohol or catalytic dehydrogenation of isobutane. Gasoline oxygenates MTBE and ETBE are generally produced by reacting methanol or ethanol with isobutene contained in butene streams from olefin steam crackers or refineries. Isobutene is not isolated before the reaction as separating the ethers from the remaining butenes is simpler.Serine Pathway Compounds

[0149] Compounds that may be co-produced with MEG (or glycolic acid) include serine pathway compounds, for example, serine, glycine, monoethanolamine (MEA) and ethylenediamine (EDA).

[0150] Serine is a non-essential amino acid that can be synthesized in the human body. Being highly water soluble, serine finds application as moisturizer in lotions of pharma and cosmetic industry. Further, there is a huge market for serine in the chemical industry because it can be converted into other chemicals such as plastics, detergents, dietary supplements and a variety of other products. In fact, serine has been mentioned as one of the 30 most promising biological substances to replace chemicals from the oil industry.

[0151] The α-decarboxylation of serine yields ethanolamine, an industrial product used as an intermediate in the herbicide, textile, metal, detergent, plastics, and personal care products industries with a production volume running into several hundreds of kilotonnes per annum (Scott, E. et al. (2007) Biomass in the manufacture of industrial products—the use of proteins and amino acids. Appl Microbiol Biotechnol. 75 (4): 751-762).

[0152] Glycine, the simplest amino acid, is valuable for pharmaceutical and industrial applications. It is included as an additive in pet food and animal feed. For humans, glycine is sold as a sweetener / taste enhancer. Certain food supplements and protein drinks contain glycine. Certain drug formulations include glycine to improve gastric absorption of the drug. Glycine serves as a buffering agent in antacids, analgesics, antiperspirants, cosmetics, and toiletries. Many miscellaneous products use glycine or its derivatives, such as the production of rubber sponge products, fertilizers and metal complexants. Glycine is also valuable as an intermediate in the synthesis of a variety of chemical products. It is used in the manufacture of the herbicide glyphosate. Glycine can be converted to oxalic acid, which is used as a bleaching agent in the textile and pulp industries and wastewater treatment. Glycine is also extensively used in laboratory research, for example, in gel electrophoresis.

[0153] Ethylenediamine (EDA) (1,2-diaminoethane, C2H4 (NH2)2) is used in large quantities for production of many industrial chemicals. It forms derivatives with carboxylic acids (including fatty acids), nitriles, alcohols (at elevated temperatures), alkylating agents, carbon disulfide, and aldehydes and ketones. Because of its bifunctional nature, having two amines, it readily forms heterocycles such as imidazolidines. A most prominent derivative of ethylenediamine is the chelating agent EDTA, which is derived from ethylenediamine via a Strecker synthesis involving cyanide and formaldehyde. Hydroxyethylethylenediamine is another commercially significant chelating agent. Numerous bio-active compounds and drugs contain the N—CH2-CH2-N linkage, including some antihistamines. Salts of ethylenebisdithiocarbamate are commercially significant fungicides under the brand names Maneb, Mancozeb, Zineb, and Metiram. Some imidazoline-containing fungicides are derived from ethylenediamine. Ethylenediamine is an ingredient in the common bronchodilator drug aminophylline, where it serves to solubilize the active ingredient theophylline. Ethylenediamine has also been used in dermatologic preparations. When used as a pharmaceutical excipient, after oral administration its bioavailability is about 0.34, due to a substantial first-pass effect. Less than 20% is eliminated by urinal excretion. Ethylenediamine, because it contains two amine groups, is a widely used precursor to various polymers. Condensates derived from formaldehyde are plasticizers. It is widely used in the production of polyurethane fibers. The PAMAM class of dendrimers are derived from ethylenediamine. The bleaching activator tetraacetylethylenediamine is generated from ethylenediamine. The derivative N,N-ethylenebis (stearamide) (EBS) is a commercially significant mold-release agent and a surfactant in gasoline and motor oil.

[0154] Ethylenediamine is also used as: a solvent to solubilize proteins such as albumins and casein; certain electroplating baths; corrosion inhibitor in paints and coolants; chemicals for color photography developing, binders, adhesives, fabric softeners, curing agents for epoxys, and dyes. Ethylenediamine dihydroiodide (EDDI) is added to animal feeds as a source of iodide.Xylitol

[0155] Xylitol is a chemical compound, a sugar alcohol, of considerable value as a sweetener. It is detected by the human palatte as approximately as sweet as sucrose, and it is non-toxic and non-cariogenic.

[0156] One method of producing xylitol utilizes xylan, a hemicellulose, which is extracted from hardwoods and corncobs. Xylans can be hydrolyzed into xylose, which is then catalytically hydrogenated into xylitol. Catalytic routes to xylitol are cost- and energy-intensive due to the use of extensive separation and purification steps involved in the process and have have low overall yield. Another method of producing xylitol includes utilizing fermentative and biocatalytic processes in bacteria, fungi, and / or yeast cells.Enzymes

[0157] Exemplary enzymes that may be used in the MEG (or glycolic acid), or optionally, MEG (or glycolic acid) and one or more co-product, biosynthesis pathways disclosed herein are listed in Table 1.TABLE 1SEQSEQRequiredNatural / GeneIDIDenzyme GeneSourceannotatedIdentifierNOUniprotNODescribed ReactionEC no.activitycandidateOrganismfunction(nt)(nt)ID(AA)Isomerases that may be used in D-xylonate pathways of the present disclosureD-xylose + 1.1.1.307xylose xyl1ScheffersomycesD-xylose GeneID:  82, P3186784NAD(P)H <=>reductasestipitisreductase4839234 83Xylitol + NAD(P)+ D-xylose + 1.1.1.307xylose GRE3Saccharomycesaldose reductaseGeneID:  85, P3871587NAD(P)H <=>reductasecerevisiae856504 86Xylitol + NAD(P)+ Xylitol + NAD+ <=>1.1.1.9xylitolxyl2ScheffersomycesD-xyluloseGeneID:  88, P2214490D-xylulose + NADHdehydrogenasestipitisreductase4852013 89Xylitol + NAD+ <=>1.1.1.9xylitolxdh1TrichodermaXylitolENA Nr.: 91Q876R292D-xylulose + NADHdehydrogenasereeseidehydrogenaseAF428150.1D-xylopyranose <=>5.3.1.5xylose xylAPyromyces sp.xylose isomeraseENA Nr.:  93, Q9P8C995D-xyluloseisomeraseCAB76571.1 94D-xylopyranose <=>5.3.1.5xylose xylAEscherichiaxylose isomeraseGeneID:143P00944144D-xyluloseisomerasecoli948141Glycolaldehyde reductases that may be used in all MEG pathwaysglycolaldehyde + 1.1.1.-glycolaldehydegldAEscherichiaglycerolGeneID: 12P0A9S513NAD(P)H <=>reductasecolidehydrogenase12933659monoethylene glycol + NAD(P)+ glycolaldehyde + 1.1.1.- glycolaldehydeGRE2SaccharomycesmethylglyoxalGeneID: 14Q1206815NAD(P)H <=>reductasecerevisiaereductase854014monoethylene glycol +NAD(P)+ glycolaldehyde + 1.1.1.-glycolaldehydeGRE3Saccharomycesaldose reductaseGeneID: 16P3871517NAD(P)H <=>reductasecerevisiae856504monoethylene glycol + NAD(P)+ glycolaldehyde + 1.1.1.-glycolaldehydeyqhD*EscherichiaAlcoholGeneID:  18, Modified20NAD(P)H <=>reductasecolidehydrogenase947493 19version ofmonoethylene glycol + Q46856;NAD(P)+ G149Eglycolaldehyde + 1.1.1.-glycolaldehydeyqhDEscherichiaAlcoholGeneID:  21, Q4685623NAD(P)H <=>reductasecolidehydrogenase947493 22monoethylene glycol +NAD(P)+ glycolaldehyde + 1.1.1.- glycolaldehydeydjgEscherichiamethylglyoxalGeneID: 24P7725625NAD(P)H <=>reductasecolireductase12930149monoethylene glycol + NAD(P)+ glycolaldehyde + 1.1.1.- glycolaldehydefucOEscherichialactaldehydeGeneID:  26, P0A9S128NAD(P)H <=>reductasecolireductase947273 27monoethylene glycol +NAD(P)+ glycolaldehyde + 1.1.1.- glycolaldehydeyafBEscherichiamethylglyoxal545778205 29P3086330NAD(P)H <=>reductase(dkgB)colireductasemonoethylene glycol +[multifunctional]NAD(P)+ glycolaldehyde + 1.1.1.-glycolaldehydeyqhEEscherichia2,5-diketo-D-GeneID: 31Q4685732NAD(P)H <=>reductase(dkgA)coligluconic acid947495monoethylene glycol + reductase ANAD(P)+ Enzymes that may be used in D-ribulose-1-phosphate pathway to MEGD-xylulose <=> D-5.1.3.- D-ribulose-3-DTEPseudomonasD-tagatose 3-ENA Nr.:  1, O505803ribuloseepimerasecichoriiepimeraseBAA24429.1 2D-xylulose <=> D-5.1.3.-D-ribulose-3-C1KKR1RhodobacterD-tagatose 3-ENA Nr.: 4C1KKR15ribuloseepimerasesphaeroidesepimeraseFJ851309.1D-ribulose + ATP <=>2.7.1.-D-ribulose-1-fucKEscherichiaL-fuculokinaseGeneID:  6, P115538D-ribulose-1-kinasecoli946022  7,phosphate + ADP257D-ribulose-1-phos-4.1.2.-D-ribulose-1-fucAEscherichiaL-fuculoseGeneID:  9, P0AB8711phate <=> glycer- phosphatecoliphosphate 947282 10aldehyde +aldolasealdolasedihydroxyacetone-phosphateEnzymes that may be used in D-xylulose-1-phosphate pathway to MEGD-xylulose + ATP <=>2.7.1.- D-xylulose 1-khk-CHomosapiensketohexo-GenBank:  53,P5005355D-xylulose-1-kinase(cDNA)kinase CCR456801.1  54,phosphate + ADP256D-xylulose-1-4.1.2.- D-xylulose-1-aldoBHomosapiensFructose-CCDS6756.1  56, P0506258phosphate <=> glycer-phosphate(cDNA)bisphosphate 57aldehyde+ dihydroxy-aldolasealdolase BacetonephosphateEnzymes that may be used in D-xylonate pathway to MEGD-xylose + NAD+ <=>1.1.1.175xylosexylBCaulobacterD-xylose 1-GeneID:  59, B8H1Z061D-xylonolactone + dehydro-crescentusdehydrogenase7329904 60NADH, or D-xylose + genaseNAD+ <=>D-xylonate + NADHD-xylose + NADP+ <=>1.1.1.179xylosexdh1,HaloferaxD-xylose 1-GeneID: 62D4GP2963D-xylonolactone +dehydro-HVO_B00volcaniidehydrogenase8919161NADPH, or D-xylose +genase28NADP+ <=> D-xylonate + NADPHD-xylose + NADP+ <=>1.1.1.179xylosexyd1TrichodermaD-xylose 1-ENA Nr.: 64A0A024S65D-xylonolactone +dehydro-reeseidehydrogenaseEF136590.1MV2NADPH, or D-xylose +genaseNADP+ <=> D-xylonate + NADPHD-xylonolactone + 3.1.1.68xylono-xylCCaulobacterXylonolactonaseGeneID: 66A0A0H3C67H2O <=> D-xylonatelactonasecrescentus73299036P8D-xylonate <=> 2-keto-4.2.1.82xylonatexylDCaulobacterxylonateGeneID: 68A0A0H3C693-deoxy-xylonate + H2Odehydratasecrescentusdehydratase73299026H6D-xylonate <=> 2-keto-4.2.1.82xylonateyjhGEscherichiaxylonateGeneID:  70, P39358723-deoxy-xylonate + H2Odehydratasecolidehydratase946829 71D-xylonate <=> 2-keto-4.2.1.82xylonateyagFEscherichiaxylonateGeneID:  73, P77596753-deoxy-xylonate + H2Odehydratasecolidehydratase944928 742-keto-3-deoxy-4.1.2.- 2-keto-3-yjhHEscherichiaUncharacterizedGeneID:  76, P3935978xylonate <=>deoxy-colilyase948825 77glycolaldehyde + D-pentonatepyruvatealdolase2-keto-3-deoxy-4.1.2.-2-keto-3-yagEEscherichiaProbable 2-keto-GeneID: 79, P7568281xylonate <=>deoxy-coli3-deoxy-944925 80glycolaldehyde + D-pentonategalactonatepyruvatealdolasealdolaseEnzymes that may be used in 2-propanol (IPA) pathway via acetone or in acetone pathway to isobutene2 acetyl-Coa →2.3.1.9acetyl thIAClostridiumacetyl coenzyme 3309200  33,P4535935acetoacetyl-CoA + CoAcoenzyme AacetobutylicumA 34acetyl-acetyltransferasetransferase2 acetyl-Coa →2.3.1.9acetyl atoBEscherichiaacetyl coenzyme GeneID: 36P7646137acetoacetyl-CoA + CoAcoenzyme AcoliA946727acetyl-acetyltransferasetransferase2 acetyl-Coa →2.3.1.9acetyl ERG10Saccharomycesacetyl coenzyme 856079 38P4133839acetoacetyl-CoA + CoAcoenzyme AcerevisiaeAacetyl-acetyltransferasetransferaseacetoacetyl-CoA + 2.8.3.8Acetyl-atoAEscherichiaAcetyl-CoA:48994873  41, P7645943acetate → acetoacetate + CoA:aceto-coliacetoacetate- 42acetyl-CoAacetate-CoACoA transferasetransferasesubunitsubunitacetoacetyl-CoA + 2.8.3.8Acetyl-atoDEscherichiaAcetyl-CoA:48994873  44, P7645846acetate → acetoacetate +CoA:aceto-coliacetoacetate- 45acetyl-CoAacetate-CoACoA transferasetransferasesubunitsubunitacetoacetate →4.1.1.4acetoacetateadcClostridiumacetoacetate6466901  47, P2367049acetone + CO2decarboxylaseacetobutylicumdecarboxylase 48acetoacetate →4.1.1.4acetoacetateadcClostridiumacetoacetate149901357  50, A6M02052acetone + CO2decarboxylasebeijerinckiidecarboxylase 51acetone + acetyl-CoA + 2.3.3.-3-hydroxy-Hmgcs1Musmusculushydroxymethyl-CCDS56901.1;104Q3UWQ9105H2O ↔ 3-hydroxy-isovalerateglutaryl-CoA GeneID:isovaleratesynthasesynthase208715acetone + acetyl-CoA + 2.3.3.-3-hydroxy-ERG13Saccharomyceshydroxymethyl-GeneID:106P54839107H2O ↔ 3-hydroxy-isovaleratecerevisiaeglutaryl-CoA 854913isovaleratesynthasesynthaseacetone + acetyl-CoA +2.3.3.-3-hydroxy-PksGLactobacillushydroxymethyl-GeneID:108AEL95_01109H2O ↔ 3-hydroxy-isovaleratecrispatus ST1glutaryl-CoA9107446455isovaleratesynthasesynthase / polyketideintermediatetransferaseacetone + acetyl-CoA +2.3.3.-3-hydroxy-Pnap_0477Polaromonashydroxymethyl-ABM35799.1110A1VJH1111H2O ↔ 3-hydroxy-isovaleratenaph-glutaryl-CoA isovaleratesynthasethalenivoranslyase3-hydroxy-isovalerate + 2.7.1.-hydroxy-TA1305Thermoplasmamevalonate-GeneID:112Q9HIN1113ATP ↔ ADP + isovalerateacidophilumdiphosphate1456782H(+ ) + 3-kinasedecarboxylase / phosphonoxyisovaleratemevalonate-monophosphatedecarboxylase3-hydroxy-isovalerate + 2.7.1.-hydroxy-TA1305*Thermoplasmamevalonate-GeneID:114Modified115ATP ↔ ADP + isovalerate(L200E)acidophilumdiphosphate1456782version ofH(+ ) + 3-kinasedecarboxylase / Q9HIN1;phosphonoxyisovaleratemevalonate-L200Emonophosphatedecarboxylase3-hydroxy-isovalerate + 2.7.1.-hydroxy-PTO1356Picrophilusmevalonate-GeneID:116Q6KZB1117ATP ↔ ADP + isovaleratetorridusdiphosphate2845209H(+ ) + 3-kinasedecarboxylasephosphonoxyisovalerate3-4.1.1.-3-smi_1746Streptococcusmevalonate-Genbank:118D3HAT7119phosphonoxy-phosphonoxy-mitisdiphosphateCBJ22986.1isovalerate →isovaleratedecarboxylaseCO(2) + isobutenedecarboxylase3-4.1.1.-3-mvaDStreptococcusmevalonate-GeneID:120A8AUU9121phosphonoxy-phosphonoxy-gordoniidiphosphate25051665isovalerate →isovaleratedecarboxylaseCO(2) + isobutenedecarboxylase3-4.1.1.-hydroxy-TA1305Thermoplasmamevalonate-GeneID:112Q9HIN1113phosphonoxy-isovalerateacidophilumdiphosphate1456782isovalerate →decarboxylasedecarboxylase3-hydroxy-isovalerate →4.1.1.-hydroxy-PTO1356Picrophilusmevalonate-GeneID:116Q6KZB1117CO(2) + isobuteneisovaleratetorridusdiphosphate2845209decarboxylasedecarboxylase3-hydroxy-isovalerate →4.1.1.- hydroxy-mvaDStreptococcusmevalonate-GeneID:120A8AUU9121CO(2) + isobuteneisovalerategordoniidiphosphate25051665decarboxylasedecarboxylaseHydrolases that may be used in improved acetone pathway to isobuteneAcetoacetyl-CoA + 3.1.2.11acetate:ctfAClostridiumbutyrate-NCBI- 96P3375297H(2)O <=> CoA + acetoaceacetobutylicumacetoacetate GeneID:acetoacetatetyl-CoA CoA-transferase,1116168hydrolasecomplex AAcetoacetyl-CoA + 3.1.2.11acetate:ctfBClostridiumbutyrate-NCBI- 98P2367399H(2)O <=> CoA + acetoaceacetobutylicumacetoacetate GeneID:acetoacetatetyl-CoA CoA-transferase, 1116169hydrolasesubunit BAcetoacetyl-CoA + 3.1.2.11acetate:atoAEscherichiaAcetyl-GeneID:100P76459101H(2)O <=> CoA + acetoacecoliCoA:946719acetoacetatetyl-CoA (strain K12)acetoacetate-hydrolaseCoA transferasesubunitAcetoacetyl-CoA + 3.1.2.11acetate:atoDEscherichiaAcetyl-GeneID:102P76458103H(2)O <=> CoA + acetoacecoliCoA:947525acetoacetatetyl-CoA (strain K12)acetoacetate-hydrolaseCoA transferasesubunitEnzymes that may be used in HMG-CoA pathway to isobuteneacetyl-CoA + H2O + 2.3.3.10HMG-CoAhmgSSaccharomycesHMG-CoA GeneID:122P54839123acetoacetyl-CoA <=>synthasecerevisiaesynthase854913(S)-3-hydroxy-3-methylglutaryl-CoA + CoA(S)-3-hydroxy-3-4.2.1.18methyl-liuCPseudomonasmethyl-GeneID:124Q88FM3125methylglutaryl-CoA <=>glutaconyl-putidaglutaconyl-1041856trans-3-CoA hydrataseCoA hydratasemethylglutaconyl-CoA+ H(2)OADP + phosphate + 3-6.4.1.4.methyl-liuBPseudomonasmethylcrotonyl-GeneID:126091297127methylglutaconyl- crotonyl-CoA aeruginosaCoA carboxylase 878244CoA <=>ATP + 3-carboxylasesubunit betamethylcrotonoyl-CoA + HCO(3)(-)ADP + phosphate + 3-6.4.1.4.methyl-liuDPseudomonasmethylcrotonyl-GeneID:128091299129methylglutaconyl- crotonyl-CoA aeruginosaCoA carboxylase 879012CoA <=>ATP + 3-carboxylasesubunit alphamethylcrotonoyl-CoA + HCO(3)(-)trans-2(or 3)-enoyl-4.2.1.17methyl-fadAE.colifatty acid GeneID:130P21151131CoA + H(2)O <=> (3S)-crotonyl-CoAoxidation9483243-hydroxyacyl-CoAhydratasecomplex, 3-ketoacyl-CoAthiolasetrans-2(or 3)-enoyl- 4.2.1.17methyl-fadBE.colifatty acid GeneID:132P21177133CoA + H(2)O <=> (3S)-crotonyl-CoA oxidation9483363-hydroxyacyl-CoAhydratasecomplex, enoyl-CoA hydratase3-hydroxy-isovaleryl-3.1.2.-3-hydroxy-tesBE.coliacyl-CoAGeneID:134POAGG2135CoA + H2O <=> 3-isovaleryl-CoAthioesterase945074hydroxy-isovalerate +thioesteraseCoAEnzymes that may be used in 2-propanol (IPA) pathway via acetoneacetone + NAD(P)H →1.1.1.2secondaryadhClostridiumsecondary 60592972 136,P259841382-propanol + NAD(P)+alcoholbeijerinckiialcohol137dehydrogenasedehydrogenaseacetone + NAD(P)H →1.1.1.2secondaryadhClostridiumalcohol308066805139C6PZV51402-propanol + NAD(P)+ alcoholcarboxidivoransdehydrogenasedehydrogenaseADH + NADP+ ↔1.6.1.1.Soluble pyri-udhAEscherichiaSoluble pyridineGeneID:141P27306142NAD+ + NADPHdine nucleotide colinucleotide trans-948461trans-hydrogenasehydrogenaseEnzymes that may be used in hexose to pentose-5-phosphate pathwaysATP + D-xylulose = 2.7.1.17Xylulose xylBE.coliXylulose kinaseGeneID:145P09099146ADP + D-xylulose 5-5-kinase948133phosphateD-erythrose 4-2.2.1.1TransketolasetktAE.coliTransketolaseGeneID:147P27302148phosphate + D-xylulose9474205-phosphate ↔β-D-fructofuranose 6-phosphate + D-glyceraldehyde 3-phosphateD-sedoheptulose 7-2.2.1.1TransketolasetktAE.coliTransketolaseGeneID:147P27302148phosphate + D-947420glyceraldehyde 3-phosphate ↔ D-ribose5-phosphate + D-xylulose 5-phosphateD-erythrose 4-2.2.1.1TransketolasetktBE.coliTransketolaseGeneID:149P33570150phosphate + D-xylulose9458655-phosphate ↔β-D-fructofuranose 6-phosphate + D-glyceraldehyde 3-phosphateD-sedoheptulose7-2.2.1.1TransketolasetktBE.coliTransketolaseGeneID:149P33570150phosphate + D-945865glyceraldehyde 3-phosphate ↔ D-ribose5-phosphate + D-xylulose 5-phosphateD-sedoheptulose 7-2.2.1.2TransaldolasetalAE.coliTransaldolaseGeneID:151P0A867152phosphate + D-947006glyceraldehyde 3-phosphate ↔β-D-fructofuranose 6-phosphate + D-erythrose 4-phosphateD-sedoheptulose 7-2.2.1.2TransaldolasetalBE.coliTransaldolaseGeneID:153P0A870154phosphate + D-944748glyceraldehyde 3-phosphate ↔β-D-fructofuranose 6-phosphate + D-erythrose 4-phosphateD-ribose 5-phosphate ↔5.3.1.6Ribose-5-rpiAE.coliRibose-5-GeneID:155P0A7Z0156D-ribulose 5-phosphatephosphate947407phosphateisomeraseisomeraseD-ribose 5-phosphate ↔5.3.1.6Ribose-5-rpiBE.coliRibose-5-GeneID:254P37351253D-ribulose 5-phosphatephosphate948602phosphateisomeraseisomeraseD-ribulose 5-phos-5.1.3.1Ribulose-5-rpeE.coliRibulose-5-GeneID:157P0AG07158phate ↔ D-xylulose phosphate 3-phosphate 3-9478965-phosphateepimeraseepimeraseD-pentose 5-phosphate + 3.1.3.1D-pentose-5-phoAE.colialkalineGeneID:159P00634160H2O → D-pentose + phosphatase phosphatase945041phosphate(PP)D-ribose 5-phosphate + 3.1.3.23D-ribose-5-SGPPArabidopsisHaloacidGeneID:161Q9ZVJ5162H2O → D-ribose + phosphatase thalianadehalogenase-818456phosphate(PP)like hydrolaseD-xylulose 5-phos-3.1.3.23D-xylulose-5-araLBacillussugar GeneID:163P94526164phate + H2O → D- phosphatase subtilisphosphatase937431xylulose + phosphate(PP)D-ribose 5-phosphate + 3.1.3.23D-ribose-5-PFLU_2693PseudomonashaloacidGeneID:165C3K9U8166H2O → D-ribose + phosphatase fluorescensdehalogenase-7821858phosphate(PP)likee nzymeD-pentose 5-phosphate +3.1.3.23D-pentose-5-yfbTE.colisugar GeneID:167P77625168H2O → D-pentose +phosphatase phosphatase946777phosphate(PP)D-ribose 5-phosphate + 3.1.3.23D-ribose-5-ybiVE.colisugar GeneID:169P75792170H2O → D-ribose + phosphatase phosphatase945432phosphate(PP)D-pentose 5-phos-3.1.3.23D-pentose-5-yidAE.colisugar GeneID:171P0A8Y5172phate + H2O → D- phosphatase phosphatase948204pentose + phosphate(PP)D-ribulose 5-phos-3.1.3.23D-ribulose-5-PF10_0325PlasmodiumHaloacidGeneID:173Q8IJ74174phate + H2O → D-phosphatase falciparumdehalogenase-810482ribulose + phosphate(PP)like hydrolaseD-arabitol 1-phos-1.1.1.301D-arabitol 1-APDHEnterococcusD-arabitol-GenBank:175Q8KQL2176phate + NAD+ ↔phosphate 4-aviumphosphateAY078980.1D-xylulose 5-phos-dehydrogenasedehydrogenasephate + NADH + (APD)H+ D-arabitol 5-phos-1.1.1.- D-arabitol 5-APDHEnterococcusD-arabitol-GenBank:175Q8KQL2176phate + NAD+ ↔phosphate 2-aviumphosphateAY078980.1D-ribulose 5-phos-dehydrogenasedehydrogenasephate + NADH + (APD)H+D-arabitol 1-phos-1.1.1.-D-arabitol 1-ARD1CandidaD-arabitol 2-EMBL177P43066178phate + NAD+ ↔phosphate 2-albicansdehydrogenaseTranslation:D-ribulose 1-phos-dehydrogenase(strain AAC37430.1phate + NADH + (APD)WO-1)H+ D-arabitol 1-phos-1.1.1.- D-arabitol 1-ARD1CandidaD-arabitol 2-EMBL179P50166180phate + NAD+ ↔phosphate 2-tropicalisdehydrogenaseTranslation:D-ribulose 1-phos-dehydrogenaseAAA66355.1phate+ NADH + (APD)H+ D-arabitol 1-phos-1.1.1.-D-arabitol 1-ARDHScheffersomycesD-arabitol 2-EMBL181P50167182phate + NAD+ ↔ D-phosphate 2-stipitis (strain dehydrogenaseTranslation:ribulose 1-phos-dehydrogenaseATCC 58785)CAA86939.1phate + NADH + (APD)H+D-arabitol 5-phosphate1.1.1.-D-arabitol 5-mtIDPseudomonasD-arabitol 4-GenBank:183GenBank:184+ NAD+ ↔ D-xylulosephosphate 4-fluorescensdehydrogenaseAF007800.1AAC04472.11-phosphate + NADHdehydrogenase+ H+ (APD)D-arabitol 5-phosphate1.1.1.-D-arabitol 5-dalDKlebsiellaD-arabitol 4-NCBI:185O52720186+ NAD+ ↔ D-xylulosephosphate 4-pneumoniaedehydrogenaseNZ_FLCX0101-phosphate + NADHdehydrogenase00003.1+ H+ (APD)D-arabitol 5-phosphate1.1.1.-D-arabitol 5-dalDRalstoniaD-arabitol 4-GeneID:187P58708188+ NAD+ ↔ D-xylulosephosphate 4-solanacearumdehydrogenase12209711-phosphate + NADHdehydrogenase(strain+ H+ (APD)GMI1000)D-arabitol 5-phosphate1.1.1.-D-arabitol 5-egsABacillusGlycerol-1-GeneID:189P94527190+ NAD+ ↔ D-xylulosephosphate 4-(araM)subtilisphosphate9380111-phosphate + NADHdehydrogenasedehydrogenase+ H+ (APD)D-arabitol 1-phosphate +1.1.1.- D-arabitol 1-egsABacillusGlycerol-1-GeneID:189P94527190NAD+ ↔ D-ribulosephosphate 2-(araM)subtilisphosphate9380111-phosphate + NADHdehydrogenasedehydrogenase+ H+ (APD)D-arabitol 5-phosphate + 1.1.1.- D-arabitol 5-egsAAeropyrumGlycerol-1-EMBL:191Q9YER2192NAD+ ↔ D-xylulosephosphate 4-pernix (strainphosphateBAA79484.31-phosphate + NADH + dehydrogenaseATCC dehydrogenaseH+ (APD)700893)D-arabitol 1-phosphate +1.1.1.- D-arabitol 1-egsAAeropyrumGlycerol-1-EMBL:191Q9YER2192NAD+ ↔ D-ribulosephosphate 2-pernix (strainphosphateBAA79484.31-phosphate + NADH +dehydrogenaseATCC dehydrogenaseH+ (APD)700893)D-arabitol 5-phosphate + 1.1.1.-D-arabitol 5-gpsAE.coliglycerol-3-GeneID:193P0A6S7194NAD+ ↔ D-xylulosephosphate 4-phosphate9481251-phosphate + NADH +dehydrogenasedehydrogenaseH+ (APD)D-arabitol 1-phosphate +1.1.1.- D-arabitol 1-gpsAE.coliglycerol-3-GeneID:193P0A6S7194NAD+ ↔ D-ribulosephosphate 2-phosphate9481251-phosphate + NADH +dehydrogenasedehydrogenaseH+ (APD)D-arabitol 5-phosphate + 1.1.1.- D-arabitol 5-GPD1Saccharomycesglycerol-3-GeneID:195Q00055196NAD+ ↔ D-xylulosephosphate 4-cerevisiaephosphate8515391-phosphate + NADH + dehydrogenasedehydrogenaseH+ (APD)D-arabitol 1-phosphate +1.1.1.-D-arabitol 1-GPD1Saccharomycesglycerol-3-GeneID:195Q00055196NAD+ ↔ D-ribulosephosphate 2-cerevisiaephosphate8515391-phosphate + NADH +dehydrogenasedehydrogenaseH+ (APD)D-xylu lose 5-phos-5.4.2.- phospho-deoBE.coliphospho-GeneID:197P0A6K6198phate ↔ D-xylulose 1-pentomutase pentomutase948910phosphate(PPM)D-ribulose 5-phos-5.4.2.- phospho-deoBE.coliphospho-GeneID:197P0A6K6198phate ↔ D-ribulose 1-pentomutase pentomutase948910phosphate(PPM)D-xylulose 5-phos-5.4.2.- phospho-pgmE.colialpha-GeneID:199P36938200phate ↔ D-xylulose 1-pentomutase phospho-945271phosphate(PPM)glucomutaseD-ribulose 5-phos-5.4.2.- phospho-pgmE.colialpha-GeneID:199P36938200phate ↔ D-ribulose 1-pentomutase phospho-945271phosphate(PPM)glucomutaseD-xylulose 5-phos-5.4.2.-phospho-pgcABacillussubtilisalpha-GeneID:201P18159202phate ↔ D-xylulose pentomutase phosphogluco-9362471-phosphate(PPM)mutaseD-ribulose 5-phos-5.4.2.- phospho-pgcABacillussubtilisalpha-GeneID:201P18159202phate ↔ D-ribulose pentomutase phosphogluco-9362471-phosphate(PPM)mutaseD-xylulose 5-phos-5.4.2.-phospho-pgmBLactococcusbeta-GeneID:203P71447204phate ↔ D-xylulose pentomutase lactisphospho-11140411-phosphate(PPM)glucomutasD-ribulose 5-phos-5.4.2.-phospho-pgmBLactococcusbeta-GeneID:203P71447204phate ↔ D-ribulose pentomutase lactisphospho-11140411-phosphate(PPM)glucomutasD-xylulose 5-phos-5.4.2.-phospho-ycjUE.colibeta-GeneID:205P77366206phate ↔ D-xylulose pentomutase phospho-9458911-phosphate(PPM)glucomutasD-ribulose 5-phos-5.4.2.- phospho-ycjUE.colibeta-GeneID:205P77366206phate ↔ D-ribulose pentomutase phospho-9458911-phosphate(PPM)glucomutasD-ribulose 5-phos-5.4.2.7phospho-PGM3Saccharomycesphosphoribo-GenBank:255Q03262258phate ↔ D-ribulose pentomutase (PRM15)cerevisiaemutaseNM_0011821-phosphate(PPM)785.1Gene ID:855321D-xylulose 5-phos-5.4.2.- phospho-algCPseudomonasphospho-GenBank:207P26276208phate ↔ D-xylulose pentomutase aeruginosamannoseM60873.11-phosphate(PPM)mutaseD-ribulose 5-phos-5.4.2.- phospho-algCPseudomonasphospho-GenBank:207P26276208phate ↔ D-ribulose pentomutase aeruginosamannoseM60873.11-phosphate(PPM)mutaseD-xylulose 5-phos-5.4.2.- phospho-cpsGE.coliphospho-GeneID:209P24175210phate ↔ D-xylulose pentomutase mannose9465741-phosphate(PPM)mutaseD-ribulose 5-phos-5.4.2.-phospho-cpsGE.coliphospho-GeneID:209P24175210phate ↔ D-ribulose pentomutase mannose9465741-phosphate(PPM)mutaseD-fructose 6-phos-4.1.2.22fructose 6-BDP_1006Bifidobacteriumfructose 6-EMBL:211D2QA13212phate + phos-phosphatedentiumphosphateADB09649.1phate ↔ acetylphos-phospho-phospho-phate + D-erythrose ketolaseketolase4-phosphate + H2O(Fpk)D-fructose 6-phos-4.1.2.22fructose 6-xfpBifidobacteriumXylulose-5-GeneID:213Q9AEM9214phate + phosphate ↔phosphatelactisphosphate / 29696432acetyl phosphate + D-phospho-fructose-erythrose 4-phos-ketolase6-phosphatephate + H2O(Fpk)phosphoketolaseD-fructose 6-phos-4.1.2.22fructose 6-xpkALactobacillusphosphoketolaseEMBL:215Q6UPD8216phate + phosphate ↔phosphateparaplantarumAAQ64626.2acetyl phosphate + D-phospho-erythrose 4-phos-ketolasephate + H2O(Fpk)D-fructose 6-phos-4.1.2.22fructose 6-xfpBifidobacteriumphosphoketolaseEMBL:217D6PAH1218phate + phosphate ↔phosphatebreveADF97524.1acetyl phosphate + D-phospho-erythrose 4-phos-ketolasephate + H2O(Fpk)Acetyl-CoA + 2.3.1.8PhosphateptaE.coliPhosphateGeneID:219P0A9M8220phosphate ↔ CoA + acetyl-acetyltransferase946778acetyl phosphate.transferaseAcetyl-CoA + 2.3.1.8PhosphateptaClostridiumPhosphateGeneID:221P71103222phosphate ↔ CoA + acetyl-acetobutylicumacetyltransferase1117925acetyl phosphate.transferasehydroxypyruvate + 4.1.1.-Hydroxy-kivdLactococcusa-ketoisovalerateGenBank:223Q684J7224H ↔ CO2 + pyruvatelactisdecarboxylaseAJ746364.1glycolaldehydedecarboxylasehydroxypyruvate + 4.1.1.- Hydroxy-sucAE.coli2-oxoglutarateGeneID:225P0AFG3226H ↔ CO2 + pyruvatedecarboxylase945303glycolaldehydedecarboxylase3-phospho-D-glycerate +1.1.1.95D-3-serAE.coliD-3-GeneID:227P0A9T0228NAD+ ↔ 3-phospho-phospho-phosphoglycerate945258hydroxypyruvate + glyceratedehydrogenaseNADH + H+ dehydrogenase3-phospho-L-serine + 2.6.1.52PhosphoserineserCE.coliPhosphoserineGeneID:229P237212302-oxoglutarate ↔ L-amino-aminotransferase945527glutamate + 3-transferasephospho-hydroxypyruvate3-phospho-—3-phospho-yeaBE. coliputative CoAGeneID:231P43337232hydroxypyruvate + hydroxy(nudL)pyrophos946330H2O → hydroxy-pyruvatephohydrolasepyruvate + phosphatephosphatase3-phospho-L-serine + 3.1.3.3PhosphoserineserBE. coliPhosphoserineGeneID:233P0AGB0234H2O → L-serine +phosphatasephosphatase948913phosphateL-serine + H+ →4.1.1.65serineAtSDCArabidopsisserineGeneID:235Q9MA74236ethanolamine + CO2decarboxylase(AT1G437thalianadecarboxylase84095810)ethanolamine + 1.4.3.8EthanolaminetynAE.coliamine oxidaseGeneID:237P46883238oxygen + H2O →oxidase945939ammonium + hydrogen peroxide +glycolaldehydeethanolamine + 2-2.6.1.-EthanolaminealaAE.coliglutamate-GeneID:239P0A959240oxoglutarate →amino-pyruvate amino-946772glycolaldehyde + L-transferasetransferaseglutamateD-glycerate + NAD1.1.1.- Hydroxy-ghrBE.coliglyoxylate GeneID:241P37666242(P)+ ↔ hydroxy-pyruvatereductase948074pyruvate + NAD(P)H +reductaseH+pyruvate + L-serine ↔2.6.1.51serine-AGXT1Homoserine-GeneID:243P21549244L-alanine + pyruvatesapienspyruvate189,hydroxypyruvateamino-amino-CCDS2543.1transferasetransferase3-phospho-D-glycer-3.1.3.383-phospho-phoAE.coliphospho-GeneID:245P00634246ate + H2O →glycerateglycerate945041D-glycerate +phosphatephosphatasephosphatase2-phospho-D-glycer3.1.3.202-phoAE. coliphospho-GeneID:245P00634246ate + H2O → D- phospho-glycerate945041glycerate + phosphateglycerate phosphatasephosphataseD-glycerate + ATP ↔2.7.1.31Glycerate 3-GLYKArabidopsisGlycerate GeneID:247Q944I42483-phospho-D-glycer-kinasethaliana3-kinase844378,ate + ADP + H+ mRNANM_179581.2D-glycerate + ATP ↔2.7.1.165Glycerate 2-glxKE.coliGlycerate GeneID:249P773642502-phospho-D-glycer-kinase2-kinase945129ate +ADP + H+ D-glycerate + ATP ↔2.7.1.165Glycerate 2-garKE.coliGlycerate GeneID:251P235242522-phospho-D-glycer-kinase2-kinase947632ate +ADP + H+ D-tagatose 3-epimerase (EC 5.1.3.31)

[0158] The present disclosure describes enzymes that can catalyze the epimerization of various ketoses at the C-3 position, interconverting D-fructose and D-psicose, D-tagatose and D-sorbose, D-ribulose and D-xylulose, and L-ribulose and L-xylulose. The specificity depends on the species. The enzymes from Pseudomonas cichorii and Rhodobacter sphaeroides require Mn2+. In one embodiment, the enzyme is D-tagatose 3-epimerase (dte). In another embodiment, the D-tagatose 3-epimerase catalyzes the conversion of D-xylulose to D-ribulose.

[0159] In one embodiment, the D-tagatose 3-epimerase is encoded by one or more nucleic acid molecules obtained from a microorganism selected from the group consisting of Pseudomonas sp., Mesorhizobium sp. and Rhodobacter sp. In some embodiments, the D-tagatose 3-epimerase is encoded by one or more nucleic acid molecules obtained from a microorganism selected from the group consisting of Pseudomonas cichorii, Pseudomonas sp. ST-24, Mesorhizobium loti and Rhodobacter sphaeroides. In some embodiments, the one or more nucleic acid molecules is dte and / or FJ851309.1, or homolog thereof. In a further embodiment, the D-tagatose 3-epimerase comprises an amino acid sequence selected from the group consisting of SEQ ID NOs: 3 and 5. In yet a further embodiment, the D-tagatose 3-epimerase is encoded by a nucleic acid sequence selected from the group consisting of SEQ ID NOs: 1, 2 and 4.

[0160] D-tagatose 3-epimerase may also be known as L-ribulose 3-epimerase or ketose 3-epimerase.D-ribulokinase (EC 2.7.1.16)

[0161] The present disclosure describes enzymes that can catalyze the following reactions:L-fuculose+ATP→L-fuculose 1-phosphate+ADP+H+D-ribulose+ATP→D-ribulose 1-phosphate+ADP+H+D-ribulokinase may also be known as L-fuculokinase, fuculokinase, ATP: L-fuculose 1-phosphotransferase or L-fuculose kinase.

[0163] Thus, in some embodiments, the disclosure provides for an enzyme that plays roles in the fucose degradation pathway, the super pathway of fucose and rhamnose degradation and / or the D-arabinose degradation I pathway.

[0164] In some embodiments, the enzyme can function as both an L-fucolokinase and a D-ribulokinase, the second enzyme of the L-fucose and D-arabinose degradation pathways, respectively.

[0165] In particular embodiments, the enzyme converts D-ribulose to D-ribulose-1-phosphate. In one embodiment, the D-ribulokinase is encoded by one or more nucleic acid molecules obtained from E. coli. In some embodiments, the one or more nucleic acid molecules is fucK, or homolog thereof. In a further embodiment, the D-ribulokinase comprises an amino acid sequence set forth in SEQ ID NO: 8. In yet a further embodiment, the D-ribulokinase is encoded by a nucleic acid sequence selected from the group consisting of SEQ ID NOs: 6 and 7.D-ribulose-1-phosphate Aldolase (EC 4.1.2.17)

[0166] The present disclosure describes enzymes that can catalyze the following reversible reactions:L-fuculose 1-phosphate⇄(S)-lactaldehyde+dihydroxy acetone phosphate (DHAP)D-ribulose 1-phosphate⇄glycolaldehyde+dihydroxy acetone phosphate (DHAP)D-ribulose-1-phosphate aldolase may also be known as L-fuculose-phosphate aldolase, L-fuculose 1-phosphate aldolase or L-fuculose-1-phosphate(S)-lactaldehyde-lyase.

[0168] Thus, in some embodiments, the disclosure provides for an enzyme that plays roles in the fucose degradation pathway, the super pathway of fucose and rhamnose degradation and / or the D-arabinose degradation I pathway. In one embodiment, the enzyme may use Zn2+ as a cofactor. In another embodiment, an inhibitor of this enzyme may be phosphoglycolohydroxamate.

[0169] In some embodiments, the enzyme can function as both an L-fuculose-phosphate aldolase and a D-ribulose-phosphate aldolase, the third enzyme of the L-fucose and D-arabinose degradation pathways, respectively.

[0170] The substrate specificity of the enzyme has been tested with a partially purified preparation from an E. coli strain.

[0171] Crystal structures of the enzyme and a number of point mutants have been solved. The combination of structural data and enzymatic activity of mutants allowed modelling and refinement of the catalytic mechanism of the enzyme. The enantiomeric selectivity of the enzyme has been studied.

[0172] In particular embodiments, the enzyme converts D-ribulose-1-phosphate to glycolaldehyde and DHAP. In one embodiment, the D-ribulose-1-phosphate aldolase is encoded by one or more nucleic acid molecules obtained from E. coli. In some embodiments, the one or more nucleic acid molecules is fucA, or homolog thereof. In a further embodiment, the D-ribulose-1-phosphate aldolase comprises an amino acid sequence set forth in SEQ ID NO: 11. In yet a further embodiment, the D-ribulose-1-phosphate aldolase is encoded by a nucleic acid sequence selected from the group consisting of SEQ ID NOs: 9 and 10.Glycolaldehyde Reductase (EC 1.1.1.77)

[0173] The present disclosure describes enzymes that can catalyze the following reversible reactions:ethylene glycol+NAD+⇄glycolaldehyde+NADH+H+(S)-propane-1,2-diol+NAD+⇄(S)-lactaldehyde+NADH+H+Glycolaldehyde reductase may also be known as lactaldehyde reductase, propanediol oxidoreductase, (R) [or(S)]-propane-1,2-diol:NAD+ oxidoreductase or L-1,2-propanediol oxidoreductase.

[0175] Thus, in some embodiments, the disclosure provides for an enzyme that plays roles in the ethylene glycol degradation pathway, the super pathway of glycol metabolism and degradation, the anaerobic L-lactaldehyde degradation pathway and / or the super pathway of fucose and rhamnose degradation. In one embodiment, the enzyme may use Fe2+ as a cofactor.

[0176] L-1,2-propanediol oxidoreductase is an iron-dependent group III dehydrogenase. It anaerobically reduces L-lactaldehyde, a product of both the L-fucose and L-rhamnose catabolic pathways, to L-1,2-propanediol, which is then excreted from the cell.

[0177] Crystal structures of the enzyme have been solved, showing a domain-swapped dimer in which the metal, cofactor and substrate binding sites could be located. An aspartate and three conserved histidine residues are required for Fe2+ binding and enzymatic activity.

[0178] In vitro, the enzyme can be reactivated by high concentrations of NAD+ and efficiently inactivated by a mixture of Fe3+ and ascorbate or Fe2+ and H2O2. Metal-catalyzed oxidation of the conserved His277 residue is proposed to be the cause of the inactivation.

[0179] Expression of FucO enables engineered one-turn reversal of the β-oxidation cycle. FucO activity contributes to the conversion of isobutyraldehyde to isobutanol in an engineered strain.

[0180] In particular embodiments, the enzyme converts glycolaldehyde to MEG. In some embodiments, the glycolaldehyde reductase is from Escherichia coli. In some embodiments, the glycolaldehyde reductase is encoded by the fucO gene.

[0181] In one embodiment, the glycolaldehyde reductase is encoded by one or more nucleic acid molecules obtained from a microorganism selected from E. coli and S. cerevisiae. In another embodiment, the one or more nucleic acid molecules is selected from gldA, GRE2, GRE3, yqhD, ydjG, fucO, yafB (dkgB), and / or yqhE (dkgA), or homolog thereof. In another embodiment, the one or more nucleic acid molecules is yqhD. In some embodiments, the yqhD comprises a G149E mutation. In a further embodiment, the glycolaldehyde reductase comprises an amino acid sequence selected from the group consisting of SEQ ID NOs: 13, 15, 17, 20, 23, 25, 28, 30 and 32. In yet a further embodiment, the glycolaldehyde reductase is encoded by a nucleic acid sequence selected from the group consisting of SEQ ID NOS: 12, 14, 16, 18, 19, 21, 22, 24, 26, 27, 29 and 31.Aldehyde Reductases

[0182] A number of aldehyde reductases may be used to convert glycolaldehyde to MEG.

[0183] An NADPH-dependent aldehyde reductase (YqhD) can catalyze the following reactions:acetol+NADP+⇄methylglyoxal+NADPH+H+ (reversible, EC 1.1.1.-)an alcohol+NADP+⇄an aldehyde+NADPH+H+ (reversibility unspecified, EC 1.1.1.2)an aldehyde+NADP++H2O→a carboxylate+NADPH+2H+ (EC 1.2.1.4)1,3-propanediol+NADP+⇄3-hydroxypropionaldehyde+NADPH+H+ (reversibility unspecified, EC 1.1.1.-)D-3,4-dihydroxybutanal+NADPH⇄1,3,4-butanetriol+NADP+ (reversibility unspecified)YqhD is an NADPH-dependent aldehyde reductase that may be involved in glyoxal detoxification and / or be part of a glutathione-independent response to lipid peroxidation.It has been reported that various alcohols, aldehydes, amino acids, sugars and α-hydroxy acids have been tested as substrates for YqhD. The purified protein only shows NADP-dependent alcohol dehydrogenase activity, with a preference for alcohols longer than C (3), but with Km values in the millimolar range, suggesting that they are not the physiological substrates. In contrast, YqhD does exhibit short-chain aldehyde reductase activity with substrates such as propanaldehyde, acetaldehyde, and butanaldehyde, as well as acrolein and malondialdehyde. In a metabolically engineered strain, phenylacetaldehyde and 4-hydroxyphenylacetaldehyde are reduced to 2-phenylethanol and 2-(4-hydroxyphenyl) ethanol by the endogenous aldehyde reductases YqhD, YjgB, and YahK.Overexpression of YqhD increases 1,3-propanediol oxidoreductase activity of the cell. E. coli has been engineered to express YqhD for the industrial production of 1,3-propanediol. YqhD activity contributes to the production of isobutanol, 1,2-propanediol, 1,2,4-butanetriol and acetol as well. Mutation of yqhD enables production of butanol by an engineered one-turn reversal of the β-oxidation cycle.YqhD has furfural reductase activity, which appears to cause growth inhibition due to depletion of NADPH in metabolically engineered strains that produce alcohol from lignocellulosic biomass.

[0188] The crystal structure of YqhD has been solved at 2 Å resolution. YqhD is an asymmetric dimer of dimers, and the active site contains a Zn2+ ion. The NADPH cofactor is modified by hydroxyl groups at positions 5 and 6 in the nicotinamide ring.

[0189] Overexpression of yqhD leads to increased resistance to reactive oxygen-generating compounds such as hydrogen peroxide, paraquat, chromate and potassium tellurite. A yqhD deletion mutant shows increased sensitivity to these compounds and to glyoxal, and contains increased levels of reactive aldehydes that are generated during lipid peroxidation. Conversely, yqhD deletion leads to increased furfural tolerance.

[0190] In particular embodiments, an NADPH-dependent aldehyde reductase converts glycolaldehyde to MEG. In some embodiments, the NADPH-dependent aldehyde reductase is from Escherichia coli. In some embodiments, the NADPH-dependent aldehyde reductase is encoded by the yqhD gene.

[0191] A multi-functional methylglyoxal reductase (DkgA) can catalyze the following reactions:acetol+NADP+⇄methylglyoxal+NADPH+H+ (the reaction is physiologically favored in the opposite direction, EC 1.1.1.-)isobutanol+NADP+⇄isobutanal+NADPH+H+ (reversibility unspecified, EC 1.1.1.-)ethyl-(2R)-methyl-(3S)-hydroxybutanoate+NADP+⇄ethyl-2-methylacetoacetate+NADPH+H+ (reversibility unspecified, EC 1.1.1.-)2-keto-L-gulonate+NADP+→-2,5-didehydro-D-gluconate+NADPH+H+ (the reaction is favored in the opposite direction, EC 1.1.1.346)DkgA (YqhE) belongs to the aldo-keto reductase (AKR) family and has been shown to have methylglyoxal reductase and beta-keto ester reductase activity.dkgA is reported to encode a 2,5-diketo-D-gluconate reductase (25DKGR) A, one of two 25DKG reductases in E. coli. The enzyme uses NADPH as the preferred electron donor and is thought to be involved in ketogluconate metabolism. The specific activity of the enzyme towards 2,5-diketo-D-gluconate is reported to be almost 1000-fold lower than its activity towards methylglyoxal.Due to its low Km for NADPH, reduction of furans by DkgA may deplete NADPH pools and thereby limit cellular biosynthesis. A broad survey of aldehyde reductases showed that DkgA was one of several endogenous aldehyde reductases that contribute to the degradation of desired aldehyde end products of metabolic engineering.

[0195] A crystal structure of DkgA has been solved at 2.16 Å resolution.

[0196] In particular embodiments, a multi-functional methylglyoxal reductase converts glycolaldehyde to MEG. In some embodiments, the multi-functional methylglyoxal reductase is from Escherichia coli. In some embodiments, the multi-functional methylglyoxal reductase is encoded by the dkgA gene.

[0197] A multi-functional methylglyoxal reductase (DkgB) can catalyze the following reactions:acetol+NADP+⇄methylglyoxal+NADPH+H+ (the reaction is physiologically favored in the opposite direction, EC 1.1.1.-)4-nitrobenzyl alcohol+NADP+⇄4-nitrobenzaldehyde+NADPH+H+ (reversibility unspecified, EC 1.1.1.91)2-keto-L-gulonate+NADP+←2,5-didehydro-D-gluconate+NADPH+H+ (the reaction is favored in the opposite direction, EC 1.1.1.346)DkgB (YafB) is a member of the aldo-keto reductase (AKR) subfamily 3F. DkgB was shown to have 2,5-diketo-D-gluconate reductase, methylglyoxal reductase and 4-nitrobenzaldehyde reductase activities.dkgB is reported to encode 2,5-diketo-D-gluconate reductase (25DKGR) B, one of two 25DKG reductases in E. coli. The enzyme uses NADPH as the preferred electron donor and is thought to be involved in ketogluconate metabolism. However, the specific activity of the enzyme towards 2,5-diketo-D-gluconate is reported to be almost 1000-fold lower than its activity towards methylglyoxal.

[0200] In particular embodiments, a multi-functional methylglyoxal reductase converts glycolaldehyde to MEG. In some embodiments, the multi-functional methylglyoxal reductase is from Escherichia coli. In some embodiments, the multi-functional methylglyoxal reductase is encoded by the dkgB gene.

[0201] A methylglyoxal reductase (YeaE) can catalyze the following reaction:acetol+NADP+⇄methylglyoxal+NADPH+H+ (the reaction is physiologically favored in the opposite direction, EC 1.1.1.-)

[0202] YeaE has been shown to have methylglyoxal reductase activity.

[0203] The subunit structure of YeaE has not been determined, but its amino acid sequence similarity to the aldo-keto reductases DkgA (YqhE) and DkgB (YafB) suggests that it may be monomeric.

[0204] In particular embodiments, a methylglyoxal reductase converts glycolaldehyde to MEG. In some embodiments, the methylglyoxal reductase is from Escherichia coli. In some embodiments, the methylglyoxal reductase is encoded by the yeaE gene.

[0205] A L-glyceraldehyde 3-phosphate reductase (yghZ) can catalyze the following reactions:L-glyceraldehyde 3-phosphate+NADPH+H+→sn-glycerol 3-phosphate+NADP+ (EC 1.1.1.-)acetol+NADP+⇄methylglyoxal+NADPH+H+ (the reaction is physiologically favored in the opposite direction, EC 1.1.1.-)YghZ is an L-glyceraldehyde 3-phosphate (L-GAP) reductase. The enzyme is also able to detoxify methylglyoxal at a low rate. YghZ defines the AKR14 (aldo-keto reductase 14) protein family.

[0207] L-GAP is not a natural metabolite and is toxic to E. coli. L-GAP is a substrate of both the glycerol-3-phosphate and hexose phosphate transport systems of E. coli K-12. It has been postulated that the physiological role of YghZ is the detoxification of L-GAP, which may be formed by non-enzymatic racemization of GAP or by an unknown cellular process.

[0208] The crystal structure of the E. coli enzyme has been determined and is suggested to be a tetramer. However, others have found that the protein forms an octamer based on gel filtration and electron microscopy studies.

[0209] In particular embodiments, a L-glyceraldehyde 3-phosphate reductase converts glycolaldehyde to MEG. In some embodiments, the L-glyceraldehyde 3-phosphate reductase is from Escherichia coli. In some embodiments, the L-glyceraldehyde 3-phosphate reductase is encoded by the yghZ gene.

[0210] An L-1,2-propanediol dehydrogenase / glycerol dehydrogenase (GldA) can catalyze the following reactions:(S)-propane-1,2-diol+NAD+⇄acetol+NADH+H+ (reversible reaction)aminoacetone+NADH+H+→(R)-1-aminopropan-2-ol+NAD+ (EC 1.1.1.75)glycerol+NAD+⇄dihydroxyacetone+NADH+H+ (reversible reaction, EC 1.1.1.6)The physiological function of the GldA enzyme has long been unclear. The enzyme was independently isolated as a glycerol dehydrogenase and a D-1-amino-2-propanol: NAD+ oxidoreductase. At that time, D-1-amino-2-propanol was thought to be an intermediate for the biosynthesis of vitamin B12, and although E. coli is unable to synthesize vitamin B12 de novo, enzymes catalyzing the synthesis of this compound were sought. It was later found that GldA was responsible for both activities.The primary in vivo role of GldA was recently proposed to be the removal of dihydroxyacetone by converting it to glycerol. However, a dual role in the fermentation of glycerol has also recently been established. Glycerol dissimilation in E. coli can be accomplished by two different pathways. The glycerol and glycerophosphodiester degradation pathway requires the presence of a terminal electron acceptor and utilizes an ATP-dependent kinase of the Glp system, which phosphorylates glycerol to glycerol-3-phosphate. However, upon inactivation of the kinase and selection for growth on glycerol, it was found that an NAD+-linked dehydrogenase, GldA, was able to support glycerol fermentation. Recently, it was shown that GldA was involved in glycerol fermentation both as a glycerol dehydrogenase, producing dihydroxyacetone, and as a 1,2-propanediol dehydrogenase, regenerating NAD+ by producing 1,2-propanediol from acetol.

[0213] The enzyme is found in two catalytically active forms, a large form of eight subunits and a small form of two subunits. The large form appears to be the major species.

[0214] In particular embodiments, an L-1,2-propanediol dehydrogenase / glycerol dehydrogenase converts glycolaldehyde to MEG. In some embodiments, the L-1,2-propanediol dehydrogenase / glycerol dehydrogenase is from Escherichia coli. In some embodiments, the L-1,2-propanediol dehydrogenase / glycerol dehydrogenase is encoded by the gldA gene.

[0215] An NADPH-dependent methylglyoxal reductase (GRE2) from Saccharomyces cerevisiae can catalyze the following reactions:(S)-lactaldehyde+NADP+⇄methylglyoxal+NADPH3-methylbutanol+NAD(P)+⇄3-methylbutanal+NAD(P)HGre2 is a versatile enzyme that catalyzes the stereoselective reduction of a broad range of substrates including aliphatic and aromatic ketones, diketones, as well as aldehydes, using NADPH as the cofactor.

[0217] The crystal structures of Gre2 from S. cerevisiae in an apo-form at 2.00 Å and NADPH-complexed form at 2.40 Å resolution have been solved. Gre2 forms a homodimer, each subunit of which contains an N-terminal Rossmann-fold domain and a variable C-terminal domain, which participates in substrate recognition. The induced fit upon binding to the cofactor NADPH makes the two domains shift toward each other, producing an interdomain cleft that better fits the substrate. Computational simulation combined with site-directed mutagenesis and enzymatic activity analysis enabled characterization of a potential substrate-binding pocket that determines the stringent substrate stereoselectivity for catalysis.

[0218] Gre2 catalyzes the irreversible reduction of the cytotoxic compound methylglyoxal (MG) to (S)-lactaldehyde as an alternative to detoxification of MG by glyoxalase|GLO1. MG is synthesized via a bypath of glycolysis from dihydroxyacetone phosphate and is believed to play a role in cell cycle regulation and stress adaptation. GRE2 also catalyzes the reduction of isovaleraldehyde to isoamylalcohol. The enzyme serves to suppress isoamylalcohol-induced filamentation by modulating the levels of isovaleraldehyde, the signal to which cells respond by filamentation. GRE2 is also involved in ergosterol metabolism.

[0219] In particular embodiments, an NADPH-dependent methylglyoxal reductase converts glycolaldehyde to MEG. In some embodiments, the NADPH-dependent methylglyoxal reductase is from S. cerevisiae. In some embodiments, the NADPH-dependent methylglyoxal reductase is encoded by the GRE2 gene.Thiolase / Acetyl Coenzyme A Acetyltransferase (EC 2.3.1.9)

[0220] The present disclosure describes enzymes that can catalyze the following reaction:2 acetyl-CoA⇄acetoacetyl-CoA+coenzyme A (reversible reaction)

[0221] Thiolase / Acetyl coenzyme A acetyltransferase may also be known as acetyl-CoA-C-acetyltransferase, acetoacetyl-CoA thiolase, acetyl-CoA:acetyl-CoA C-acetyltransferase or thiolase II.

[0222] Thus, in some embodiments, the disclosure provides for an enzyme that plays a role in acetoacetate degradation (to acetyl COA). In one embodiment, an inhibitor of this enzyme may be acetoacetyl-CoA.

[0223] In particular embodiments, the enzyme converts acetyl-CoA to acetoacetyl-CoA. In one embodiment, the thiolase or acetyl coenzyme A acetyltransferase is encoded by one or more nucleic acid molecules obtained from a microorganism selected from the group consisting of Clostridium sp., Bacillus sp., E. coli, Saccharomyces sp. and Marinobacter sp. In some embodiments, the thiolase or acetyl coenzyme A acetyltransferase is encoded by one or more nucleic acid molecules obtained from a microorganism selected from the group consisting of Clostridium acetobutylicum, Clostridium thermosaccharolyticum, Bacillus cereus, E. coli, Saccharomyces cerevisiae and Marinobacter hydrocarbonoclasticus. In some embodiments, the one or more nucleic acid molecules is thlA, atoB and / or ERG10, or homolog thereof. In a further embodiment, the thiolase or acetyl coenzyme A acetyltransferase comprises an amino acid sequence selected from the group consisting of SEQ ID NOs: 35, 37 and 40. In yet a further embodiment, the thiolase or acetyl coenzyme A acetyltransferase is encoded by a nucleic acid sequence selected from the group consisting of SEQ ID NOS: 33, 34, 36, 38 and 39.Acetyl-CoA:Acetoacetate-CoA Transferase (EC 2.8.3.-)

[0224] The present disclosure describes enzymes that can catalyze the following reaction:acetoacetate+acetyl-CoA⇄acetoacetyl-CoA+acetate (reversible reaction, EC 2.8.3.-)

[0225] Acetyl-CoA:acetoacetate-CoA transferase may also be known as acetate:acetoacetyl-CoA transferase or acetoacetyl-CoA transferase.

[0226] Thus, in some embodiments, the disclosure provides for an enzyme that plays a role in acetoacetate degradation (to acetyl COA). In one embodiment, inhibitors of this enzyme may include acetyl-CoA and coenzyme A.

[0227] The growth of E. coli on short-chain fatty acids (C3-C6) requires the activation of the acids to their respective thioesters. This activation is catalyzed by acetoacetyl-CoA transferase. The reaction takes place in two half-reactions which involves a covalent enzyme-CoA. The enzyme undergoes two detectable conformational changes during the reaction. It is thought likely that the reaction proceeds by a ping-pong mechanism. The enzyme can utilize a variety of short-chain acyl-CoA and carboxylic acid substrates but exhibits maximal activity with normal and 3-keto substrates.

[0228] In particular embodiments, the enzyme converts acetoacetyl-CoA to acetoacetate. In some embodiments, the acetyl-CoA:acetoacetate-CoA transferase is from Clostridium spp. In some embodiments, the acetyl-CoA:acetoacetate-CoA transferase is from Clostridium acetobutylicum. In some embodiments, the acetyl-CoA:acetoacetate-CoA transferase is from Escherichia coli. In some embodiments, the acetyl-CoA:acetoacetate-CoA transferase is encoded by the atoA and atoD genes. In another embodiment, the subunit composition of acetoacetyl-CoA transferase is [(AtoA)2][(AtoD)2], with (AtoA)2 being the β complex and (AtoD)2 being the α complex. In one embodiment, the acetyl-CoA:acetoacetate-CoA transferase is a fused acetyl-CoA:acetoacetate-CoA transferase: α subunit / β subunit. In another embodiment, the acetyl-CoA:acetoacetate-CoA transferase is encoded by the ydiF gene.Acetate:Acetoacetyl-CoA hydrolase (EC 3.1.2.11)

[0229] The present disclosure describes enzymes that can catalyze the following reaction:acetoacetyl-CoA+H2O→CoA+acetoacetate

[0230] Acetoacetyl-CoA hydrolase may also be known as acetoacetyl coenzyme A hydrolase, acetoacetyl CoA deacylase or acetoacetyl coenzyme A deacylase.

[0231] This enzyme belongs to the family of hydrolases, specifically those acting on thioester bonds.

[0232] In particular embodiments, the enzyme converts acetoacetyl-CoA to acetoacetate. In some embodiments, the acetate:acetoacetyl-CoA hydrolase is from Clostridium spp. In some embodiments, the acetate:acetoacetyl-CoA hydrolase is from Clostridium acetobutylicum. In another embodiment, the Acetoacetyl-CoA hydrolase is encoded by the ctfA (subunit A) and / or ctfB (subunit B) genes.

[0233] In a further embodiment, the acetyl-CoA:acetoacetate-CoA transferase or acetate:acetoacetyl-CoA hydrolase comprises an amino acid sequence selected from the group consisting of SEQ ID NOs: 43, 46, 97, 99, 101 and 103. In yet a further embodiment, the acetyl-CoA:acetoacetate-CoA transferase or acetate:acetoacetyl-CoA hydrolase is encoded by a nucleic acid sequence selected from the group consisting of SEQ ID NOs: 41, 42, 44, 45, 96, 98, 100 and 102.Acetoacetate Decarboxylase (EC 4.1.1.4)

[0234] The present disclosure describes enzymes that can catalyze the following reaction:acetoacetate+H+→acetone+CO2

[0235] Acetoacetate decarboxylase may also be known as ADC, AADC or acetoacetate carboxy-lyase.

[0236] Thus, in some embodiments, the disclosure provides for an enzyme that plays roles in isopropanol biosynthesis, pyruvate fermentation to acetone, the super pathway of Clostridium acetobutylicum acidogenic and solventogenic fermentation and / or the super pathway of Clostridium acetobutylicum solventogenic fermentation.

[0237] Acetoacetate decarboxylase (ADC) plays a key role in solvent production in Clostridium acetobutylicum. During the acidogenic phase of growth, acids accumulate causing a metabolic shift to solvent production. In this phase acids are re-assimilated and metabolized to produce acetone, butanol and ethanol.

[0238] Preliminary purification and crystallization of the enzyme has revealed that a lysine residue is implicated in the active site. The enzyme is a large complex composed of 12 copies of a single type of subunit.

[0239] The enzyme of Clostridium acetobutylicum ATCC 824 has been purified and the adc gene encoding it cloned. The enzyme has also been purified from the related strain Clostridium acetobutylicum DSM 792 and the gene cloned and sequenced. The decarboxylation reaction proceeds by the formation of a Schiff base intermediate.

[0240] ADC is a key enzyme in acid uptake, effectively pulling the CoA-transferase reaction in the direction of acetoacetate formation.

[0241] In particular embodiments, the enzyme converts acetoacetate to acetone. In one embodiment, the acetoacetate decarboxylase is encoded by one or more nucleic acid molecules obtained from a microorganism selected from the group consisting of Clostridium sp., Bacillus sp., Chromobacterium sp. and Pseudomonas sp. In another embodiment, the acetoacetate decarboxylase is encoded by one or more nucleic acid molecules obtained from a microorganism selected from the group consisting of Clostridium acetobutylicum, Clostridium beijerinckii, Clostridium cellulolyticum, Bacillus polymyxa, Chromobacterium violaceum and Pseudomonas putida. In some embodiments, the one or more nucleic acid molecules encoding the acetoacetate decarboxylase is adc, or homolog thereof. In a further embodiment, the acetoacetate decarboxylase comprises an amino acid sequence selected from the group consisting of SEQ ID NOs: 49 and 52. In yet another embodiment, the acetoacetate decarboxylase is encoded by a nucleic acid sequence selected from the group consisting of SEQ ID NOs: 47, 48, 50 and 51.Alcohol Dehydrogenase (EC 1.1.1.-)

[0242] The present disclosure describes enzymes that can catalyze the reversible oxidation of primary or secondary alcohols to aldehydes or ketones, respectively. In one embodiment, the enzyme is a secondary alcohol dehydrogenase (S-ADH) and catalyzes the reduction of ketones such as acetone into secondary alcohols such as 2-propanol (isopropanol).

[0243] In some embodiments the S-ADH is from Burkholderia sp. In some embodiments, the S-ADH is from Burkholderia sp. AIU 652. In some embodiments, the S-ADH is from Alcaligenes sp. In some embodiments, the S-ADH is from Alcaligenes eutrophus. In some embodiments, the S-ADH is from Clostridium sp. In some embodiments, the S-ADH is from Clostridium ragsdalei. In some embodiments, the S-ADH is from Clostridium beijerinckii. In some embodiments, the S-ADH is from Thermoanaerobacter sp. In some embodiments, the S-ADH is from Thermoanaerobacter brockii. In some embodiments, the S-ADH is from Thermoanaerobacter ethanolicus (Clostridium thermohydrosulfuricum). In some embodiments, the S-ADH is encoded by the adhB gene. In some embodiments, the S-ADH is from the trypanosomatid Phytomonas sp. In some embodiments, the S-ADH is from Rhodococcus sp. In some embodiments, the S-ADH is from Rhodococcus ruber. In some embodiments, the S-ADH is from Methanobacterium palustre. In some embodiments, the S-ADH is from methanogenic archaea Methanogenium liminatans. In some embodiments, the S-ADH is from the parasitic protist Entamoeba histolytica (EhAdh1). In some embodiments, the S-ADH is from parasitic protozoan Tritrichomonas foetus. In some embodiments, the S-ADH is from human parasite Trichomonas vaginalis.

[0244] In some embodiments, the S-ADH is predicted from homology and can be from Thermoanaerobacter mathranii, Micrococcus luteus, Nocardiopsis alba, Mycobacterium hassiacum, Helicobacter suis, Candida albicans, Candida parapsilosis, Candida orthopsilosis, Candida metapsilosis, Grosmannia clavigera and Scheffersomyces stipitis.

[0245] In some embodiments, the alcohol dehydrogenase has at least 70% sequence identity, at least 80% sequence identity, or at least 90% sequence identity with an alcohol dehydrogenase from Clostridium sp. In other embodiments, the alcohol dehydrogenase is an alcohol dehydrogenase selected from Clostridium beijerinckii adh and Clostridium carboxidivorans adh. In a further embodiment, the alcohol dehydrogenase comprises an amino acid sequence selected from the group consisting of SEQ ID NOs: 138 and 140. In yet another embodiment, the alcohol dehydrogenase is encoded by a nucleic acid sequence selected from the group consisting of SEQ ID NOs: 136, 137, and 139.Dehydratase (EC 4.2.1.-)

[0246] The present disclosure describes enzymes that can catalyze the following reactions:isopropanol⇄propene+H2OD-xylulose 1-kinase (EC 2.7.1.-)The present disclosure describes enzymes that can catalyze the conversion of D-xylulose to D-xylulose-1-phosphate. In some embodiments, the conversion can be catalyzed by a human ketohexokinase C (khk-C), also known as fructokinase.

[0248] Ketohexokinase, or fructokinase, phosphorylates fructose to fructose-1-phosphate. The enzyme is involved in fructose metabolism, which is part of carbohydrate metabolism. It is found in the liver, intestine and kidney cortex.

[0249] In human liver, purified fructokinase, when coupled with aldolase, has been discovered to contribute to an alternative mechanism to produce oxalate from xylitol. In coupled sequence, fructokinase and aldolase produce glycolaldehyde, a precursor to oxalate, from D-xylulose via D-xylulose 1-phosphate.

[0250] In particular embodiments, the enzyme converts D-xylulose to D-xylulose-1-phosphate. In one embodiment, the D-xylulose 1-kinase is encoded by one or more nucleic acid molecules obtained from Homo sapiens. In some embodiments, the one or more nucleic acid molecules encoding the D-xylulose 1-kinase is ketohexokinase C (khk-C), or homolog thereof. In another embodiment, the one or more nucleic acid molecules encoding the D-xylulose 1-kinase comprises an amino acid sequence set forth in SEQ ID NOs: 55 or 256. In a further embodiment, the one or more nucleic acid molecules encoding the D-xylulose 1-kinase is encoded by a nucleic acid sequence selected from the group consisting of SEQ ID NOs: 53 and 54.D-xylulose-1-phosphate Aldolase (EC 4.1.2.-)

[0251] The present disclosure describes enzymes that can catalyze the conversion of D-xylulose-1-phosphate to glycolaldehyde and DHAP. In some embodiments, the conversion can be catalyzed by a human aldolase B, which is also known as fructose-bisphosphate aldolase B or liver-type aldolase.

[0252] Aldolase B is one of three isoenzymes (A, B, and C) of the class I fructose 1,6-bisphosphate aldolase enzyme (EC 4.1.2.13), and plays a key role in both glycolysis and gluconeogenesis. The generic fructose 1,6-bisphosphate aldolase enzyme catalyzes the reversible cleavage of fructose 1,6-bisphosphate (FBP) into glyceraldehyde 3-phosphate and dihydroxyacetone phosphate (DHAP) as well as the reversible cleavage of fructose 1-phosphate (F1P) into glyceraldehyde and dihydroxyacetone phosphate. In mammals, aldolase B is preferentially expressed in the liver, while aldolase A is expressed in muscle and erythrocytes and aldolase C is expressed in the brain. Slight differences in isozyme structure result in different activities for the two substrate molecules: FBP and fructose 1-phosphate. Aldolase B exhibits no preference and thus catalyzes both reactions, while aldolases A and C prefer FBP.

[0253] Aldolase B is a homotetrameric enzyme, composed of four subunits. Each subunit has a molecular weight of 36 kDa and contains an eight-stranded α / β barrel, which encloses lysine 229 (the Schiff-base forming amino acid that is key for catalysis).

[0254] In particular embodiments, the enzyme converts D-xylulose-1-phosphate to glycolaldehyde and DHAP. In one embodiment, the D-xylulose-1-phosphate aldolase is encoded by one or more nucleic acid molecules obtained from Homo sapiens. In another embodiment, the one or more nucleic acid molecules encoding the D-xylulose-1-phosphate aldolase is aldolase B (aldoB), or homolog thereof. In some embodiments, the one or more nucleic acid molecules encoding the D-xylulose-1-phosphate aldolase comprises an amino acid sequence set forth in SEQ ID NO: 58. In some embodiments, the one or more nucleic acid molecules encoding the D-xylulose-1-phosphate aldolase is encoded by a nucleic acid sequence selected from the group consisting of SEQ ID NOs: 56 and 57.D-xylose Isomerase (EC 5.3.1.5)

[0255] The present disclosure describes enzymes that can catalyze the following reversible reaction:D-xylopyranose⇄D-xylulose

[0256] D-xylose isomerase may also be known as xylose isomerase or D-xylose ketol-isomerase.

[0257] Thus, in some embodiments, the disclosure provides for an enzyme that plays a role in xylose degradation.

[0258] Xylose isomerase catalyzes the first reaction in the catabolismof D-xylose.

[0259] Two conserved histidine residues, H101 and H271, were shown to be essential for catalytic activity. The fluorescence of two conserved tryptophan residues, W49 and W188, is quenched during binding of xylose, and W49 was shown to be essential for catalytic activity. The presence of Mg2+, Mn2+ or Co2+ protects the enzyme from thermal denaturation.

[0260] The subunit composition has not been established experimentally.

[0261] In particular embodiments, the enzyme converts D-xylose to D-xylulose. In one embodiment, the recombinant microorganism further comprises an endogenous or exogenous xylose isomerase that catalyzes the conversion of D-xylose to D-xylulose. In one embodiment, the xylose isomerase is exogenous. In another embodiment, the xylose isomerase is encoded by one or more nucleic acid molecules obtained from Pyromyces sp or E. coli. In another embodiment, the one or more nucleic acid molecules encoding the xylose isomerase is xylA, or homolog thereof. In yet another embodiment, the one or more nucleic acid molecules encoding the xylose isomerase comprises an amino acid sequence selected from SEQ ID NOs: 95 and 144. In a further embodiment, the one or more nucleic acid molecules encoding the xylose isomerase is encoded by a nucleic acid sequence selected from the group consisting of SEQ ID NOs: 93, 94 and 143.

[0262] In some embodiments, a recombinant microorganism producing MEG or GA, or optionally, MEG or GA and one or more co-product, comprises a deletion, insertion, or loss of function mutation in a gene encoding a D-xylose isomerase to prevent conversion of D-xylose to D-xylulose and instead shunt the reaction toward the conversion of D-xylose to D-xylonate.D-xylulose 5-kinase / xylulokinase

[0263] The present disclosure describes enzymes that can catalyze the following reactions:D-xylulose+ATP→D-xylulose 5-phosphate+ADP+H+ (EC 2.7.1.17)ATP+1-deoxy-D-xylulose→1-deoxy-D-xylulose 5-phosphate+ADP+H+ (EC 2.7.1.-)D-xylulose 5-kinase may also be known as xylulose kinase or xylulokinase.

[0265] Xylulokinase catalyzes the phosphorylation of D-xylulose, the second step in the xylose degradation pathway, producing D-xylulose-5-phosphate, an intermediate of the pentose phosphate pathway.

[0266] In the absence of substrate, xylulokinase has weak ATPase activity. Xylulokinase can also catalyze the phosphorylation of 1-deoxy-D-xylulose. This would allow a potential salvage pathway for generating 1-deoxy-D-xylulose 5-phosphate for use in the biosynthesis of terpenoids, thiamine and pyridoxal. The rate of phosphorylation of 1-deoxy-D-xylulose is 32-fold lower than the rate of phosphorylation of D-xylulose.

[0267] The kinetic mechanism of the bacterial enzyme has been studied, suggesting a predominantly ordered reaction mechanism. The enzyme undergoes significant conformational changes upon binding of the substrate and of ATP. Two conserved aspartate residues, D6 and D233, were found to be essential for catalytic activity, and a catalytic mechanism has been proposed.

[0268] Crystal structures of bacterial xylulokinase in the apo form and bound to D-xylulose have been determined at 2.7 and 2.1 Å resolution, respectively.

[0269] In particular embodiments, the enzyme converts D-xylulose to D-xylulose-5-phosphate. In some embodiments, the D-xylulose 5-kinase is from Escherichia coli. In some embodiments, the D-xylulose 5-kinase is encoded by the xylB gene. In some embodiments, the D-xylulose 5-kinase is from Saccharomyces cerevisiae. In some embodiments the D-xylulose 5-kinase is encoded by the XKS1 gene. In some embodiments, the D-xylulose 5-kinase is from Pichia stipitis. In some embodiments the D-xylulose 5-kinase is encoded by the XYL3 gene.

[0270] In some embodiments, the D-xylulose 5-kinase is encoded by an amino acid sequence having at least 70% sequence identity to xylB from E. coli. In a further embodiment, the D-xylulose 5-kinase is encoded by an amino acid sequence having at least 80% sequence identity to xylB from E. coli. In yet a further embodiment, the D-xylulose 5-kinase is encoded by an amino acid sequence having at least 90% sequence identity to xylB from E. coli. In other embodiments, the D-xylulose 5-kinase is xylB from E. coli.

[0271] In one embodiment, the D-xylulose 5-kinase is encoded by one or more nucleic acid molecules obtained from E. coli. In some embodiments, the one or more nucleic acid molecules encoding the D-xylulose 5-kinase is xylB, or homolog thereof. In another embodiment, the one or more nucleic acid molecules encoding the D-xylulose 5-kinase comprises an amino acid sequence set forth in SEQ ID NO: 146. In a further embodiment, the one or more nucleic acid molecules encoding the D-xylulose 5-kinase is encoded by a nucleic acid sequence set forth in SEQ ID NO: 145.Xylose Dehydrogenase (EC 1.1.1.175 or EC 1.1.1.179)

[0272] The present disclosure describes enzymes that can catalyze the following reactions:aldehydo-D-xylose+NAD++H2O→D-xylonate+NADH+2H+α-D-xylopyranose+NAD+⇄D-xylonolactone+NADH+H+ (reversibility unspecified, EC 1.1.1.175)Xylose dehydrogenase may also be known as D-xylose dehydrogenase, D-xylose 1-dehydrogenase, (NAD+)-linked D-xylose dehydrogenase, NAD+-D-xylose dehydrogenase, D-xylose: NAD+1-oxidoreductase

[0274] D-xylose dehydrogenase catalyzes the NAD+-dependent oxidation of D-xylose to D-xylonolactone. This is the first reaction in the oxidative, non-phosphorylative pathway for the degradation of D-xylose in Caulobacter crescentus. This pathway is similar to the pathway for L-arabinose degradation in Azospirillum brasilense. The amino acid sequence of the C. crescentus enzyme is unrelated to that of xylose dehydrogenase from the archaeon Haloarcula marismortui, or the L-arabinose 1-dehydrogenase of Azospirillum brasilense.

[0275] D-xylose is the preferred substrate for recombinant D-xylose dehydrogenase from Caulobacter crescentus. The enzyme can use L-arabinose, but it is a poorer substrate. The Km for L-arabinose is 166 mM. Other substrates such as D-arabinose, L-xylose, D-ribose, D-galactose, D-glucose and D-glucose-6-phosphate showed little or no activity in the assay, as measured by NADH production. C. crescentus D-xylose dehydrogenase can convert D-xylose to D-xylonate directly.

[0276] Partially purified, native D-xylose dehydrogenase from C. crescentus had a Km of 70 μM for D-xylose. This value was lower than the Km of 760 μM for the recombinant, His-tagged enzyme.

[0277] In some embodiments, the D-xylose dehydrogenase is from the halophilic archaeon Haloferax volcanii. The Haloferax volcanii D-xylose dehydrogenase catalyzes the first reaction in the oxidative xylose degradation pathway of the halophilic archaeon Haloferax volcanii. The H. volcanii D-xylose dehydrogenase shows 59% amino acid sequence identity to a functionally characterized xylose dehydrogenase from Haloarcula marismortui and 56% identity to an ortholog in Halorubrum lacusprofundi, but is only 11% identical to the bacterial NAD+-dependent xylose dehydrogenase from Caulobacter crescentus CB15.

[0278] In particular embodiments, the enzyme converts D-xylose to D-xylonolactone. In one embodiment, the xylose dehydrogenase is encoded by one or more nucleic acid molecules obtained from a microorganism selected from the group consisting of Caulobacter sp., Haloarcula sp., Haloferax sp., Halorubrum sp. and Trichoderma sp. In another embodiment, the xylose dehydrogenase is encoded by one or more nucleic acid molecules obtained from a microorganism selected from the group consisting of Caulobacter crescentus, Haloarcula marismortui, Haloferax volcanii, Halorubrum lacusprofundi and Trichoderma reesei. In some embodiments, the one or more nucleic acid molecules encoding the xylose dehydrogenase is selected from xylB, xdh1 (HVO_B0028) and / or xyd1, or homolog thereof. In a further embodiment, the one or more nucleic acid molecules encoding the xylose dehydrogenase comprises an amino acid sequence selected from the group consisting of SEQ ID NOs: 61, 63 and 65. In yet another embodiment, the one or more nucleic acid molecules encoding the xylose dehydrogenase is encoded by a nucleic acid sequence selected from the group consisting of SEQ ID NOs: 59, 60, 62 and 64.Xylonolactonase (3.1.1.68)

[0279] The present disclosure describes enzymes that can catalyze the following reaction:D-xylono-1,4-lactone+H2OD-xylonate

[0280] This enzyme belongs to the family of hydrolases, specifically those acting on carboxylic ester bonds. This enzyme participates in pentose and glucuronate interconversions.

[0281] Xylonolactonase may also be known as D-xylonolactonase, xylono-1,4-lactonase, xylono-gamma-lactonase or D-xylono-1,4-lactone lactonohydrolase.

[0282] In particular embodiments, the enzyme converts D-xylonolactone to D-xylonate. In one embodiment, the xylonolactonase is encoded by one or more nucleic acid molecules obtained from a microorganism selected from Caulobacter sp. and Haloferax sp. In another embodiment, the xylonolactonase is encoded by one or more nucleic acid molecules obtained from a microorganism selected from the group consisting of Caulobacter crescentus, Haloferax volcanii and Haloferax gibbonsii. In some embodiments, the one or more nucleic acid molecules encoding the xylonolactonase is xylC, or homolog thereof. In a further embodiment, the one or more nucleic acid molecules encoding the xylonolactonase comprises an amino acid sequence set forth in SEQ ID NO: 67. In yet another embodiment, the one or more nucleic acid molecules encoding the xylonolactonase is encoded by a nucleic acid sequence set forth in SEQ ID NO: 66.Xylonate Dehydratase (EC 4.2.1.82)

[0283] The present disclosure describes enzymes that can catalyze the following reaction:D-xylonate2-keto-3-deoxy-D-xylonate+H2O

[0284] This enzyme belongs to the family of lyases, specifically the hydro-lyases, which cleave carbon-oxygen bonds. This enzyme participates in pentose and glucuronate interconversions.

[0285] Xylonate dehydratase may also be known as D-xylonate hydro-lyase, D-xylo-aldonate dehydratase or D-xylonate dehydratase.

[0286] In particular embodiments, the enzyme converts D-xylonate to 2-keto-3-deoxy-D-xylonate. In one embodiment, the xylonate dehydratase is encoded by one or more nucleic acid molecules obtained from a microorganism selected from the group consisting of Caulobacter sp., Sulfolobus sp. and E. coli. In another embodiment, the xylonate dehydratase is encoded by one or more nucleic acid molecules obtained from a microorganism selected from the group consisting of Caulobacter crescentus, Sulfolobus solfataricus and E. coli. In some embodiments, the one or more nucleic acid molecules encoding the xylonate dehydratase is selected from xylD, yjhG and / or yagF, or homolog thereof. In a further embodiment, the one or more nucleic acid molecules encoding the xylonate dehydratase comprises an amino acid sequence selected from the group consisting of SEQ ID NOs: 69, 72 and 75. In yet another embodiment, the one or more nucleic acid molecules encoding the xylonate dehydratase is encoded by a nucleic acid sequence selected from the group consisting of SEQ ID NOs: 68, 70, 71, 73 and 74.2-keto-3-deoxy-D-pentonate Aldolase (4.1.2.28)

[0287] The present disclosure describes enzymes that can catalyze the following reaction:2-dehydro-3-deoxy-D-pentonate⇄glycolaldehyde+pyruvate (reversibility unspecified)

[0288] This enzyme belongs to the family of lyases, specifically the aldehyde-lyases, which cleave carbon-carbon bonds. This enzyme participates in pentose and glucuronate interconversions.

[0289] 2-keto-3-deoxy-D-pentonate aldolase may also be known as 2-dehydro-3-deoxy-D-pentonate glycolaldehyde-lyase (pyruvate-forming), 2-dehydro-3-deoxy-D-pentonate aldolase, 3-deoxy-D-pentulosonic acid aldolase, and 2-dehydro-3-deoxy-D-pentonate glycolaldehyde-lyase.

[0290] YjhH appears to be a 2-dehydro-3-deoxy-D-pentonate aldolase. Genetic evidence suggests that YagE may also function as a 2-dehydro-3-deoxy-D-pentonate aldolase. yagE is part of the prophage CP4-6.

[0291] A yjhH yagE double mutant cannot use D-xylonate as the sole source of carbon, and crude cell extracts do not contain 2-dehydro-3-deoxy-D-pentonate aldolase activity. Both phenotypes are complemented by providing yjhH on a plasmid.

[0292] ArcA appears to activate yjhH gene expression under anaerobiosis. Two putative ArcA binding sites were identified 211 and 597 bp upstream of this gene, but no promoter upstream of it has been identified.

[0293] The crystal structure of YagE suggests that the protein is a homotetramer. Co-crystal structures of YagE in the presence of pyruvate and 2-keto-3-deoxygalactonate have been solved.

[0294] In particular embodiments, the enzyme converts 2-keto-3-deoxy-xylonate to glycolaldehyde and pyruvate. In one embodiment, the 2-keto-3-deoxy-D-pentonate aldolase is encoded by one or more nucleic acid molecules obtained from a microorganism selected from Pseudomonas sp. and E. coli. In another embodiment, the 2-keto-3-deoxy-D-pentonate aldolase is encoded by one or more nucleic acid molecules obtained from E. coli. In some embodiments, the one or more nucleic acid molecules encoding the 2-keto-3-deoxy-D-pentonate aldolase is selected from yjhH and / or yagE, or homolog thereof. In a further embodiment, the one or more nucleic acid molecules encoding the 2-keto-3-deoxy-D-pentonate aldolase comprises an amino acid sequence selected from the group consisting of SEQ ID NOs: 78 and 81. In yet another embodiment, the one or more nucleic acid molecules encoding the 2-keto-3-deoxy-D-pentonate aldolase is encoded by a nucleic acid sequence selected from the group consisting of SEQ ID NOs: 76, 77, 79 and 80.Glycolaldehyde Dehydrogenase (1.2.1.21)

[0295] The present disclosure describes enzymes that can catalyze the following reaction:glycolaldehyde+NAD++H2Oglycolate+NADH+2H+

[0296] This enzyme belongs to the family of oxidoreductases, specifically those acting on the aldehyde or oxo group of donor with NAD+ or NADP+ as acceptor. This enzyme participates in glyoxylate and dicarboxylate metabolism.

[0297] Glycolaldehyde dehydrogenase may also be known as glycolaldehyde: NAD+ oxidoreductase or glycol aldehyde dehydrogenase.

[0298] In E. coli aldehyde dehydrogenase A (AldA) is an enzyme of relatively broad substrate specificity for small α-hydroxyaldehyde substrates. It is thus utilized in several metabolic pathways.

[0299] L-fucose and L-rhamnose are metabolized through parallel pathways which converge after their corresponding aldolase reactions yielding the same products: dihydoxy-acetone phosphate and L-lactaldehyde. Aerobically, aldehyde dehydrogenase A oxidizes L-lactaldehyde to L-lactate.

[0300] In parallel pathways utilizing the same enzymes, D-arabinose and L-xylose can be metabolized to dihydoxy-acetone phosphate and glycolaldehyde, which is oxidized to glycolate by aldehyde dehydrogenase A.

[0301] Crystal structures of the enzyme alone and in ternary and binary complexes have been solved.

[0302] Aldehyde dehydrogenase A is only present under aerobic conditions and is most highly induced by the presence of fucose, rhamnose or glutamate. The enzyme is inhibited by NADH, which may act as a switch to shift from oxidation of lactaldehyde to its reduction by propanediol oxidoreductase. AldA is upregulated during short-term adaptation to glucose limitation.

[0303] Based on sequence similarity, AldA was predicted to be a succinate-semialdehyde dehydrogenase.

[0304] Regulation of aldA expression has been investigated. The gene is regulated by catabolite repression, repression under anaerobic conditions via ArcA, and induction by the carbon source.

[0305] In particular embodiments, the enzyme converts glycolaldehyde to glycolate. In some embodiments, the glycolaldehyde dehydrogenase is from Escherichia coli. In some embodiments, the glycolaldehyde dehydrogenase is encoded by the aldA gene.

[0306] In some embodiments, a recombinant microorganism producing MEG, or optionally, MEG and one or more co-product, comprises a deletion, insertion, or loss of function mutation in a gene encoding a glycolaldehyde dehydrogenase to prevent the production of glycolic acid from glycolaldehyde and instead shunt the reaction toward conversion of glycolaldehyde to MEG. In some embodiments, the deletion, disruption, mutation, and / or reduction in the activity of a glycolaldehyde dehydrogenase that catalyzes the conversion of glycolaldehyde to glycolic acid is partial, wherein an amount of glycolic acid is still produced.

[0307] In other embodiments, a recombinant microorganism producing glycolic acid comprises or expresses at least one nucleic acid molecule encoding a glycolaldehyde dehydrogenase.Lactate Dehydrogenase (1.1.1.28)

[0308] The present disclosure describes enzymes that can catalyze the following reaction:(R)-lactate+NAD+←pyruvate+NADH+H+

[0309] Lactate dehydrogenase (LDH) is an enzyme found in nearly all living cells such as in animals, plants and prokaryotes. LDH catalyzes the conversion of lactate to pyruvic acid and back, as it converts NADH to NAD+ and back. A dehydrogenase is an enzyme that transfers a hydride from one molecule to another.

[0310] LDH exist in four distinct enzyme classes. The most common one is NAD (P)-dependent L-lactate dehydrogenase. Other LDHs act on D-lactate and / or are dependent on cytochrome c: D-lactate dehydrogenase (cytochrome) and L-lactate dehydrogenase (cytochrome).

[0311] LDH has been of medical significance because it is found extensively in body tissues, such as blood cells and heart muscle. Because it is released during tissue damage, it is a marker of common injuries and disease such as heart failure.

[0312] Lactate dehydrogenase may also be known as lactic acid dehydrogenase, (R)-lactate:NAD+ oxidoreductase or D-lactate dehydrogenase-fermentative.

[0313] In E. coli, lactate dehydrogenase (LdhA) is a soluble NAD-linked lactate dehydrogenase (LDH) that is specific for the production of D-lactate. LdhA is a homotetramer and shows positive homotropic cooperativity under higher pH conditions.

[0314] E. coli contains two other lactate dehydrogenases: D-lactate dehydrogenase and L-lactate dehydrogenase. Both are membrane-associated flavoproteins required for aerobic growth on lactate.

[0315] LdhA is present under aerobic conditions but is induced when E. coli is grown on a variety of sugars under anaerobic conditions at acidic pH. Unlike most of the genes involved in anaerobic respiration, IdhA is not activated by Fnr; rather the ArcAB system and several genes involved in the control of carbohydrate metabolism (csrAB and mlc) appear to regulate expression. The expression of IdhA is negatively affected by the transcriptional regulator ArcA. IdhA belongs to the 032 regulon.

[0316] The IdhA gene is a frequent target for mutations in metabolic engineering, most often to eliminate production of undesirable fermentation side products, but also to specifically produce D-lactate.

[0317] In particular embodiments, the enzyme converts pyruvate to lactate. In some embodiments, the lactate dehydrogenase is from Escherichia coli. In some embodiments, the lactate dehydrogenase is encoded by the IdhA gene.

[0318] In some embodiments, a recombinant microorganism producing MEG or GA, or optionally, MEG or GA and one or more co-product, comprises a deletion, insertion, or loss of function mutation in a gene encoding a lactate dehydrogenase to prevent the production of lactate from pyruvate and instead shunt the reaction toward production of one or more co-products.Xylose Reductase or Aldose Reductase (EC 1.1.1.21)

[0319] The present disclosure describes enzymes that can catalyze the following reactions:α-D-xylose+NADPH+H+xylitol+NADPan alditol+NAD(P)+NAD(P)H+aldoseAldose reductase may also be known as alditol:NAD(P)+1-oxidoreductase, polyol dehydrogenase or aldehyde reductase.

[0321] Aldose reductase is a cytosolic oxidoreductase that catalyzes the reduction of a variety of aldehydes and carbonyls, including monosaccharides.

[0322] Aldose reductase may be considered a prototypical enzyme of the aldo-keto reductase enzyme superfamily. The enzyme comprises 315 amino acid residues and folds into a β / α-barrel structural motif composed of eight parallel β strands. Adjacent strands are connected by eight peripheral α-helical segments running anti-parallel to the β sheet. The catalytic active site is situated in the barrel core. The NADPH cofactor is situated at the top of the β / α barrel, with the nicotinamide ring projecting down in the center of the barrel and pyrophosphate straddling the barrel lip.

[0323] The reaction mechanism of aldose reductase in the direction of aldehyde reduction follows a sequential ordered path where NADPH binds, followed by the substrate. Binding of NADPH induces a conformational change (Enzyme·NADPH→Enzyme*·NADPH) that involves hinge-like movement of a surface loop (residues 213-217) so as to cover a portion of the NADPH in a manner similar to that of a safety belt. The alcohol product is formed via a transfer of the pro-R hydride of NADPH to the face of the substrate's carbonyl carbon. Following release of the alcohol product, another conformational change occurs (E*·NAD(P)+→E·NAD(P)+) in order to release NADP+. Kinetic studies have shown that reorientation of this loop to permit release of NADP+ appears to represent the rate-limiting step in the direction of aldehyde reduction. As the rate of coenzyme release limits the catalytic rate, it can be seen that perturbation of interactions that stabilize coenzyme binding can have dramatic effects on the maximum velocity (Vmax).

[0324] D-xylose-fermenting Pichia stipitis and Candida shehatae were shown to produce one single aldose reductase (ALR) that is active both with NADPH and NADH. Other yeasts such as Pachysolen tannophilus and C. tropicalis synthesize multiple forms of ALR with different coenzyme specificities. The significant dual coenzyme specificity distinguishes the P. stipitis and the C. shehatae enzymes from most other ALRs so far isolated from mammalian or microbial sources. The yeast Candida tenuis CBS 4435 produces comparable NADH- and NADPH-linked aldehyde-reducing activities during growth on D-xylose.

[0325] In particular embodiments, the enzyme converts D-xylose to xylitol. In some embodiments, the xylose reductase or aldose reductase is encoded by one or more nucleic acid molecules obtained from a microorganism selected from the group consisting of Hypocrea sp., Scheffersomyces sp., Saccharomyces sp., Pachysolen sp., Pichia sp., Candida sp., Aspergillus sp., Neurospora sp., and Cryptococcus sp. In some embodiments, the xylose reductase or aldose reductase is encoded by one or more nucleic acid molecules obtained from a microorganism selected from the group consisting of Hypocrea jecorina, Scheffersomyces stipitis, Saccharomyces cerevisiae, Pachysolen tannophilus, Pichia stipitis, Pichia quercuum, Candida shehatae, Candida tenuis, Candida tropicalis, Aspergillus niger, Neurospora crassa and Cryptococcus lactativorus. In another embodiment, the one or more nucleic acid molecules encoding the xylose reductase or aldose reductase is xyl1 and / or GRE3 or homolog thereof. In some embodiments, the one or more nucleic acid molecules encoding the xylose reductase or aldose reductase comprises an amino acid sequence selected from the group consisting of SEQ ID NOs: 84 and 87. In some embodiments, the one or more nucleic acid molecules encoding the xylose reductase or aldose reductase is encoded by a nucleic acid sequence selected from the group consisting of SEQ ID NOs: 82, 83, 85 and 86.Xylitol Dehydrogenase (1.1.1.9)

[0326] The present disclosure describes enzymes that can catalyze the following reaction:xylitol+NAD+D-xylulose+NADH+H+

[0327] Xylitol dehydrogenase may also be known as D-xylulose reductase, NAD+-dependent xylitol dehydrogenase, erythritol dehydrogenase, 2,3-cis-polyol (DPN) dehydrogenase (C3-5), pentitol-DPN dehydrogenase, xylitol-2-dehydrogenase or xylitol: NAD+2-oxidoreductase (D-xylulose-forming).

[0328] Xylitol dehydrogenase (XDH) is one of several enzymes responsible for assimilating xylose into eukaryotic metabolism and is useful for fermentation of xylose contained in agricultural byproducts to produce ethanol. For efficient xylose utilization at high flux rates, cosubstrates should be recycled between the NAD+-specific XDH and the NADPH-preferring xylose reductase, another enzyme in the pathway.

[0329] In particular embodiments, the enzyme converts xylitol to D-xylulose. In one embodiment of any aspect disclosed above, the xylitol dehydrogenase is encoded by one or more nucleic acid molecules obtained from a microorganism selected from the group consisting of Scheffersomyces sp., Trichoderma sp., Pichia sp., Saccharomyces sp., Gluconobacter sp., Galactocandida sp., Neurospora sp., and Serratia sp. In another embodiment, the xylitol dehydrogenase is encoded by one or more nucleic acid molecules obtained from a microorganism selected from the group consisting of Scheffersomyces stipitis, Trichoderma reesei, Pichia stipitis, Saccharomyces cerevisiae, Gluconobacter oxydans, Galactocandida mastotermitis, Neurospora crassa and Serratia marcescens. In another embodiment, the one or more nucleic acid molecules encoding the xylitol dehydrogenase is xyl2 and / or xdh1, or homolog thereof. In some embodiments, the one or more nucleic acid molecules encoding the xylitol dehydrogenase comprises an amino acid sequence selected from the group consisting of SEQ ID NOs: 90 and 92. In some embodiments, the one or more nucleic acid molecule encoding the xylitol dehydrogenase is encoded by a nucleic acid sequence selected from the group consisting of SEQ ID NOs: 88, 89 and 91. In another embodiment, the enzyme converts D-xylulose to xylitol. In another embodiment, the enzyme has high activity for the conversion of D-xylulose to xylitol and preferably low activity or no activity for the reverse reaction, i.e. for the conversion of xylitol to D-xylulose. In another embodiment, this is achieved through enzyme engineering.Soluble Pyridine Nucleotide Transhydrogenase (EC 1.6.1.1.)

[0330] The present disclosure describes enzymes that can catalyze the following reaction:NADH+NADP+NAD++NADPH

[0331] Soluble pyridine nucleotide transhydrogenase may also be known as NAD (P)+ transhydrogenase (B-specific), STH, pyridine nucleotide transhydrogenase, or transhydrogenase.

[0332] E. coli contains both a soluble and a membrane-bound pyridine nucleotide transhydrogenase. The soluble pyridine nucleotide transhydrogenase is the sthA or udhA gene product; its primary physiological role appears to be the reoxidation of NADPH. The membrane-bound proton-translocating transhydrogenase is the pntAB gene product; PntAB is a major source of NADPH.

[0333] UdhA contains noncovalently bound FAD and is present in a form consisting of seven or eight monomers.

[0334] Moderate overexpression of UdhA (SthA) allows an increased maximal growth rate of a phosphoglucose isomerase mutant, and a pgi sthA double mutant is not viable. These phenotypes may be due to the ability of UdhA to restore the cellular redox balance under conditions of excess NADPH formation. Mutations in sthA appear during adaptation of a pgi mutant strain to growth on glucose minimal medium.

[0335] Transcription of sthA is downregulated by growth on glycerol.

[0336] In some embodiments, expression of a transhydrogenase can increase activity of a NADPH-dependent alcohol dehydrogenase, leading to improved acetone to 2-propanol conversion. In one embodiment, the soluble pyridine nucleotide transhydrogenase is encoded by one or more nucleic acid molecules obtained from E. coli. In another embodiment, the one or more nucleic acid molecules encoding the soluble pyridine nucleotide transhydrogenase is udhA, or homolog thereof. In some embodiments, the one or more nucleic acid molecules encoding the soluble pyridine nucleotide transhydrogenase comprises an amino acid sequence set forth in SEQ ID NO: 142. In some embodiments, the one or more nucleic acid molecules encoding the soluble pyridine nucleotide transhydrogenase is encoded by a nucleic acid sequence set forth in SEQ ID NO: 141.Hydroxymethylglutaryl-CoA Synthase (EC 2.3.3.-)

[0337] The present disclosure describes enzymes that can catalyze the following reaction:acetoacetyl-CoA+acetyl-CoA+H2O↔(S)-3-hydroxy-3-methylglutaryl-CoA+coenzyme A+H+

[0338] Hydroxymethylglutaryl-CoA synthase may also be known as (S)-3-hydroxy-3-methylglutaryl-CoA acetoacetyl-CoA-lyase (CoA-acetylating), 3-hydroxy-3-methylglutaryl CoA synthetase, 3-hydroxy-3-methylglutaryl coenzyme A synthase, 3-hydroxy-3-methylglutaryl coenzyme A synthetase, 3-hydroxy-3-methylglutaryl-CoA synthase, 3-hydroxy-3-methylglutaryl-coenzyme A synthase, β-hydroxy-β-methylglutaryl-CoA synthase, HMG-COA synthase, acetoacetyl coenzyme A transacetase, hydroxymethylglutaryl coenzyme A synthase, and hydroxymethylglutaryl coenzyme A-condensing enzyme.

[0339] Hydroxymethylglutaryl-CoA synthase catalyzes the condensation of acetyl-CoA with acetoacetyl-CoA to form (S)-3-hydroxy-3-methylglutaryl-CoA, an early stage in the synthesis of (R)-mevalonate, a precursor of cholesterol.

[0340] The enzyme catalyzes a complex reaction that can be divided into four steps. The first step involves the formation of an enzyme acetyl-CoA binary complex, followed by the transfer of the acetyl group from the CoA thioester to a cysteine residue on the enzyme, forming a thioester acyl-enzyme intermediate. In the next step the now reduced CoA dissociates, and the second substrate, acetoacetyl-CoA, binds the enzyme. The third step involves the formation of a carbanion by removal of a proton from the methyl of the acetylcysteine. The activated acetylcysteine then undergoes a Claisen-like condensation with the γ-carbon of the acetoacetyl-CoA ligand, which forms the HMG-CoA while retaining the thioester bond to the enzyme. The last step comprises the hydrolysis of this bond, resulting in free HMG-CoA.

[0341] The HMGCS1 gene from Homo sapiens has been cloned and sequenced (Russ A P et al. (1992) Amplification and direct sequencing of a cDNA encoding human cytosolic 3-hydroxy-3-methylglutaryl-coenzyme A synthase. Biochim Biophys Acta 1132 (3): 329-31). The gene was expressed in Escherichia coli, and the recombinant protein was purified and characterized (Rokosz L L et al. (1994) Human cytoplasmic 3-hydroxy-3-methylglutaryl coenzyme A synthase: expression, purification, and characterization of recombinant wild-type and Cys129 mutant enzymes. Arch Biochem Biophys 312 (1): 1-13). The enzyme is a homodimer of 120 kDa. Catalysis proceeds by formation of a covalent acetyl-enzyme intermediate. Kinetic data suggest that the two substrates (acetyl-CoA and acetoacetyl-CoA) compete for binding to the same site.

[0342] In one embodiment, the hydroxymethylglutaryl-CoA synthase can have a 3-hydroxyisovalerate (3HIV) synthase activity and can catalyze the following reaction:acetone+acetyl-CoA+H2O↔3-hydroxyisovalerate

[0343] In one embodiment, the 3HIV synthase is encoded by one or more nucleic acid molecules obtained from a microorganism selected from Mus sp., Saccharomyces sp., Lactobacillus sp. and Polaromonas sp. In another embodiment, the 3HIV synthase is encoded by one or more nucleic acid molecules obtained from a microorganism selected from Mus musculus, Saccharomyces cerevisiae, Lactobacillus crispatus and Polaromonas naphthalenivorans. In some embodiments, the one or more nucleic acid molecules encoding the 3HIV synthase is selected from Hmgcs1, ERG13, PksG and / or Pnap_0477, or homolog thereof. In a further embodiment, the one or more nucleic acid molecules encoding the 3HIV synthase comprises an amino acid sequence selected from the group consisting of SEQ ID NOs: 105, 107, 109 and 111. In yet another embodiment, the one or more nucleic acid molecules encoding the 3HIV synthase is encoded by a nucleic acid sequence selected from the group consisting of SEQ ID NOs: 104, 106, 108 and 110. In some embodiments, the one or more nucleic acid molecules encoding the hydroxymethylglutaryl-CoA synthase is hmgS, or homolog thereof. In a further embodiment, the one or more nucleic acid molecules encoding the hydroxymethylglutaryl-CoA synthase comprises an amino acid sequence set forth in SEQ ID NO: 123. In yet another embodiment, the one or more nucleic acid molecules encoding the hydroxymethylglutaryl-CoA synthase is encoded by a nucleic acid sequence set forth in SEQ ID NO: 122.Methylglutaconyl-CoA Hydratase (EC 4.2.1.18)

[0344] The present disclosure describes enzymes that can catalyze the following reaction:(S)-3-hydroxy-3-methylglutaryl-CoA↔trans-3-methylglutaconyl-CoA+H2O

[0345] This enzyme catalyzes the syn-hydration of 3-methylglutaconyl-CoA to(S)-3-hydroxy-3-methylglutaryl-CoA in the leucine degradation pathway. The bacterial enzyme has been characterized in Pseudomonas putida. It differs from the mammalian enzyme in having only one glutamyl residue in its active site rather than two, resulting in a different reaction mechanism. These enzymes are members of the crotonase superfamily (Wong B J and Gerlt J A (2004) Evolution of function in the crotonase superfamily: (3S)-methylglutaconyl-CoA hydratase from Pseudomonas putida. Biochemistry 43 (16): 4646-4654) and reviewed in (Hamed R B et al. (2008) Mechanisms and structures of crotonase superfamily enzymes—how nature controls enolate and oxyanion reactivity. Cell Mol Life Sci 65 (16): 2507-2527).

[0346] Recombinant enzyme was expressed in Escherichia coli, purified and characterized. The apparent molecular mass of the 10-His-tagged polypeptide was determined to be 32.251 kDa by ESI-MS. The 10-His-tag was subsequently removed before characterization of the enzyme (Wong and Gerlt 2004).

[0347] In one embodiment, the methylglutaconyl-CoA hydratase is encoded by one or more nucleic acid molecules obtained from Pseudomonas sp. In another embodiment, the methylglutaconyl-CoA hydratase is encoded by one or more nucleic acid molecules obtained from Pseudomonas putida. In some embodiments, the one or more nucleic acid molecules encoding the methylglutaconyl-CoA hydratase is liuC, or homolog thereof. In a further embodiment, the one or more nucleic acid molecules encoding the methylglutaconyl-CoA hydratase comprises an amino acid sequence set forth in SEQ ID NO: 125. In yet another embodiment, the one or more nucleic acid molecules encoding the methylglutaconyl-CoA hydratase is encoded by a nucleic acid sequence set forth in SEQ ID NO: 124.Methylcrotonyl-CoA Carboxylase (EC 6.4.1.4)

[0348] The present disclosure describes enzymes that can catalyze the following reaction:ADP+phosphate+H++3-methylglutaconyl-CoA↔ATP+3-methylcrotonoyl-CoA+HCO3−

[0349] The enzyme activity is associated with the 3-methylcrotonyl-CoA carboxylase complex. This enzyme is a biotin-containing, biotin-dependent carboxylase involved in the L-leucine (and isovalerate) degradation pathway of Pseudomonas aeruginosa PAO1. This pathway is also the last phase of the acyclic terpene utilization pathway (citronellol degradation and cis-genanyl-CoA degradation pathways). The enzyme is not expressed in citronellol or citronellate grown cells, but is expressed in isovalerate grown cells. Genes liuB and liuD encode the two subunits of 3-methylcrotonyl-CoA carboxylase. The subunits are encoded in the liuRABCDE gene cluster of this organism (Hoschle B et al. (2005) Methylcrotonyl-CoA and geranyl-CoA carboxylases are involved in leucine / isovalerate utilization (Liu) and acyclic terpene utilization (Atu), and are encoded by liuB / liuD and atuC / atuF, in Pseudomonas aeruginosa. Microbiology 151 (Pt 11): 3649-3656; Forster-Fromme K and Jendrossek D (2010). Catabolismof citronellol and related acyclic terpenoids in pseudomonads. Appl Microbiol Biotechnol 87 (3): 859-869).

[0350] The enzyme was purified from cell extracts by avidin-affinity chromatography and the SDS-gel-isolated subunits were subjected to trypsin fingerprint analysis and ESI-MS which allowed identification of their corresponding genes (Hoschle et al. 2005).

[0351] The 3-methylcrotonyl-CoA carboxylase of Pseudomonas citronellolis was characterized in earlier work (Hector M L and Fall R R (1976) Multiple acyl-coenzyme A carboxylases in Pseudomonas citronellolis. Biochemistry 15 (16): 3465-3472; Fall R R and Hector M L (1977) Acyl-coenzyme A carboxylases. Homologous 3-methylcrotonyl-CoA and geranyl-CoA carboxylases from Pseudomonas citronellolis. Biochemistry 16 (18): 4000-4005; Fall R R (1981) 3-Methylcrotonyl-CoA and geranyl-CoA carboxylases from Pseudomonas citronellolis. Methods Enzymol 71 Pt C: 791-799).

[0352] In one embodiment, the methylcrotonyl-CoA carboxylase is encoded by one or more nucleic acid molecules obtained from Pseudomonas sp. In another embodiment, the methylcrotonyl-CoA carboxylase is encoded by one or more nucleic acid molecules obtained from Pseudomonas aeruginosa. In some embodiments, the one or more nucleic acid molecules encoding the methylcrotonyl-CoA carboxylase is selected from liuB and / or liuD, or homologs thereof. In a further embodiment, the one or more nucleic acid molecules encoding the methylcrotonyl-CoA carboxylase comprises an amino acid sequence selected from SEQ ID NOs: 127 and 129. In yet another embodiment, the one or more nucleic acid molecules encoding the methylcrotonyl-CoA carboxylase is encoded by a nucleic acid sequence selected from SEQ ID NOs: 126 and 128.Methylcrotonyl-CoA Hydratase (EC 4.2.1.17)

[0353] The present disclosure describes enzymes that can catalyze the following reaction:trans-2(or 3)-enoyl-CoA+H2O↔(3S)-3-hydroxyacyl-CoA

[0354] An exemplary enzyme is a 3-ketoacyl-CoA thiolase. It is involved in the degradation of fatty acids via the β-oxidation cycle. It has broad chain-length specificity for substrates although it exhibits its highest activity with medium-chain substrates. It is part of a multienzyme complex and is coded for by the fadA gene (Yang S Y et al (1990) Nucleotide sequence of the fadA gene. Primary structure of 3-ketoacyl-coenzyme A thiolase from Escherichia coli and the structural organization of the fadAB operon. J Biol Chem 265 (18): 10424-10429;).

[0355] 3-ketoacyl-CoA thiolase may also be known as acetyl-CoA C-acyltransferase, β-ketothiolase, acetyl-CoA acyltransferase and acyl-CoA:acetyl-CoA C-acyltransferase.

[0356] Another exemplary enzyme is an enoyl-CoA hydratase. The alpha subunit has four enzymatic activities associated with it. It is part of a multienzyme complex. Two of the activities, enoyl-CoA hydratase (EC 4.2.1.17) and 3-OH acyl-CoA epimerase (EC 5.1.2.3) are carried out by the same N terminal active site (Yang S Y and Elzinga M (1993) Association of both enoyl coenzyme A hydratase and 3-hydroxyacyl coenzyme A epimerase with an active site in the amino-terminal domain of the multifunctional fatty acid oxidation protein from Escherichia coli. J Biol Chem 268 (9): 6588-6592).

[0357] In one embodiment, the methylcrotonyl-CoA hydratase is a 3-ketoacyl-CoA thiolase. In another embodiment, the methylcrotonyl-CoA hydratase is encoded by one or more nucleic acid molecules obtained from Escherichia coli. In some embodiments, the one or more nucleic acid molecules encoding the methylcrotonyl-CoA hydratase is fadA, or homolog thereof. In a further embodiment, the one or more nucleic acid molecules encoding the methylcrotonyl-CoA hydratase comprises an amino acid sequence set forth in SEQ ID NO: 131. In yet another embodiment, the one or more nucleic acid molecules encoding the methylcrotonyl-CoA hydratase is encoded by a nucleic acid sequence set forth in SEQ ID NO: 130.

[0358] In one embodiment, the methylcrotonyl-CoA hydratase is an enoyl-CoA hydratase. In another embodiment, the methylcrotonyl-CoA hydratase is encoded by one or more nucleic acid molecules obtained from Escherichia coli. In some embodiments, the one or more nucleic acid molecules encoding the methylcrotonyl-CoA hydratase is fadB, or homolog thereof. In a further embodiment, the one or more nucleic acid molecules encoding the methylcrotonyl-CoA hydratase comprises an amino acid sequence set forth in SEQ ID NO: 133. In yet another embodiment, the one or more nucleic acid molecules encoding the methylcrotonyl-CoA hydratase is encoded by a nucleic acid sequence set forth in SEQ ID NO: 132.3-hydroxy-isovaleryl-CoA Thioesterase (EC 3.1.2.-)

[0359] The present disclosure describes enzymes that can catalyze the following reactions:3-hydroxyisovaleryl-CoA+H2O↔3-hydroxyisovalerate+CoAan acyl-CoA+H2O→a carboxylate+coenzyme A+H+An exemplary acyl-CoA thioesterase is TesB. Thioesterase II (TesB) is one of a number of thioesterases present in E. coli. The enzyme has relatively broad substrate specificity, cleaving medium- and long-chain acyl-CoA substrates; the best tested substrate was 3,5-tetradecadienoyl-CoA (Nie L et al. (2008) A novel paradigm of fatty acid beta-oxidation exemplified by the thioesterase-dependent partial degradation of conjugated linoleic acid that fully supports growth of Escherichia coli. Biochemistry 47 (36): 9618-9626). Thioesterase II is one of the thioesterases supporting growth on oleate or conjugated linoleic acid as the sole source of carbon (Nie et al. 2008).

[0361] A crystal structure of the enzyme has been solved at 1.9 Å resolution. The D204 residue was predicted to be in the active site; its importance was confirmed by kinetic analysis of mutants (Li J et al. (2000) Crystal structure of the Escherichia coli thioesterase II, a homolog of the human Nef binding enzyme. Nat Struct Biol 7 (7): 555-559).

[0362] Strains either lacking or overproducing tesB have no obvious defect (Narasimhan M L et al. (1986) Genetic and biochemical characterization of an Escherichia coli K-12 mutant deficient in acyl-coenzyme A thioesterase II. J Bacteriol 165 (3): 911-917; Naggert J et al. (1991) Cloning, sequencing, and characterization of Escherichia coli thioesterase II. J Biol Chem 266 (17): 11044-11050). Overproduction of TesB relieves inhibition of fatty acid synthesis by long-chain acyl-ACP molecules that accumulate upon glycerol starvation (Jiang P and Cronan J E (1994) Inhibition of fatty acid synthesis in Escherichia coli in the absence of phospholipid synthesis and release of inhibition by thioesterase action. J Bacteriol 176 (10): 2814-2821).

[0363] In one embodiment, the 3-hydroxy-isovaleryl-CoA thioesterase is encoded by one or more nucleic acid molecules obtained from E. coli. In some embodiments, the one or more nucleic acid molecules encoding the 3-hydroxy-isovaleryl-CoA thioesterase is tesB, or homolog thereof. In a further embodiment, the one or more nucleic acid molecules encoding the 3-hydroxy-isovaleryl-CoA thioesterase comprises an amino acid sequence set forth in SEQ ID NO: 135. In yet another embodiment, the one or more nucleic acid molecules encoding the 3-hydroxy-isovaleryl-CoA thioesterase is encoded by a nucleic acid sequence set forth in SEQ ID NO: 134.Mevalonate-3-kinase (EC 2.7.1.-)

[0364] The present disclosure describes enzymes that can catalyze the following reaction:3-hydroxyisovalerate+ATPADP+H(+)+3-phosphonoxyisovalerate(R)-mevalonate+ATP→(R)-mevalonate 3-phosphate+ADP+H+Mevalonate-3-kinase may also be known as (R)-MVA 3-phosphotransferase or 3-hydroxyisovalerate (3HIV) kinase.

[0366] The subunit structure of this enzyme from Thermoplasma acidophilum has not been reported.

[0367] The mevalonate-3-kinase from the thermophilic archaeon Thermoplasma acidophilum is thought to participate in a variant of the mevalonate pathway found in archaea Azami Y et al. (2014) (R)-Mevalonate 3-Phosphate Is an Intermediate of the Mevalonate Pathway in Thermoplasma acidophilum. J Biol Chem 289 (23): 15957-15967; Vinokur J M et al. (2014) Evidence of a Novel Mevalonate Pathway in Archaea. Biochemistry 53 (25): 4161-4168).

[0368] Recombinant His-tagged enzyme was expressed in Escherichia coli, purified and characterized. Despite its homology with diphosphomevalonate decarboxylase, it showed no decarboxylase activity (Azami et al. 2014; Vinokur et al. 2014). The enzyme showed weak phosphomevalonate kinase activity, producing small amounts of (R)-mevalonate diphosphate (Azami et al. 2014). It had no mevalonate-5-kinase activity (Vinokur et al. 2014).

[0369] In one embodiment, the 3HIV kinase is encoded by one or more nucleic acid molecules obtained from a microorganism selected from the group consisting of Thermoplasma sp. and Picrophilus sp. In another embodiment, the 3HIV kinase is encoded by one or more nucleic acid molecules obtained from a microorganism selected from the group consisting of Thermoplasma acidophilum and Picrophilus torridus. In some embodiments, the one or more nucleic acid molecules encoding the 3HIV kinase is TA1305 and / or PTO1356, or homolog thereof. In some embodiments, the TA1305 comprises a L200E mutation. In a further embodiment, the one or more nucleic acid molecules encoding the 3HIV-kinase comprises an amino acid sequence selected from the group consisting of SEQ ID NOs: 113, 115 and 117. In yet another embodiment, the one or more nucleic acid molecules encoding the 3HIV kinase is encoded by a nucleic acid sequence selected from the group consisting of SEQ ID NOs: 112, 114 and 116.Mevalonate Diphosphate Decarboxylase (EC 4.1.1.-)

[0370] The present disclosure describes enzymes that can catalyze the following reactions:(R)-mevalonate diphosphate+ATP→isopentenyl diphosphate+CO2+ADP+phosphate3-phosphonoxyisovalerate→CO2+isobutene3-hydroxyisovalerate→CO2+isobuteneMevalonate diphosphate decarboxylase may also be known as pyrophosphomevalonate decarboxylase, mevalonate-5-pyrophosphate decarboxylase, pyrophosphomevalonic acid decarboxylase, 5-pyrophosphomevalonate decarboxylase, mevalonate 5-diphosphate decarboxylase, and ATP: (R)-5-diphosphomevalonate carboxy-lyase (dehydrating), 3-phosphonoxyisovalerate decarboxylase, 3-hydroxyisovalerate-3-phosphate decarboxylase, 3HIV-3-phosphate decarboxylase, 3-hydroxyisovalerate decarboxylase and 3HIV decarboxylase.This enzyme converts mevalonate 5-diphosphate (MVAPP) to isopentenyl diphosphate (IPP) through ATP dependent decarboxylation. The two substrates of this enzyme are ATP and mevalonate 5-diphosphate, whereas its four products are ADP, phosphate, isopentenyl diphosphate, and CO2.

[0373] Mevalonate diphosphate decarboxylase catalyzes the final step in the mevalonate pathway. The mevalonate pathway is responsible for the biosynthesis of isoprenoids from acetate. This pathway plays a key role in multiple cellular processes by synthesizing sterol isoprenoids, such as cholesterol, and non-sterol isoprenoids, such as dolichol, heme A, IRNA isopentenyltransferase, and ubiquinone. This enzyme belongs to the family of lyases, specifically the carboxy-lyases, which cleave carbon-carbon bonds.

[0374] Mevalonate diphosphate decarboxylase recognizes and binds two substrates: ATP and mevalonate 5-diphosphate. After binding, the enzyme performs three types of reactions that can be separated into two main stages. First, phosphorylation occurs. This creates a reactive intermediate, which in the second stage undergoes concerted dephosphorylation and decarboxylation.

[0375] In one embodiment, the enzyme that catalyzes the reaction 3-phosphonoxyisovalerate→CO2+isobutene is a 3HIV-3-phosphate decarboxylase. In another embodiment, the 3HIV-3-phosphate decarboxylase is encoded by one or more nucleic acid molecules obtained from Streptococcus sp. In some embodiments, the microorganism is selected from Streptococcus mitis and / or Streptococcus gordonii. In some embodiments, the one or more nucleic acid molecules encoding the 3HIV-3-phosphate decarboxylase comprises an amino acid sequence selected from SEQ ID NOs: 119 and 121. In further embodiments, the one or more nucleic acid molecule encoding the 3HIV-3-phosphate decarboxylase is encoded by a nucleic acid sequence selected from SEQ ID NOs: 118 and 120.

[0376] In one embodiment, the enzyme that catalyzes the reaction 3-hydroxyisovalerate→CO2+isobutene is a 3HIV decarboxylase. In another embodiment, the 3HIV decarboxylase is encoded by one or more nucleic acid molecules obtained from a microorganism selected from the group consisting of Streptococcus sp., Thermoplasma sp. and Picrophilus sp. In another embodiment, the 3HIV decarboxylase is encoded by one or more nucleic acid molecules obtained from a microorganism selected from the group consisting of Streptococcus gordonii, Thermoplasma acidophilum and Picrophilus torridus. In some embodiments, the one or more nucleic acid molecules encoding the 3HIV decarboxylase comprises mvaD, TA1305 and / or PTO1356, or homolog thereof. In a further embodiment, the one or more nucleic acid molecules encoding the 3HIV decarboxylase comprises an amino acid sequence selected from the group consisting of SEQ ID NOs: 113, 117 and 121. In yet another embodiment, the one or more nucleic acid molecules encoding the 3HIV decarboxylase is encoded by a nucleic acid sequence selected from the group consisting of SEQ ID NOs: 112, 116 and 120.Transketolase (EC 2.2.1.1)

[0377] The present disclosure describes enzymes that can catalyze the following reactions:D-erythrose 4-phosphate+D-xylulose 5-phosphate+↔β-D-fructofuranose 6-phosphate+D-glyceraldehyde 3-phosphateD-sedoheptulose 7-phosphate+D-glyceraldehyde 3-phosphate+↔D-ribose 5-phosphate+D-xylulose 5-phosphateTransketolase may also be known as glycolaldehydetransferase.

[0379] Transketolase catalyzes the reversible transfer of a ketol group between several donor and acceptor substrates. This key enzyme is a reversible link between glycolysis and the pentose phosphate pathway. The enzyme is involved in the catabolismof pentose sugars, the formation of D-ribose 5-phosphate, and the provision of D-erythrose 4-phosphate, a precursor of aromatic amino acids and PLP. E. coli contains two transketolase isozymes, TktA and TktB. TktA is responsible for the major transketolase activity.

[0380] In addition to its function in central carbon metabolism, transketolase appears to also have an unexpected role in chromosome structure; a tktA mutant affects chromosome topology.

[0381] Crystal structures of TktA in complex with donor and acceptor substrates have been solved, elucidating the reaction mechanism and mode of action of transketolase. A computational model of transketolase activity using a quantum mechanical / molecular mechanical method has been proposed, defining a new route for thiamine diphosphate activation. Transketolase I (TktA) is homodimeric. The urea denaturation pathways of wild type and active site mutants of TktA have been investigated, and the effects of temperature and pH on the structure, stability, aggregation and activity of transketolase have been determined. The acceptor specificity of TktA has been investigated.

[0382] TktA abundance is affected by the SOS inducer and mutagen 7-methoxy-2-nitronaphtho [2,1-b]furan (R7000). tktA is negatively regulated during entry into stationary phase. The effect by RpoS is likely indirect and might be mediated by an intermediate regulator that itself is directly regulated by RpoS.

[0383] The subunit structure of transketolase II (TktB) has not been explicitly determined. Overproduction of TktB suppresses the tktA mutant phenotype. Expression of tktB is increased in a tyrR mutant in the presence of phenylalanine. tktB expression is increased in stationary phase and positively regulated by RpoS and ppGpp. Levels of TktB protein increase during osmotic stress under aerobic, but not anaerobic growth conditions. TktB appears to be associated with the degradosome and may connect carbon metabolism to replication.

[0384] Expression of tktA and tktB is complementary, resulting in approximately constant levels of transketolase expression throughout growth.

[0385] In some embodiments, the transketolase is encoded by an amino acid sequence having at least 70% sequence identity to tktA from E. coli. In a further embodiment, the transketolase is encoded by an amino acid sequence having at least 80% sequence identity to tktA from E. coli. In yet a further embodiment, the transketolase is encoded by an amino acid sequence having at least 90% sequence identity to tktA from E. coli. In other embodiments, the transketolase is tktA from E. coli. In some embodiments, the transketolase is encoded by an amino acid sequence having at least 70% sequence identity to tktB from E. coli. In a further embodiment, the transketolase is encoded by an amino acid sequence having at least 80% sequence identity to tktB from E. coli. In yet a further embodiment, the transketolase is encoded by an amino acid sequence having at least 90% sequence identity to tktB from E. coli. In other embodiments, the transketolase is tktB from E. coli.

[0386] In some embodiments, the one or more nucleic acid molecules encoding the transketolase is tktA, or homolog thereof. In some embodiments, the one or more nucleic acid molecules encoding the transketolase is tktB, or homolog thereof. In another embodiment, the one or more nucleic acid molecules encoding the transketolase comprises an amino acid sequence selected from the group consisting of SEQ ID NOs: 148 and 150. In a further embodiment, the one or more nucleic acid molecule encoding the transketolase is encoded by a nucleic acid sequence selected from the group consisting of SEQ ID NOs: 147 and 149.Transaldolase (EC 2.2.1.2)

[0387] The present disclosure describes enzymes that can catalyze the following reaction:D-sedoheptulose 7-phosphate+D-glyceraldehyde 3-phosphate↔β-D-fructofuranose 6-phosphate+D-erythrose 4-phosphate

[0388] Transaldolase may also be known as dihydroxyacetonetransferase; dihydroxyacetone synthase; formaldehyde transketolase.

[0389] Transaldolase B is an enzyme of the non-oxidative branch of the pentose phosphate pathway. Along with transketolase, transaldolase creates a reversible link between the pentose phosphate pathway and glycolysis. It catalyzes the interconversion of glyceraldehyde-3-phosphate and sedoheptulose-7-phosphate to fructose-6-phosphate and erythrose-4-phosphate. The reversibility of this reaction and carbon flux through the pentose phosphate pathway has been addressed both experimentally and theoretically.

[0390] There are two closely related transaldolases in E. coli, encoded by talA and talB. Only transaldolase B has been biochemically characterized. TalB is a dimer in solution and in the crystal structure. Mutation of the R300 residue leads to the formation of catalytically active monomers. Catalytically important active site residues have been identified by site-directed mutagenesis.

[0391] Crystal structures of transaldolase B have been determined, confirming the presence of a Schiff-base intermediate at the active site and leading to a proposed reaction mechanism.

[0392] A talB null mutant has no growth defect on minimal media with glucose as the carbon source.

[0393] In some embodiments, the transaldolase is encoded by an amino acid sequence having at least 70% sequence identity to talA or talB from E. coli. In a further embodiment, the transaldolase is encoded by an amino acid sequence having at least 80% sequence identity to talA or talB from E. coli. In yet a further embodiment, the transaldolase is encoded by an amino acid sequence having at least 90% sequence identity to talA or talB from E. coli. In other embodiments, the transaldolase is talA from E. coli. In yet further embodiments, the transaldolase is talB from E. coli.

[0394] In some embodiments, the one or more nucleic acid molecules encoding the transaldolase is talA, or homolog thereof. In some embodiments, the one or more nucleic acid molecules encoding the transaldolase is talB, or homolog thereof. In another embodiment, the one or more nucleic acid molecules encoding the transaldolase comprises an amino acid sequence selected from the group consisting of SEQ ID NOs: 152 and 154. In a further embodiment, the one or more nucleic acid molecule encoding the transaldolase is encoded by a nucleic acid sequence selected from the group consisting of SEQ ID NOs: 151 and 153.Ribose-5-phosphate Isomerase (EC 5.3.1.6)

[0395] The present disclosure describes enzymes that can catalyze the following reaction:D-ribose 5-phosphate↔D-ribulose 5-phosphate

[0396] Ribose-5-phosphate isomerase may also be known as phosphopentosisomerase; phosphoriboisomerase; ribose phosphate isomerase; 5-phosphoribose isomerase; D-ribose 5-phosphate isomerase; D-ribose-5-phosphate ketol-isomerase.

[0397] There are two physically and genetically distinct ribose-5-phosphate isomerases present in E. coli. The constitutive ribose-5-phosphate isomerase A (rpiA) normally accounts for more than 99% of the ribose-5-phosphate isomerase activity in the cell and functions in the pentose phosphate pathway (non-oxidative branch). The inducible ribose-5-phosphate isomerase B (rpiB) can substitute for rpiA's function if its expression is induced. There is no sequence similarity between the two enzymes.

[0398] Crystal structures of rpiA have been solved and active site residues and an acid-base catalytic mechanism were predicted. An rpiA mutant requires ribose for growth.

[0399] In some embodiments, the ribose-5-phosphate isomerase is encoded by an amino acid sequence having at least 70% sequence identity to rpiA or rpiB from E. coli. In a further embodiment, the ribose-5-phosphate isomerase is encoded by an amino acid sequence having at least 80% sequence identity to rpiA or rpiB from E. coli. In yet a further embodiment, the ribose-5-phosphate isomerase is encoded by an amino acid sequence having at least 90% sequence identity to rpiA or rpiB from E. coli. In other embodiments, the ribose-5-phosphate isomerase is rpiA or rpiB from E. coli.

[0400] In some embodiments, the one or more nucleic acid molecules encoding the ribose-5-phosphate isomerase is rpiA, or homolog thereof. In another embodiment, the one or more nucleic acid molecules encoding the ribose-5-phosphate isomerase comprise an amino acid sequence set forth in SEQ ID NO: 156. In a further embodiment, the one or more nucleic acid molecules encoding the ribose-5-phosphate isomerase is encoded by a nucleic acid sequence set forth in SEQ ID NO: 155. In some embodiments, the one or more nucleic acid molecules encoding the ribose-5-phosphate isomerase is rpiB, or homolog thereof. In another embodiment, the one or more nucleic acid molecules encode the ribose-5-phosphate comprising an amino acid sequence set forth in SEQ ID NO: 253. In a further embodiment, the one or more nucleic acid molecules encoding the ribose-5-phosphate isomerase is encoded by a nucleic acid sequence set forth in SEQ ID NO: 254.Ribulose-5-phosphate 3-epimerase (EC 5.1.3.1)

[0401] The present disclosure describes enzymes that can catalyze the following reaction:D-ribulose 5-phosphate↔D-xylulose 5-phosphate

[0402] Ribulose-5-phosphate 3-epimerase may also be known as ribulose-phosphate 3-epimerase; phosphoribulose epimerase; erythrose-4-phosphate isomerase; phosphoketopentose 3-epimerase; xylulose phosphate 3-epimerase; phosphoketopentose epimerase; D-ribulose phosphate-3-epimerase; D-ribulose 5-phosphate epimerase; D-ribulose-5-P 3-epimerase; D-xylulose-5-phosphate 3-epimerase; pentose-5-phosphate 3-epimerase.

[0403] Ribulose-5-phosphate 3-epimerase (Rpe) is an enzyme of the non-oxidative branch of the pentose phosphate pathway.

[0404] Rpe requires ferrous iron for activity and is vulnerable to damage by H2O2 due to Fenton chemistry. Mn2+, Co2+ and Zn2+ can substitute for Fe2+ to varying degrees, and Rpe containing these alternative cations is not vulnerable to H2O2. Induction of the manganese transporter can protect Rpe from H2O2 damage.

[0405] In some embodiments, the ribulose-5-phosphate 3-epimerase is encoded by an amino acid sequence having at least 70% sequence identity to rpe from E. coli. In a further embodiment, the ribulose-5-phosphate 3-epimerase is encoded by an amino acid sequence having at least 80% sequence identity to rpe from E. coli. In yet a further embodiment, the ribulose-5-phosphate 3-epimerase is encoded by an amino acid sequence having at least 90% sequence identity to rpe from E. coli. In other embodiments, the ribulose-5-phosphate 3-epimerase is rpe from E. coli.

[0406] In some embodiments, the one or more nucleic acid molecules encoding the ribulose-5-phosphate 3-epimerase is rpe, or homolog thereof. In another embodiment, the one or more nucleic acid molecules encoding the ribulose-5-phosphate 3-epimerase comprise an amino acid sequence set forth in SEQ ID NO: 158. In a further embodiment, the one or more nucleic acid molecule encoding the ribulose-5-phosphate 3-epimerase is encoded by a nucleic acid sequence set forth in SEQ ID NO: 157.Fructose 6-phosphate Phosphoketolase (Fpk, EC 4.1.2.22)

[0407] The present disclosure describes enzymes that can catalyze the following reaction:D-fructose 6-phosphate+phosphate↔acetyl phosphate+D-erythrose 4-phosphate+H2O

[0408] The phosphoketolase reaction by which β-D-fructofuranose 6-phosphate is converted to D-erythrose 4-phosphate and acetyl phosphate is one of the key reactions in the Bifidobacterium shunt. There is evidence for the existence of two distinct F6P-phosphoketolase enzymes in bifidobacteria. One is specific solely for F6P while the other is able to utilize both F6P and D-xylulose 5-phosphate (EC: 4.1.2.9), a reaction that appears later in the Bifidobacterium shunt. The enzyme encoded by the xfp gene, originally discovered in Bifidobacterium animalis lactis, is the dual-specificity enzyme. A phosphoketolase has also been purified from Leuconostoc nesenteroides (LEUM_1961).

[0409] In some embodiments, an enzyme having fructose-6-phosphate phosphoketolase activity is encoded by an amino acid sequence having at least 70% sequence identity, at least 80% sequence identity, or at least 90% sequence identity to an enzyme having fructose-6-phosphate phosphoketolase activity selected from the group consisting of Bifidobacterium dentium BDP_1006, Bifidobacterium lactis xfp, Lactobacillus paraplantarum xpkA and Bifidobacterium breve xfp. In a preferred embodiment, an enzyme having fructose-6-phosphate phosphoketolase activity is selected from the group consisting of Bifidobacterium dentium BDP_1006, Bifidobacterium lactis xfp, Lactobacillus paraplantarum xpkA and Bifidobacterium breve xfp. In another embodiment, the one or more nucleic acid molecules encoding the fructose-6-phosphate phosphoketolase comprise an amino acid sequence selected from the group consisting of SEQ ID NOs: 212, 214, 216 and 218. In a further embodiment, the one or more nucleic acid molecule encoding the fructose-6-phosphate phosphoketolase is encoded by a nucleic acid sequence selected from the group consisting of SEQ ID NOs: 211, 213, 215 and 217.Phosphate Acetyltransferase (EC 2.3.1.8)

[0410] The present disclosure describes enzymes that can catalyze the following reaction:Acetyl-CoA+phosphate↔CoA+acetyl phosphate

[0411] Phosphate acetyltransferase (Pta) catalyzes the reversible conversion between acetyl-CoA and acetylphosphate, a step in the metabolism of acetate. Both pyruvate and phosphoenolpyruvate activate the enzyme in the direction of acetylphosphate synthesis and inhibit the enzyme in the direction of acetyl-CoA synthesis. The acetate formation from acetyl-CoA I pathway has been the target of metabolic engineering to reduce the flux to acetate and increase the production of commercially desired end products. It has also been studied using systems biology approaches such as metabolic modeling and flux balance analysis.

[0412] Pta is composed of three domains; only the C-terminal domain is required for phosphate acetyltransferase activity. The N-terminal domain is involved in stabilization of the native quarternary structure and metabolic regulation.

[0413] Pta may be able to utilize both acetyl-CoA and propionyl-CoA. An ack pta double mutant has reduced levels of propionate from L-threonine, suggesting that the enzyme is part of the anaerobic pathway metabolizing L-threonine to propionate. A pta mutant does not grow on acetate as the sole source of carbon. Both pta and pta ackA mutants are impaired in their ability to survive glucose starvation. The growth defect of a pta mutant appears to be due to perturbation of acetyl-CoA flux. pta mutants produce large amounts of lactate when grown on glucose as the carbon source under microaerophilic conditions. The effect of a pta mutation on metabolism, enzyme activity and gene expression has been thoroughly studied recently. pta and recBC mutants are synthetically growth inhibited.

[0414] Levels of Pta are decreased by growth on acetate and under low pH conditions. pta belongs to the CreBC regulon. FNR has a slightly positive effect on pta expression. The growth-rate dependent expression pattern of pta-ackA was measured.

[0415] The pta gene that encodes the enzyme has been cloned from Clostridium acetobutylicum, sequenced and expressed in Escherichia coli. The gene is adjacent to the ackA gene, which encodes the enzyme that catalyzes the second step-acetate kinase. Enzyme activity assays performed on cell extracts from Escherichia coli and Clostridium acetobutylicum harboring the subclone showed elevated activity. The enzymes shows a decrease in specific activity when the organism reaches the solvent formation stage.

[0416] Enzymes having phosphate acetyltransferase activity or phosphate acetyltransferase genes have also been identified or measured from E. coli (eutD, pta), Roseovarius nubinhibens ISM, Clostridium kluyveri, Chlamydomonas reinhardtii (PAT2), Dasytricha ruminantium, Pelobacter acetylenicus, Gottschalkia acidurici, Lactobacillus sanfranciscensis, Paracoccus denitrificans NKNIS, Eubacterium oxidoreducens G41, Mycoplasma pneumoniae M129, Thermotoga maritima, Moorella thermoacetica, Methanosarcina thermophile, Clostridium propionicum and Fusobacterium nucleatum.

[0417] In some embodiments, an enzyme having phosphate acetyltransferase activity is encoded by an amino acid sequence having at least 70% sequence identity, at least 80% sequence identity, or at least 90% sequence identity to an enzyme having phosphate acetyltransferase activity selected from E. coli pta and Clostridium acetobutylicum pta. In a preferred embodiment, an enzyme having phosphate acetyltransferase activity is selected from E. coli pta and Clostridium acetobutylicum pta. In another embodiment, the one or more nucleic acid molecules encoding the phosphate acetyltransferase comprise an amino acid sequence selected from SEQ ID NOs: 220 and 222. In a further embodiment, the one or more nucleic acid molecule encoding the phosphate acetyltransferase is encoded by a nucleic acid sequence selected from SEQ ID NOs: 219 and 221.Pentose Phosphatase (EC 3.1.3.23 and EC 3.1.3.1)

[0418] The present disclosure describes enzymes that can catalyze the following reactions:D-pentose 5-phosphate+H2O→D-pentose+phosphateD-ribose 5-phosphate+H2O→D-ribose+phosphateD-xylulose 5-phosphate+H2O→D-xylulose+phosphateD-ribulose 5-phosphate+H2O→D-ribulose+phosphatea sugar phosphate+H2O→a sugar+phosphateE. coli YbiV is a sugar phosphatase belonging to the family of type II haloacid dehalogenase (HAD)-like hydrolases. It shows a low level of discrimination between its preferred substrates. In addition, YbiV appears to have a low level of phosphotransferase activity using monophosphates as the phosphate donor. The phosphatase activity of YbiV was also discovered in a high-throughput screen of purified proteins. Crystal structures of YbiV have been solved, and a catalytic mechanism was suggested. YbiV may exist as a homodimer in solution.E. coli YidA is a promiscuous sugar phosphatase belonging to the superfamily of haloacid dehalogenase (HAD)-like hydrolases. Its preferred substrate is erythrose-4-phosphate. YidA selectively hydrolyzes α-D-glucose-1-phosphate and has no activity with the β form. The reaction proceeds via the canonical phosphomonoester hydrolase mechanism, which involves breakage of the P—O bond, not the C1-O bond. The phosphatase activity of YidA was first discovered in a high-throughput screen of purified proteins. Mutagenesis of the predicted catalytic Asp residue in YidA results in loss of phosphatase activity. YidA does not catalyze phosphoryl transfer to a sugar acceptor.E. coli alkaline phosphatase (phoA) is a periplasmic, homodimeric enzyme that catalyses the hydrolysis and transphosphorylation of a wide variety of phosphate monoesters. The reaction proceeds through a phosphoseryl intermediate with the subsequent release of inorganic phosphate and alcohol. The transphosphorylation reaction results in the transfer of a phosphoryl group to the alcohol of acceptors such as Tris or ethanolamine. Alkaline phosphatase is a metalloenzyme, binding two zinc atoms and one magnesium ion per monomer. Alkaline phosphatase occurs in three major forms designated isozymes 1, 2 and 3 whose relative proprotions are dependent on the growth conditions. The isozymes are differentiated by the presence or absence of an NH2-terminal arginine residue: present in both subunits of isozyme 1, absent in both subunits of isozyme 3 and heterogenous in isozyme 2. Removal of the N-terminal arginine is catalysed by the membrane-associated, proteolytic enyzyme lap. The precursor polypeptide is secreted across the inner membrane to the periplasmic space concommitant with removal of the signal sequence. Folding of PhoA in vivo is catalysed by the periplasmic protein, DsbA and is thought to occur as the polypeptide elongates from the ribosome. phoA is part of the phosphate regulon; its expression is positively regulated by the PhoB transcriptional regulator.In some embodiments, the pentose phosphatase is an alkaline phosphatase. In some preferred embodiments, the alkaline phosphatase may be evolved to preferrably act on targeted pentose 5-phosphate. In some embodiments, the pentose phosphatase is a sugar phosphatase. In other embodiments, the sugar phosphatase may be evolved to preferrably act on targeted pentose 5-phosphate. In some embodiments, the pentose phosphatase is a haloacid dehalogenase-like hydrolase. In another embodiment, the haloacid dehalogenase-like hydrolase may be evolved to preferrably act on targeted pentose 5-phosphate.

[0423] In some embodiments, the pentose phosphatase is selected from one or more of a D-pentose-5-phosphatase, a D-xylulose-5-phosphatase, a D-ribose-5-phosphatase, and a D-ribulose-5-phosphatase. In some embodiments, the pentose phosphatase is encoded by an amino acid sequence having at least 70% sequence identity, at least 80% sequence identity, or at least 90% sequence identity to a D-pentose-5-phosphatase selected from the group consisting of E. coli phoA, E. coli yfbT and E. coli yidA. In some embodiments, the D-xylulose-5-phosphatase is encoded by an amino acid sequence having at least 70% sequence identity, at least 80% sequence identity, or at least 90% sequence identity to Bacillus subtilis araL. In some embodiments, the D-ribose-5-phosphatase is encoded by an amino acid sequence having at least 70% sequence identity, at least 80% sequence identity, or at least 90% sequence identity to a D-ribose-5-phosphatase selected from the group consisting of Arabidopsis thaliana SGPP, Pseudomonas fluorescens PFLU_2693, and E. coli ybiV. In some embodiments, the D-ribulose-5-phosphatase is encoded by an amino acid sequence having at least 70% sequence identity, at least 80% sequence identity, or at least 90% sequence identity to Plasmodium falciparum PF10_0325.

[0424] In some embodiments, the one or more nucleic acid molecules encoding the D-pentose-5-phosphatase is selected from the group consisting of SEQ ID NOs: 159, 161, 163, 165, 167, 169, 171 and 173. In another embodiment, the one or more nucleic acid molecules encoding the D-pentose-5-phosphatase comprise an amino acid sequence selected from the group consisting of SEQ ID NOs: 160, 162, 164, 166, 168, 170, 172 and 174.Arabitol Phosphate Dehydrogenase (EC 1.1.1.-)

[0425] The present disclosure describes enzymes that can catalyze the following reactions:D-arabitol 1-phosphate+NAD+↔D-xylulose 5-phosphate+NADH+H+D-arabitol 5-phosphate+NAD+↔D-ribulose 5-phosphate+NADH+H+D-arabitol 1-phosphate+NAD+↔D-ribulose 1-phosphate+NADH+H+D-arabitol 5-phosphate+NAD+↔D-xylulose 1-phosphate+NADH+H+D-arabitol-phosphate dehydrogenase APDH from Enterococcus avium has been purified to homogeneity. The protein, which forms a homotetramer, catalyzes the dehydrogenation of both D-arabitol 1-phosphate and D-arabitol 5-phosphate, producing D-xylulose 5-phosphate and D-ribulose 5-phosphate, respectively. Maximal velocity with D-arabitol 1-phosphate was 10-fold than with D-arabitol 5-phosphate. The purified protein was partially sequenced, and the APDH gene encoding it was cloned. The enzyme requires Mn2+ and can not utilize Zn2+ for activity. Both NAD (+) and NADP (+) were accepted as cofactors, but reaction rates with NAD+ / NADH were about 14 times higher than with NADP+ / NADPH. The enzyme catalyzes a reversible reaction, but the rate of the reduction reaction is much higher that the oxidative reaction. Kinetic data suggests that the enzyme forms a ternary complex with its substrate and NADH. Both biochemical evidence and protein sequence homology comparisons indicate that similar enzymes are widespread among the Gram-positive bacteria and participate in arabitol catabolism.In some embodiments, the pentol dehydrogenase activity may be evolved to apply to pentol phosphate.In some embodiments, the arabitol phosphate dehydrogenase is selected from one or more of an enzyme having D-arabitol 1-phosphate 4-dehydrogenase activity, an enzyme having D-arabitol 5-phosphate 2-dehydrogenase activity, an enzyme having D-arabitol 1-phosphate 2-dehydrogenase activity and an enzyme having D-arabitol 5-phosphate 4-dehydrogenase activity.

[0429] In some embodiments, an enzyme having D-arabitol 1-phosphate 4-dehydrogenase activity is encoded by an amino acid sequence having at least 70% sequence identity, at least 80% sequence identity, or at least 90% sequence identity to APDH from Enterococcus avium. In a preferred embodiment, an enzyme having D-arabitol 1-phosphate 4-dehydrogenase activity is APDH from Enterococcus avium. In some embodiments, the one or more nucleic acid molecules encoding a D-arabitol 1-phosphate 4-dehydrogenase is set forth in SEQ ID NO: 175. In another embodiment, the one or more nucleic acid molecules encoding a D-arabitol 1-phosphate 4-dehydrogenase comprise an amino acid sequence set forth in SEQ ID NO: 176.

[0430] In some embodiments, an enzyme having D-arabitol 5-phosphate 2-dehydrogenase activity is encoded by an amino acid sequence having at least 70% sequence identity, at least 80% sequence identity, or at least 90% sequence identity to APDH from Enterococcus avium. In a preferred embodiment, an enzyme having D-arabitol 5-phosphate 2-dehydrogenase activity is APDH from Enterococcus avium. In some embodiments, the one or more nucleic acid molecules encoding a D-arabitol 5-phosphate 2-dehydrogenase is set forth in SEQ ID NO: 175. In another embodiment, the one or more nucleic acid molecules encoding a D-arabitol 5-phosphate 2-dehydrogenase comprise an amino acid sequence set forth in SEQ ID NO: 176.

[0431] In some embodiments, an enzyme having D-arabitol 1-phosphate 2-dehydrogenase activity is encoded by an amino acid sequence having at least 70% sequence identity, at least 80% sequence identity, or at least 90% sequence identity to an enzyme having D-arabitol 1-phosphate 2-dehydrogenase activity selected from the group consisting of Candida albicans ARD1, Candida tropicalis ARD1, Scheffersomyces stipitis ARDH, Bacillus subtilis egsA (araM), Aeropyrum pernix egsA, E. coli gpsA and Saccharomyces cerevisiae GPD1. In a preferred embodiment, an enzyme having D-arabitol 1-phosphate 2-dehydrogenase activity is selected from the group consisting of Candida albicans ARD1, Candida tropicalis ARD1, Scheffersomyces stipitis ARDH, Bacillus subtilis egsA (araM), Aeropyrum pernix egsA, E. coli gpsA and Saccharomyces cerevisiae GPD1. In some embodiments, the one or more nucleic acid molecules encoding a D-arabitol 1-phosphate 2-dehydrogenase is selected from the group consisting of SEQ ID NOs: 177, 179, 181, 189, 191, 193 and 195. In another embodiment, the one or more nucleic acid molecules encoding a D-arabitol 1-phosphate 2-dehydrogenase comprise an amino acid sequence selected from the group consisting of SEQ ID NOs: 178, 180, 182, 190, 192, 194 and 196.

[0432] In some embodiments, an enzyme having D-arabitol 5-phosphate 4-dehydrogenase activity is encoded by an amino acid sequence having at least 70% sequence identity, at least 80% sequence identity, or at least 90% sequence identity to an enzyme having D-arabitol 5-phosphate 4-dehydrogenase activity selected from the group consisting of Pseudomonas fluorescens mtID, Klebsiella pneumoniae daID, Ralstonia solanacearum daID, Bacillus subtilis egsA (araM), Aeropyrum pernix egsA, E. coli gpsA and Saccharomyces cerevisiae GPD1. In a preferred embodiment, an enzyme having D-arabitol 5-phosphate 4-dehydrogenase activity is selected from the group consisting of Pseudomonas fluorescens mtID, Klebsiella pneumoniae daID, Ralstonia solanacearum daID, Bacillus subtilis egsA (araM), Aeropyrum pernix egsA, E. coli gpsA and Saccharomyces cerevisiae GPD1. In some embodiments, the one or more nucleic acid molecules encoding a D-arabitol 5-phosphate 4-dehydrogenase is selected from the group consisting of SEQ ID NOs: 183, 185, 187, 189, 191, 193 and 195. In another embodiment, the one or more nucleic acid molecules encoding a D-arabitol 5-phosphate 4-dehydrogenase comprise an amino acid sequence selected from the group consisting of SEQ ID NOs: 184, 186, 188, 190, 192, 194 and 196.Phosphopentomutase (EC 5.4.2.-)

[0433] The present disclosure describes enzymes that can catalyze the following reactions:D-xylulose 5-phosphate↔D-xylulose 1-phosphateD-ribulose 5-phosphate↔D-ribulose 1-phosphateα-D-ribose-1-phosphate↔D-ribose 5-phosphate2-deoxy-α-D-ribose 1-phosphate↔2-deoxy-D-ribose 5-phosphateE. coli phosphopentomutase deoB is a catabolic enzyme which catalyzes the transfer of a phosphate group between the C1 and the C5 carbon atoms of ribose and deoxyribose, respectively.A mutation in deoB suppresses the high thymine requirement for growth of thy mutants and improves the survival of thyA mutants in stationary phase. Transposon insertion mutations in deoB suppress the growth defect of a tktA tktB mutant. Deletion of deoB increases glycerol consumption as well as hydrogen and ethanol production compared to wild type, and increases lycopene production in an engineered strain. The deo operon has a complex pattern of regulation. Expression of deoB is downregulated by nitrogen starvation. The E. coli phosphopentomutase appears to be biochemically and structurally distinct from mammalian phosphopentomutase, making it a potential target for antibiotic development.In some embodiments, the phosphopentomutase (PPM), also named here as phosphosugarmutase (PSM) also has phosphoglucomutase activity, and is Saccharomyces cerevisiae phosphoribomutase PRM15 (also known as PGM3) (SEQ ID NO. 255 or SEQ ID NO: 258). In some embodiments, the phosphopentosemutase is encoded by an aminoacid sequence having at least 70% sequence identity, at least 80% sequence identity or at least 90% sequence identity to the Pgm3 from Saccharomyces cerevisiae.

[0437] In some embodiments, the phosphopentomutase is Homo sapiens phosphoglucomutase-2 (PGM2).

[0438] In some embodiments, a phosphopentomutase activity may be evolved to apply to D-xylulose 5-phosphate. In other embodiments, a phosphopentomutase activity may be evolved to apply to D-ribulose 5-phosphate. In some embodiments, an alpha-phosphoglucomutase activity may be evolved to apply to D-ribulose 5-phosphate or D-xylulose 5-phosphate. This enzyme from the class EC 5.4.2.2 is reported to require α-glucose 1,6-bisphosphate as co-factor. In further embodiments, a beta-phosphoglucomutase activity may be evolved to apply to D-ribulose 5-phosphate or D-xylulose 5-phosphate. Enzymes from the class EC 5.4.2.6 are reported to be able to autophosphorylate themselves, thus not requiring external glucose 1,6-bisphosphate as co-factor. In yet further embodiments, a phosphomannomutase activity may be evolved to apply to D-ribulose 5-phosphate or D-xylulose 5-phosphate. This enzyme from the class EC 5.4.2.8 is reported to require α-glucose 1,6-bisphosphate or α-D-Mannose 1,6-bisphosphate as co-factor.

[0439] In some embodiments, an enzyme having phosphopentomutase activity is encoded by an amino acid sequence having at least 70% sequence identity, at least 80% sequence identity, or at least 90% sequence identity to an enzyme having phosphopentomutase activity selected from the group consisting of E. coli deoB, E. coli pgm, Bacillus subtilis pgcA, Lactococcus lactis pgmB, E. coli ycjU, Pseudomonas aeruginosa algC, and E. coli cpsG. In a preferred embodiment, an enzyme having phosphopentomutase activity is selected from the group consisting of E. coli deoB, E. coli pgm, Bacillus subtilis pgcA, Lactococcus lactis pgmB, E. coli ycjU, Pseudomonas aeruginosa algC, S. cerevisiae PGM3, and E. coli cpsG. In some embodiments, the one or more nucleic acid molecules encoding a phosphopentomutase is selected from the group consisting of SEQ ID NOs: 197, 199, 201, 203, 205, 207 and 209. In another embodiment, the one or more nucleic acid molecules encoding a phosphopentomutase comprise an amino acid sequence selected from the group consisting of SEQ ID NOs: 198, 200, 202, 204, 206, 208 and 210.Glucose-6-phosphate 1-dehydrogenase (EC 1.1.1.49)

[0440] The present disclosure describes enzymes that can catalyze the following reaction:D-glucose 6-phosphate+NADP+↔6-phospho-D-glucono-1,5-lactone+NADPH

[0441] Glucose-6-phosphate 1-dehydrogenase may also be known as glucose-6-phosphate dehydrogenase (NADP+); NADP-glucose-6-phosphate dehydrogenase; Zwischenferment; D-glucose 6-phosphate dehydrogenase; glucose 6-phosphate dehydrogenase (NADP); NADP-dependent glucose 6-phosphate dehydrogenase; 6-phosphoglucose dehydrogenase; Entner-Doudoroff enzyme; G6PDH; GPD; glucose-6-phosphate dehydrogenase.

[0442] Glucose-6-phosphate dehydrogenase (G6PDH) is the first enzyme of the pentose phosphate pathway and provides a large fraction of the NADPH needed for anabolism.

[0443] The E. coli G6PDH shows a strong preference for NADP+ over NAD+. The structural basis for this preference was studied using molecular simulations, kinetic characterization of site-directed mutants and phylogenetic analyses.

[0444] Metabolic flux through the pathways of central carbon metabolism was measured using GC-MS and 13C labeling and 2D NMR spectroscopy. Regulation of these pathways under different growth conditions was measured at the level of enzyme expression and activity.

[0445] Substitution of an NADH-producing glucose-6-phosphate dehydrogenase for the native NADPH-producing enzyme reduced the growth rate of otherwise wild-type cells, while increasing the growth rate of a Δpgi mutant. This suggests that whether production of NADH by G6PDH is beneficial or detrimental in vivo depends on the operation of the upper Embden-Meyerhof pathway.

[0446] In addition to its role in central carbon metabolism, G6PDH was found to be the source of a linear peptide with the amino acid sequence Asn-Asn-Trp-Asn-Asn (NNWNN) that acts as an “extracellular death factor” (EDF) for MazEF-mediated cell death. The peptide acts by increasing the endoribonuclease activity of the toxins MazF and ChpBK. EDF production under stress conditions is due to cleavage of the zwf mRNA at specific ACA sites by MazF, generating a leaderless truncated mRNA. The location of the EDF-coding region with respect to the MazF cleavage sites is important, and the trans-translation system is required.

[0447] zwf is one of the most consistently flux-coupled genes, which are genes whose expression transition patterns upon perturbations are correlated with their corresponding flux values. Expression of zwf is growth rate-regulated at the transcriptional level. G6PDH activity is greater in rapidly growing cells, and is greater under nitrogen-limited compared to carbon-limited growth conditions. zwf is a part of the SoxRS regulon which responds to superoxide stress. Additional regulators have been shown to activate transcription of zwf. Exposure to tellurite activates transcription of zwf and thereby increases the synthesis of NADPH.

[0448] A zwf null mutation does not affect the growth rate significantly. However, central carbon metabolism and metabolic flux is changed. A pgi zwf double mutant does not grow on glucose as the sole source of carbon. In the presence of glucose, it accumulates high levels of glucose-6-phosphate, which inhibits fructose-1,6-bisphosphatase I activity. Deletion of zwf reduces the organic solvent tolerance of E. coli JM109.

[0449] In some embodiments, a recombinant microorganism producing MEG (or glycolic acid), or optionally, MEG (or glycolic acid) and one or more co-product, comprises a deletion, insertion, or loss of function mutation in a gene encoding a glucose-6-phosphate dehydrogenase to prevent the flux of glucose-6-phosphate through the oxidative branch of the pentose phosphate pathway and instead shunt glucose-6-phosphate through the non-oxidative branch of the pentose phosphate pathway to produce one or more pentose-5-phosphate intermediate.6-phosphogluconolactonase (EC 3.1.1.31)

[0450] The present disclosure describes enzymes that can catalyze the following reaction:6-phospho D-glucono-1,5-lactone+H2O→D-gluconate 6-phosphate+H+

[0451] 6-phosphogluconolactonase may also be known as phosphogluconolactonase; 6-PGL.

[0452] 6-phosphogluconolactonase is an enzyme of the oxidative pentose phosphate pathway.

[0453] A pgl mutant strain grows only slightly slower than wild type on glucose as the sole source of carbon. Growth on glucose may be due to non-enzymatic hydrolysis of 6-phospho D-glucono-1,5-lactone or a bypass pathway that involves dephosphorylation and export of gluconolactone, hydrolysis to gluconate, followed by gluconate re-import and phosphorylation. When grown on maltose medium, strains lacking Pgl activity turn blue after iodine treatment. The phenotype of a pgl deletion strain can be complemented by expression of the pgl gene from Pseudomonas putida, although there is no detectable similarity between the two genes.

[0454] A strategy for metabolic engineering of E. coli for the production of riboflavin included overexpression of pgl, leading to an increase in riboflavin titer.

[0455] pgl is part of a genomic region that is deleted in the E. coli B strain BL21, but is present in the K-12 strain MG1655.

[0456] In some embodiments, a recombinant microorganism producing MEG (or glycolic acid), or optionally, MEG (or glycolic acid) and one or more co-product, comprises a deletion, insertion, or loss of function mutation in a gene encoding a 6-phosphogluconolactonase to prevent the flux of glucose-6-phosphate through the oxidative branch of the pentose phosphate pathway and instead shunt glucose-6-phosphate through the non-oxidative branch of the pentose phosphate pathway to produce one or more pentose-5-phosphate intermediate.6-phosphogluconate Dehydrogenase, Decarboxylating (EC 1.1.1.44)

[0457] The present disclosure describes enzymes that can catalyze the following reaction:D-gluconate 6-phosphate+NADP+→D-ribulose 5-phosphate+CO2+NADPH

[0458] 6-phosphogluconate dehydrogenase may also be known as phosphogluconate dehydrogenase (NADP+-dependent, decarboxylating); phosphogluconic acid dehydrogenase; 6-phosphogluconic dehydrogenase; 6-phosphogluconic carboxylase; 6-phospho-D-gluconate dehydrogenase; glyceraldehyde 3-phosphate dehydrogenase.

[0459] 6-phosphogluconate dehydrogenase is an enzyme of the oxidative branch of the pentose phosphate pathway.

[0460] Three crystal structures of the enzyme in complex with substrate and cosubstrate compounds have been solved. Binding of NADP+ may induce a conformational change in the enzyme. A catalytic mechanism has been proposed.

[0461] gnd is a highly polymorphic gene within E. coli populations, likely due to interstrain transfer and recombination. This may be a result of its proximity to the rfb region, which determines O antigen structure.

[0462] Expression of 6-phosphogluconate dehydrogenase is growth rate-regulated. Most of the growth rate-dependent increase in Gnd levels is due to increased transcription, leading to higher mRNA levels. Posttranscriptional regulation involves a secondary structure element between codons 67 and 78 of the gnd mRNA. This region may function by sequestration of the translation initiation region into an mRNA secondary structure, thus reducing the efficiency of translation initiation. However, the effector of this regulatory mechanism has apparently not yet been identified. truA (hisT) mutants reduce the growth rate-dependent increase of Gnd expression by post-transcriptional regulation. Growth under acidic conditions upregulates expression of gnd. gnd is one of the most consistently flux-coupled genes (FCGs), which are genes whose expression transition patterns upon perturbations are correlated with their corresponding flux values.

[0463] Certain growth conditions selected for a deletion mutation in the promoter region that results in increased transcription of gnd and increased enzyme activity. An edd gnd double mutant is unable to grow on gluconate. A null mutation in gnd does not significantly alter the growth rate. However, cellular metabolism and metabolic flux is changed; succinate production is increased during growth on glucose or glycerol. A gnd deletion mutant shows enhanced ethanol and H2 production compared to wild type during anaerobic growth on glycerol, whereas in a different, heavily engineered strain, overexpression of gnd increases ethanol and H2 production.

[0464] In some embodiments, a recombinant microorganism producing MEG (or glycolic acid), or optionally, MEG (or glycolic acid) and one or more co-product, comprises a deletion, insertion, or loss of function mutation in a gene encoding a 6-phosphogluconate dehydrogenase to prevent the flux of glucose-6-phosphate through the oxidative branch of the pentose phosphate pathway and instead shunt glucose-6-phosphate through the non-oxidative branch of the pentose phosphate pathway to produce one or more pentose-5-phosphate intermediate.Glyceraldehyde 3-phosphate Dehydrogenase, Phosphorylating (EC 1.2.1.12)

[0465] The present disclosure describes enzymes that can catalyze the following reaction:D-glyceraldehyde 3-phosphate+NAD++phosphate↔1,3-bisphospho-D-glycerate+NADH+H+

[0466] Glyceraldehyde 3-phosphate dehydrogenase may also be known as glyceraldehyde-3-phosphate dehydrogenase (phosphorylating); triosephosphate dehydrogenase; dehydrogenase, glyceraldehyde phosphate; phosphoglyceraldehyde dehydrogenase; 3-phosphoglyceraldehyde dehydrogenase; NAD+-dependent glyceraldehyde phosphate dehydrogenase; glyceraldehyde phosphate dehydrogenase (NAD+); glyceraldehyde-3-phosphate dehydrogenase (NAD+); NADH-glyceraldehyde phosphate dehydrogenase; glyceraldehyde-3-P-dehydrogenase.

[0467] Glyceraldehyde 3-phosphate dehydrogenase A catalyzes the reversible oxidative phosphorylation of D-glyceraldehyde-3-phosphate to 1,3-bisphospho-D-glycerate in the presence of NAD+ and phosphate during glycolysis and gluconeogenesis in E. coli. The enzyme is also found in many other organisms and its properties have been extensively studied.

[0468] E. coli is unusual in having two glyceraldehyde-3-phosphate dehydrogenase (GAPDH) activities encoded by gapA and epd (gapB). However, the gapA encoded enzyme has a highly efficient phosphorylating glyceraldehyde-3-phosphate dehydrogenase activity and a low phosphorylating erythrose-4-phosphate dehydrogenase activity, whereas the epd encoded enzyme has an efficient non-phosphorylating erythrose-4-phosphate dehydrogenase activity and a very low phosphorylating glyceraldehyde-3-phosphate dehydrogenase activity.

[0469] The GapA protein has a sequence that is more similar to eukaryotic sequences than to the thermophilic bacterial enzymes, and to prokaryotic enzymes in general. The gapA product is required for glycolysis, while the epd product is not. Both enzymes may be involved in production of pyridoxal 5′-phosphate (PLP).

[0470] Early studies of gapA mutants from E. coli K-10 implicated its role in glycolysis and demonstrated some of its catalytic properties. A gapA mutant exhibits a growth defect and also exhibits increased aggregation and lysis phenotypes that are rescued by high-salt media.

[0471] Regulation of gapA gene expression has been studied. The regulation of the fkpA, gapA, and hsIT genes is affected by evolution under conditions of chronic heat stress.

[0472] The E. coli sequence contains several amino acids that are conserved in all GAPDHs and are postulated to be involved in NAD+ binding, or the catalytic mechanism.

[0473] The crystal structure of the wild-type enzyme in the presence of NAD+ has been determined at 1.80 Å resolution and was similar to those of other GAPDHs. The crystal structure of a N313T mutant was also determined at 2.17 Å resolution. Several other E. coli GAPDH crystal structures have been reported with and without bound NAD+, and in the hemiacetal intermediate state.

[0474] Molecular factors responsible for the NAD+ cofactor stereospecificity have been studied using site-directed mutagenesis. The enzyme is a B-specific dehydrogenase that catalyzes transfer of the pro-S hydrogen and binds NAD(H) in the syn nicotinamide orientation. Refolding of denatured E. coli GAPDH in the presence of chaperone protein Tig; trigger factor has been studied.

[0475] ADP-ribosylated GAPDH is a secreted virulence factor in some fungi and Gram-positive pathogens, as well as in pathogenic strains of E. coli. Non-pathogenic E. coli do not secrete GAPDH. Evidence suggests that E. coli GAPDH is also involved in DNA repair.

[0476] A series of vectors inducibly expressing paired-terminus antisense RNAs was constructed to silence central carbon metabolism in host E. coli K-12 MG1655. A vector that silenced gapA at 93% efficacy caused severe growth inhibition. Regulating the expression of an engineered E. coli gapA through changes in temperature has been demonstrated to control glycolysis.

[0477] In some embodiments, a recombinant microorganism producing MEG (or glycolic acid), or optionally, MEG (or glycolic acid) and one or more co-product, comprises a deletion, insertion, or loss of function mutation in a gene encoding a glyceraldehyde 3-phosphate dehydrogenase to prevent the conversion of glyceraldehyde 3-phosphate to 1,3-bisphospho-D-glycerate and instead allow D-glyceraldehyde 3-phosphate to be converted to D-xylulose-5-phosphate (with a concurrent conversion of fructose-6-phosphate to D-erythrose-4-phosphate) by a transketolase, and thus produce a pentose-5-phosphate intermediate needed for the production of MEG (or glycolic acid), or optionally, MEG (or glycolic acid) and one or more co-product and provide more D-erythrose-4-phosphate for the non-oxidative branch of the pentose phosphate pathway to further produce one or more pentose-5-phosphate intermediate.6-phosphofructokinase (EC 2.7.1.11)

[0478] Phosphofructokinase (Pfk) catalyzes the phosphorylation of fructose-6-phosphate on the C1 carbon during glycolysis. E. coli contains two Pfk isozymes, Pfk-1 (pfkA) and Pfk-2 (pfkB), which do not share sequence similarity. More than 90% of the phosphofructokinase activity present in wild type E. coli can be attributed to Pfk-1.

[0479] PfkA catalyzes the phosphorylation of fructose-6-phosphate and is a key enzyme regulating the glycolysis pathway. The enzyme cannot catalyze the reverse reaction in vivo. The enzyme shows cooperative kinetics with the substrate fructose-6-phosphate, but not with the other substrate, ATP. Recently, it was shown that PfkA also catalyzes phosphorylation of sedoheptulose-7-phosphate as part of the sedoheptulose bisphosphate bypass. Crystal structures of PfkA have been solved with and without activators and inhibitors. Based on sequence similarity, PfkA was predicted to be an NAD+ kinase.

[0480] PfkB is a member of the ribokinase family of sugar kinases. PfkB, unlike PfkA, does not show cooperative interaction with fructose-6-phosphate, inhibition by PEP or activation by ADP. MgATP2− is the true substrate of the enzyme. PfkB can also use tagatose-6-phosphate as a substrate. This reaction is part of the galactitol catabolism pathway. A crystal structure of PfkB in the tetrameric form inhibited by MgATP has been solved at 1.98 Å resolution. Comparison of this structure with a crystal structure of PfkB in complex with fructose-6-phosphate suggests negative interplay between fructose-6-phosphate binding and MgATP binding.

[0481] In some embodiments, a recombinant microorganism producing MEG (or glycolic acid), or optionally, MEG (or glycolic acid) and one or more co-product, comprises a deletion, insertion, or loss of function mutation in a gene encoding a 6-phosphofructokinase to prevent the conversion of fructose-6-phosphate to 1,6-bisphosphate and instead allow fructose-6-phosphate to be converted to erythrose-4-phosphate and acetyl-phosphate by a fructose-6-phosphate phosphoketolase, and provide more erythrose-4-phosphate for the non-oxidative branch of the pentose phosphate pathway to further produce one or more pentose-5-phosphate intermediate needed for the production of MEG (or GA), or optionally, MEG (or GA) and one or more co-product. In some embodiments, the 6-phosphofructokinase is pfkA and / or pfkB.Hydroxypyruvate Decarboxylase, 2-oxoglutarate Decarboxylase, 2-Keto Acid Decarboxylase (EC 4.1.1.-)

[0482] The present disclosure describes enzymes that can catalyze the following reactions:hydroxypyruvate+H+↔CO2+glycolaldehyde2-oxoglutarate+coenzyme A+NAD+→succinyl-CoA+CO2+NADH4-methyl-2-oxopentanoate+H+→3-methylbutanal+CO2 3-methyl-2-oxobutanoate+H+→isobutanal+CO2 Hydroxypyruvate decarboxylase may also be known as hydroxypyruvate carboxy-lyase.2-oxoglutarate decarboxylase may also be known as oxoglutarate decarboxylase; alpha-ketoglutarate decarboxylase; alpha-ketoglutaric decarboxylase; pre-2-oxoglutarate decarboxylase; 2-oxoglutarate carboxy-lyase.E. coli SucA is responsible for the 2-oxoglutarate decarboxylase activity of the 2-oxoglutarate dehydrogenase multienzyme complex (OGDHC) that catalyzes the conversion of 2-oxoglutarate (2-ketoglutarate) to succinyl-CoA and CO2, with the production of NADH.

[0486] The OGDHC is a member of the 2-oxo acid dehydrogenase family. Members of this family contain multiple copies of three enzymatic components: 2-oxoglutarate decarboxylase (E1), lipoamide acyltransferase (E2) and lipoamide dehydrogenase (E3). In most Gram-positive bacteria and in mitochondria the E1 component is a heterodimer composed of two subunits, while in most (but not all) Gram-negative bacteria it is made up of a single type of subunit. In both cases multiple copies of the E1 component along with multiple copies of the E3 component are assembled around an E2 core of 24 subunits with octahedral symmetry, or 60 subunits with eicosahedral symmetry (depending on which complex and species). In E. coli the E3 component is shared with the pyruvate dehydrogenase and glycine cleavage multi-enzyme complexes. E1 and E2 differ slightly for the 2-oxoglutarate and pyruvate dehydrogenase complexes, and are designated (o) and (p) to distinguish them.

[0487] The E. coli OGDHC contains 12 units of the E1(o) component 2-oxoglutarate decarboxylase, thiamine-requiring encoded by sucA, 24 units of the E2(o) component dihydrolipoyltranssuccinylase encoded by sucB, and 2 units of the E3 component lipoamide dehydrogenase encoded by Ipd. The 24 E2(o) units form the octahedral core of the complex. They contain lipoyllysine and binding sites for dimers of the E1(o) and E3 subunits. Electron cryotomography showed that they are flexibly tethered to the E2 core.

[0488] During the OGDHC reaction cycle, 2-oxoglutarate is bound and decarboxylated by SucA, a thiamin-diphosphate cofactor containing enzyme. The crystal structure of a truncated, apo form of SucA lacking the N-terminal 77 residues has been determined at 2.6 Å resolution. The structure of the holo form with thiamin diphosphate and Mg2+ was determined at 3.5 Å resolution. The truncated form retained decarboxylase activity but did not assemble with E2(o) into an OGDH complex. Data also suggested the presence of an AMP binding site. An oxygen-dependent thiamin free radical was demonstrated in the OGDHC, which was generated by a side reaction with O2.

[0489] Studies of engineered SucA prepared by saturation mutagenesis of His260 and His298 suggested that His260 is required for substrate recognition, but His298 could be replaced by hydrophobic residues of similar size. Data also suggested that E2(o) has a role in specificity.

[0490] The sucA gene was cloned and sequenced in earlier work and regulation of sucABCD was studied. The sucAB and sucCD genes were shown to be mutually essential, with either pair sufficient to produce succinyl-CoA, but simultaneous deletion of sucAB and sucCD was not viable.

[0491] α-ketoisovalerate decarboxylase catalyzes the decarboxylation of 3-methyl-2-oxobutanoate to isobutanal. The enzyme is highly specific for 3-methyl-2-oxobutanoate, but also shows activity with other branched-chain 2-keto acids (4-methyl-2-oxopentanoate, 22.7% relative activity; (S)-3-methyl-2-oxopentanoate, 16.7%, 2-oxo-3-phenylpropanoate, 7.1% and 4-(methylthio)-2-oxobutanoate, 5.8%.

[0492] The enzyme is a homo-tetramer, encoded by the kivd gene, which has been sequenced and cloned. The deduced protein sequence shares 98.6% identity (over its first 438 amino acids) with an L. lactis strain IL1403 protein, encoded by the ipd gene (this gene is interrupted at position L439 by the insertion of an IS983 element). The kivd gene does not have any homology with any gene(s) in the sequenced genomes of L. lactis strains MG1363 and SK11.

[0493] A study of the Kivd activity testing 156 lactic acid bacteria strains (Lactococcus, Lactobacillus, Leuconostoc) indicated that only L. lactis strains possess the activity, and even within lactococcal strains, only 7 out of 45 strains had the activity.

[0494] A homologous protein has been described from L. lactis strain B1157 as branched-chain α-keto acid decarboxylase. That protein shows 89.8% identity with Kivd and also has a preference for 2-keto-isovalerate.

[0495] In some embodiments, an enzyme having 2-keto acid decarboxylase activity, an enzyme having hydroxypyruvate decarboxylase activity or an enzyme having 2-oxoglutarate decarboxylase activity converts hydroxypyruvate to glycolaldehyde. In some embodiments, the enzyme that converts hydroxypyruvate to glycolaldehyde is encoded by an amino acid sequence having at least 70% sequence identity, having at least 80% sequence identity, or having at least 90% sequence identity to Kivd or SucA. In some embodiments, the enzyme having 2-keto acid decarboxylase activity is Kivd. In some embodiments, the enzyme having 2-oxoglutarate decarboxylase activity is SucA.

[0496] In some embodiments, the one or more nucleic acid molecules encoding the enzyme having 2-oxoglutarate decarboxylase activity is sucA, or homolog thereof. In some embodiments, the one or more nucleic acid molecules encoding the enzyme having 2-keto acid decarboxylase activity is Kivd, or homolog thereof. In another embodiment, the one or more nucleic acid molecules encoding an enzyme having 2-keto acid decarboxylase activity, an enzyme having hydroxypyruvate decarboxylase activity or an enzyme having 2-oxoglutarate decarboxylase activity comprise an amino acid sequence selected from SEQ ID NOs: 224 and 226. In a further embodiment, the one or more nucleic acid molecule encoding an enzyme having 2-keto acid decarboxylase activity, an enzyme having hydroxypyruvate decarboxylase activity or an enzyme having 2-oxoglutarate decarboxylase activity is encoded by a nucleic acid sequence selected from SEQ ID NOs: 223 and 225.2-oxoglutarate Reductase, 3-phospho-hydroxypyruvate Reductase, 3-phosphoglycerate Dehydrogenase (EC 1.1.1.-)

[0497] The present disclosure describes enzymes that can catalyze the following reactions:(S)-2-hydroxyglutarate+NAD+↔2-oxoglutarate+NADH+H+3-phospho-D-glycerate+NAD+↔3-phospho-hydroxypyruvate+NADH+H+(R)-2-hydroxyglutarate+NAD+↔2-oxoglutarate+NADH+H+3-phosphoglycerate dehydrogenase may also be known as phosphoglycerate dehydrogenase; PHGDH (gene name); D-3-phosphoglycerate: NAD+ oxidoreductase; alpha-phosphoglycerate dehydrogenase; 3-phosphoglyceric acid dehydrogenase; D-3-phosphoglycerate dehydrogenase; glycerate 3-phosphate dehydrogenase; glycerate-1,3-phosphate dehydrogenase; phosphoglycerate oxidoreductase; phosphoglyceric acid dehydrogenase; SerA; 3-phosphoglycerate: NAD+2-oxidoreductase; SerA 3PG dehydrogenase; 3PHP reductase.3-phosphoglycerate dehydrogenase catalyzes the first committed step in the biosynthesis of L-serine. The enzyme is regulated by allosteric end-product inhibition that shows cooperativity. Inhibition by serine acts primarily through reduction of catalytic velocity and has only a small effect on the Kms of the substrates; SerA is thus classified as a type V allosteric enzyme.

[0500] The basis for allosteric and cooperative inhibition by serine has been studied extensively. Occupation of two of the four serine binding sites in the homotetramer results in 85% inhibition of activity. Further binding of serine shows negative cooperativity. Phosphate is able to reduce the site-to-site cooperative effects on serine binding; the effect was mainly due to the presence of intrinsically bound NADH. A Trp139Gly mutation results in a homodimeric enzyme that has lost cooperativity in serine binding and allosteric inhibition. Site-directed mutagenesis of residues within the effector binding site, the regulatory interface between subunits, and a flexible hinge region support a model where movement of adjacent domains is involved in inhibition of the enzymatic activity. Transient kinetic analysis showed that the cooperativity of inhibition of catalytic activity results from a conformational change due to serine binding. An enzyme missing the regulatory domain is no longer inhibited by serine, but other kinetic parameters remain the same. Hybrid tetramers provided further insight into the mechanism of allosteric inhibition.

[0501] Site-directed mutagenesis has allowed the identification of residues within the active site that contribute to substrate binding and catalysis. Mutations in the hinge region between the substrate and nucleotide binding domains affect the kcat of the enzyme; certain mutations uncouple serine binding and catalytic inhibition.

[0502] Extensive site-directed mutagenesis and structural studies have contributed to a detailed view of the interactions between allosteric regulation, cooperativity and catalytic activity. Further insight into the catalytic pathway was provided by stopped-flow kinetic analysis, indicating that the rate-limiting step in both catalytic directions is a conformational change of the enzyme. Serine binding appears to lead to the formation of a dead-end quaternary complex between the enzyme, coenzyme, substrate, and effector that eliminates the conformational change subsequent to substrate binding.

[0503] The enzyme has been shown to also have an α-ketoglutarate reductase activity, producing 2-hydroxyglutarate. While the metabolic role of this reaction is not yet known, it is thought that it may play a role in regulating serine biosynthesis and in recycling NADH back to NAD+, especially during anaerobiosis.

[0504] Crystal structures of the wild type enzyme and various mutants have been solved. The structure showed that each subunit of the homotetramer consists of three distinct domains, a nucleotide binding domain, a substrate binding domain, and a regulatory / serine binding domain.

[0505] serA is essential for growth on glycerol minimal medium; the growth defect can be rescued by addition of serine.

[0506] In some embodiments, the enzyme having 3-phosphoglycerate dehydrogenase activity can be an enzyme having 3-phospho-hydroxypyruvate reductase activity or an enzyme having 2-oxoglutarate reductase activity. In some embodiments, an enzyme having 3-phosphoglycerate dehydrogenase activity, an enzyme having 3-phospho-hydroxypyruvate reductase activity, or an enzyme having 2-oxoglutarate reductase activity catalyzes the conversion of glycerate 3-phophate to 3-phosphohydroxypyruvate. In some embodiments, an enzyme having 3-phosphoglycerate dehydrogenase activity, an enzyme having 3-phospho-hydroxypyruvate reductase activity, or an enzyme having 2-oxoglutarate reductase activity is encoded by an amino acid sequence having at least 70% sequence identity, having at least 80% sequence identity, or having at least 90% sequence identity to serA. In some embodiments, the enzyme having 3-phosphoglycerate dehydrogenase activity, the enzyme having 3-phospho-hydroxypyruvate reductase activity, or the enzyme having 2-oxoglutarate reductase activity is serA.

[0507] In some embodiments, the one or more nucleic acid molecules encoding the enzyme having 3-phosphoglycerate dehydrogenase activity is serA, or homolog thereof. In another embodiment, the one or more nucleic acid molecules encoding an enzyme having 3-phosphoglycerate dehydrogenase activity, an enzyme having 3-phospho-hydroxypyruvate reductase activity, or an enzyme having 2-oxoglutarate reductase activity comprises an amino acid sequence set forth in SEQ ID NO: 228. In a further embodiment, the one or more nucleic acid molecule encoding an enzyme having 3-phosphoglycerate dehydrogenase activity, an enzyme having 3-phospho-hydroxypyruvate reductase activity, or an enzyme having 2-oxoglutarate reductase activity is encoded by a nucleic acid sequence set forth in SEQ ID NO: 227.Phosphoserine Aminotransferase, Serine Aminotransferase, L-serine Transaminase (EC 2.6.1.52)

[0508] The present disclosure describes enzymes that can catalyze the following reactions:3-phospho-L-serine+2-oxoglutarate↔L-glutamate+3-phospho-hydroxypyruvate(3R)-3-hydroxy-2-oxo-4 phosphonooxybutanoate+L-glutamate↔4-phospho-hydroxy-L-threonine+2-oxoglutarate2-oxoglutarate+N-succinyl-L,L-2,6-diaminopimelate↔L-glutamate+N-succinyl-2-amino-6-ketopimelatePhosphoserine aminotransferase may also be known as phosphoserine transaminase; PSAT; 3-phosphoserine aminotransferase; hydroxypyruvic phosphate-glutamic transaminase; L-phosphoserine aminotransferase; phosphohydroxypyruvate transaminase; phosphohydroxypyruvic-glutamic transaminase; 3-O-phospho-L-serine: 2-oxoglutarate aminotransferase; SerC; PdxC; 3PHP transaminaseThe serC-encoded enzyme, phosphoserine / phosphohydroxythreonine aminotransferase, functions in the biosythesis of both serine and pyridoxine, by using different substrates. Pyridoxal 5′-phosphate is a cofactor for both enzyme activities, suggesting that it can act in an autocatalytic fashion, stimulating its own biosynthesis.

[0511] The redundancy and promiscuity among aminotransferase enzymes has been investigated. No activity could be observed with non-phosphorylated substrates; however, 3-hydroxypyruvate was able to be used as the substrate for an assay of SerC enzymatic activity. In addition, genetic experiments showed that SerC is a minor alanine transaminase.

[0512] The normal activities of two enzymes, ArgD and SerC, are sufficient for succinyldiaminopimelate (SDAP) and lysine biosynthesis; a third enzyme, AstC, is sufficient for SDAP biosynthesis, but alone can not fulfill the cell's requirement for lysine. Additional enzymes, including GabT and PuuE, may be able to contribute to SDAP biosynthesis. Expression of argD, astC, serC, aspC, gabT, hisC, ilvE, patA, puuE, or tyrB from a plasmid allows growth of the triple ΔargD serC astC mutant on minimal medium.

[0513] Crystal structures of the enzyme in the unligated form and in complex with the substrate analog α-methyl-L-glutamate have been solved, and a molecular reaction mechanism was proposed.

[0514] serC is essential for growth on glycerol minimal medium; the growth defect can be rescued by addition of serine and pyridoxol / pyridoxine.

[0515] In some embodiments, the enzyme having phosphoserine aminotransferase activity can be an enzyme having L-serine transaminase activity or an enzyme having serine aminotransferase activity. In some embodiments, an enzyme having phosphoserine aminotransferase activity, an enzyme having L-serine transaminase activity or an enzyme having serine aminotransferase activity catalyzes the conversion of L-serine to hydroxypyruvate. In some embodiments, the enzyme having phosphoserine aminotransferase activity, the enzyme having L-serine transaminase activity or the enzyme having serine aminotransferase activity is encoded by an amino acid sequence having at least 70% sequence identity, having at least 80% sequence identity, or having at least 90% sequence identity to serC. In some embodiments, the enzyme having phosphoserine aminotransferase activity, the enzyme having L-serine transaminase activity or the enzyme having serine aminotransferase activity is serC.

[0516] In some embodiments, the one or more nucleic acid molecules encoding the enzyme having phosphoserine aminotransferase activity is serC, or homolog thereof. In another embodiment, the one or more nucleic acid molecules encoding an enzyme having phosphoserine aminotransferase activity, an enzyme having L-serine transaminase activity, or an enzyme having serine aminotransferase activity comprise an amino acid sequence set forth in SEQ ID NO: 230. In a further embodiment, the one or more nucleic acid molecule encoding an enzyme having phosphoserine aminotransferase activity, an enzyme having L-serine transaminase activity or an enzyme having serine aminotransferase activity is encoded by a nucleic acid sequence set forth in SEQ ID NO: 229.3-phospho-hydroxypyruvate Phosphatase

[0517] The present disclosure describes enzymes that can catalyze the following reaction:3-phospho-hydroxypyruvate+H2O→hydroxypyruvate+phosphate

[0518] YeaB (NudL) belongs to the Nudix family of hydrolases and was predicted to have CoA pyrophosphohydrolase activity.

[0519] yeaB (nudL) was isolated as a multicopy suppressor of the repression of flhDC transcription in a pgsA mutant. The suppression may be due to the reduction of σS expression in cells that overexpress nudL.

[0520] yeaB (nudL) was also isolated as a multicopy suppressor of the PLP auxotrophy of a pdxB deletion strain. NudL was found to be part of a serendipitous metabolic pathway that produces an intermediate of the pyridoxal 5′-phosphate biosynthesis I pathway, 4-phospho-hydroxy-L-threonine, that lies downstream of PdxB. The pathway diverts 3-phosphohydroxypyruvate from serine biosynthesis. With a Kcat of 5.7×10−5, NudL is an inefficient catalyst of the conversion of 3-phosphohydroxypyruvate to hydroxypyruvate, but its activity appears to be sufficient for production of PLP.

[0521] In some embodiments, the enzyme having 3-phospho-hydroxypyruvate phosphatase activity is encoded by an amino acid sequence having at least 70% sequence identity, having at least 80% sequence identity, or having at least 90% sequence identity to yeaB. In some embodiments, the enzyme having 3-phospho-hydroxypyruvate phosphatase activity is yeaB.

[0522] In some embodiments, the one or more nucleic acid molecules encoding the enzyme having 3-phospho-hydroxypyruvate phosphatase activity is yeaB, or homolog thereof. In another embodiment, the one or more nucleic acid molecules encoding an enzyme having 3-phospho-hydroxypyruvate phosphatase activity comprise an amino acid sequence set forth in SEQ ID NO: 232. In a further embodiment, the one or more nucleic acid molecule encoding an enzyme having 3-phospho-hydroxypyruvate phosphatase activity is encoded by a nucleic acid sequence set forth in SEQ ID NO: 231.Phosphoserine Phosphatase (EC 3.1.3.3)

[0523] The present disclosure describes enzymes that can catalyze the following reaction:3-phospho-L-serine+H2O→L-serine+phosphate

[0524] Phosphoserine phosphatase catalyzes the last step in serine biosynthesis. The enzyme belongs to the superfamily of haloacid dehalogenase (HAD)-like hydrolases. Enzymatic studies were originally performed using partially purified enzyme from E. coli strain W; assays of the purified enzyme were performed as part of an investigation of the HAD superfamily of enzymes.

[0525] serB is essential for growth on glycerol minimal medium; the growth defect can be rescued by addition of serine. Gph, HisB and YtjC were identified as multicopy suppressors of the conditional ΔserB phenotype. Directed evolution experiments identified mutations that increased fitness and enzymatic activity of these suppressors.

[0526] In some embodiments, the enzyme having phosphoserine phosphatase activity is encoded by an amino acid sequence having at least 70% sequence identity, having at least 80% sequence identity, or having at least 90% sequence identity to serB. In some embodiments, the enzyme having phosphoserine phosphatase activity is serB.

[0527] In some embodiments, the one or more nucleic acid molecules encoding the enzyme having phosphoserine phosphatase activity is serB, or homolog thereof. In another embodiment, the one or more nucleic acid molecules encoding an enzyme having phosphoserine phosphatase activity comprise an amino acid sequence set forth in SEQ ID NO: 234. In a further embodiment, the one or more nucleic acid molecule encoding an enzyme having phosphoserine phosphatase activity is encoded by a nucleic acid sequence set forth in SEQ ID NO: 233.Serine-pyruvate Aminotransferase (EC 2.6.1.51)

[0528] The present disclosure describes enzymes that can catalyze the following reactions:pyruvate+L-serine↔L-alanine+hydroxypyruvateglyoxylate+L-alanine↔glycine+pyruvateSerine-pyruvate aminotransferase may also be known as alanine-glyoxylate aminotransferase.

[0530] The peroxisomal serine-pyruvate aminotransferase (AGXT1) and mitochondrially localized alanine-glyoxylate aminotransferase 2 (AGXT2) both catalyze the conversion of glyoxylate to glycine using alanine as the amino donor. Unlike AGXT2, AGXT1 cannot utilize asymmetric dimethylarginine (ADMA) as an amino donor.

[0531] Peroxisomal serine-pyruvate aminotransferase is a pyridoxal phosphate dependent liver specific enzyme composed of a homodimer. Its location in the peroxisome is crucial for proper enzyme activity. A peroxisomal targeting sequence (PTS1) at the C-terminus is required for translocation into peroxisomes.

[0532] Dysfunction or mistargeting of serine-pyruvate aminotransferase leading to absence in hepatic peroxisomes, causes glyoxylate to escape into the cytosol where it is further metabolized to oxalate and glycolate. Oxalate cannot be further metabolized in humans and leads to the formation of insoluble calcium oxalate in the kidney and urinary tract. Mutations in the AGXT1 gene leads to improper peroxisomal targeting and causes the autosomal recessive metabolic disorder, primary hyperoxaluria type 1, which results in irreversible kidney damage. One-third of primary hyperoxaluria type 1 patients have a unique protein sorting defect in which the hepatic peroxisomal enzyme is mistargeted to the mitochondria.

[0533] In some embodiments, the enzyme having serine-pyruvate aminotransferase activity is encoded by an amino acid sequence having at least 70% sequence identity, having at least 80% sequence identity, or having at least 90% sequence identity to Homo sapiens AGXT1. In some embodiments, the enzyme having serine-pyruvate aminotransferase activity is Homo sapiens AGXT1.

[0534] In some embodiments, the one or more nucleic acid molecules encoding the enzyme having serine-pyruvate aminotransferase activity is AGXT1, or homolog thereof. In some embodiments, the one or more nucleic acid molecules encoding an enzyme having serine-pyruvate aminotransferase activity comprise an amino acid sequence set forth in SEQ ID NO: 244. In a further embodiment, the one or more nucleic acid molecule encoding an enzyme having serine-pyruvate aminotranserase activity is encoded by a nucleic acid sequence set forth in SEQ ID NO: 243.Serine Decarboxylase (EC 4.1.1.65)

[0535] The present disclosure describes enzymes that can catalyze the following reaction:a 3-O-sn-phosphatidyl-L-serine+H+→an L-1-phosphatidylethanolamine+CO2

[0536] Serine decarboxylase may also be known as phosphatidylserine decarboxylase; PS decarboxylase; phosphatidyl-L-serine carboxy-lyase.

[0537] Phosphatidylserine decarboxylase is one of a small class of enzymes that use a covalently bound pyruvoyl prosthetic group. The pyruvoyl group is thought to act analogously to pyridoxal phosphate cofactor by forming a Schiff base with the amino group of the substrate and then serving as an electron sink to facilitate the decarboxylation.

[0538] Four of these enzymes, histidine decarboxylase (E.C. 4.1.1.22), phosphatidylserine decarboxylase, aspartate 1-decarboxylase, and S-adenosylmethionine decarboxylase are decarboxylases forming important biological amines. All of these enzymes are known to have the pyruvoyl prosthetic group attached via an amide linkage to the amino terminus of the a subunit. Two other enzymes in this group are are D-proline reductase and glycine reductase (E.C. 1.21.4.2).

[0539] Pyruvoyl-containing enzymes are expressed as a zymogen which is processed post-translationally by a self-maturation cleavage called serinolysis. In this process the pyruvoul group is formed from a serine residue, splitting the presursor protein into two parts which become the α and β subunits. In some cases additional subunits may be involved.

[0540] This enzyme differs from other pyruvoyl-dependent decarboxylases composed of nonidentical subunits in that the pyruvate prosthetic group is associated with the smaller subunit. The enzyme is a multimer of unknown number of the heterodimer.

[0541] In some embodiments, an enzyme having serine decarboxylase activity catalyzes the conversion of L-serine to ethanolamine.

[0542] In some embodiments, the enzyme having serine decarboxylase activity is encoded by an amino acid sequence having at least 70% sequence identity, having at least 80% sequence identity, or having at least 90% sequence identity to Arabidopsis thaliana SDC. In some embodiments, the enzyme having serine decarboxylase activity is Arabidopsis thaliana SDC.

[0543] In some embodiments, the one or more nucleic acid molecules encoding the enzyme having serine decarboxylase activity is SDC, or homolog thereof. In some embodiments, the one or more nucleic acid molecules encoding an enzyme having serine decarboxylase activity comprise an amino acid sequence set forth in SEQ ID NO: 236. In a further embodiment, the one or more nucleic acid molecule encoding an enzyme having serine decarboxylase activity is encoded by a nucleic acid sequence set forth in SEQ ID NO: 235.Ethanolamine Oxidoreductase (Deaminating) (EC 1.4.3.8), Ethanolamine Aminotransferase (EC 2.6.1.-)

[0544] The present disclosure describes enzymes that can catalyze the following reactions:ethanolamine+oxygen+H2O→ammonium+hydrogen peroxide+glycolaldehydeethanolamine+2-oxoglutarate→glycolaldehyde+L-glutamateEthanolamine oxidoreductase (deaminating) may also be known as ethanolamine oxidase. This enzyme belongs to the family of oxidoreductases, specifically those acting on the CH—NH2 group of donors with oxygen as acceptor.

[0546] In some embodiments, an ethanolamine oxidase or an ethanolamine aminotransferase catalyzes the conversion of ethanolamine to gylcolaldehyde.

[0547] In some embodiments, the enzyme having ethanolamine oxidase activity is encoded by an amino acid sequence having at least 70% sequence identity, having at least 80% sequence identity, or having at least 90% sequence identity to E. coli tynA. In some embodiments, the enzyme having ethanolamine oxidase activity is E. coli tynA.

[0548] In some embodiments, the one or more nucleic acid molecules encoding the enzyme having ethanolamine oxidase activity is tynA, or homolog thereof. In some embodiments, the one or more nucleic acid molecules encoding an enzyme having ethanolamine oxidase activity comprise an amino acid sequence set forth in SEQ ID NO: 238. In a further embodiment, the one or more nucleic acid molecule encoding an enzyme having ethanolamine oxidase activity is encoded by a nucleic acid sequence set forth in SEQ ID NO: 237.

[0549] In some embodiments, the enzyme having ethanolamine aminotransferase activity is encoded by an amino acid sequence having at least 70% sequence identity, having at least 80% sequence identity, or having at least 90% sequence identity to E. coli alaA. In some embodiments, the enzyme having ethanolamine aminotransferase activity is E. coli alaA.

[0550] In some embodiments, the one or more nucleic acid molecules encoding the enzyme having ethanolamine aminotransferase activity is alaA, or homolog thereof. In some embodiments, the one or more nucleic acid molecules encoding an enzyme having ethanolamine aminotransferase activity comprise an amino acid sequence set forth in SEQ ID NO: 240. In a further embodiment, the one or more nucleic acid molecule encoding an enzyme having ethanolamine aminotransferase activity is encoded by a nucleic acid sequence set forth in SEQ ID NOs: 239.Hydroxypyruvate Reductase (EC 1.1.1.-)

[0551] The present disclosure describes enzymes that can catalyze the following reactions:D-glycerate+NAD(P)+↔hydroxypyruvate+NAD(P)H+H+

[0552] Hydroxypyruvate reductase may also be known as beta-hydroxypyruvate reductase; NADH:hydroxypyruvate reductase; D-glycerate dehydrogenase.

[0553] Hydroxypyruvate reductase is an enzyme found in higher plants, algae, mammalian tissues and bacteria. In most cases it has been postulated to convert hydroxypyruvate to glycerate. However, most enzymes also carry the reduction of glyoxylate to glycolate.

[0554] In the serine cycle methylotrophs, hydroxypyruvate reductase plays a key role in the assimilation of carbon. It catalyzes the conversion of hydroxypyruvate to glycerate, a key step of the serine cycle, but it also plays an important role in the metabolism of C2 compounds, by interconverting glyoxylate and glycolate.

[0555] In some embodiments, hydroxypyruvate reductase catalyzes the conversion of glycerate to hydroxypyruvate.

[0556] In some embodiments, the enzyme having hydroxypyruvate reductase activity is encoded by an amino acid sequence having at least 70% sequence identity, having at least 80% sequence identity, or having at least 90% sequence identity to E. coli ghrB. In some embodiments, the enzyme having hydroxypyruvate reductase activity is E. coli ghrB.

[0557] In some embodiments, the one or more nucleic acid molecules encoding the hydroxypyruvate reductase is ghrB, or homolog thereof. In some embodiments, the one or more nucleic acid molecules encoding an enzyme having hydroxypyruvate reductase activity comprise an amino acid sequence set forth in SEQ ID NO: 242. In a further embodiment, the one or more nucleic acid molecule encoding an enzyme having hydroxypyruvate reductase activity is encoded by a nucleic acid sequence selected from the group consisting of SEQ ID NO: 241.Glycerate Decarboxylase

[0558] The present disclosure describes enzymes that can catalyze the following reaction:D-glycerate+H+→ethylene glycol+CO2

[0559] In some embodiments, an enzyme having glycerate decarboxylase activity catalyzes the conversion of glycerate to ethylene glycol.3-Phosphoglycerate Phosphatase (EC 3.1.3.38) or 2-phosphoglycerate Phosphatase (EC 3.1.3.20)

[0560] The present disclosure describes enzymes that can catalyze the following reaction:3-phospho-D-glycerate+H2O→D-glycerate+phosphate2-phospho-D-glycerate+H2O→D-glycerate+phosphate3-phosphoglycerate phosphatase may also be known as D-3-phosphoglycerate phosphatase; 3-PGA phosphatase. 2-phosphoglycerate phosphatase may also be known as D-2-phosphoglycerate phosphatase; 2-PGA phosphatase. These enzymes belong to the family of hydrolases, specifically those acting on phosphoric monoester bonds.

[0562] In some embodiments, the enzyme having 3-phosphoglycerate phosphatase activity or the enzyme having 2-phosphoglycerate phosphatase activity is encoded by an amino acid sequence having at least 70% sequence identity, having at least 80% sequence identity, or having at least 90% sequence identity to E. coli phoA. In some embodiments, the enzyme having 3-phosphoglycerate phosphatase activity or enzyme having 2-phosphoglycerate phosphatase activity is E. coli phoA.

[0563] In some embodiments, the one or more nucleic acid molecules encoding the enzyme having 3-phosphoglycerate phosphatase activity or enzyme having 2-phosphoglycerate phosphatase activity is phoA, or homolog thereof. In some embodiments, the one or more nucleic acid molecules encoding an enzyme having 3-phosphoglycerate phosphatase activity or enzyme having 2-phosphoglycerate phosphatase activity comprise an amino acid sequence set forth in SEQ ID NO: 246. In a further embodiment, the one or more nucleic acid molecule encoding an enzyme having 3-phosphoglycerate phosphatase activity or enzyme having 2-phosphoglycerate phosphatase activity is encoded by a nucleic acid sequence set forth in SEQ ID NO: 245.Glycerate Kinase (EC 2.7.1.31)

[0564] The present disclosure describes enzymes that can catalyze the following reaction:D-glycerate+ATP↔3-phospho-D-glycerate+ADP+H+D-glycerate+ATP↔2-phospho-D-glycerate+ADP+H+Glycerate kinase may also be known as glycerate 3-kinase; glycerate kinase (phosphorylating) (ambiguous); D-glycerate 3-kinase; D-glycerate kinase (ambiguous); glycerate-kinase (ambiguous); GK (ambiguous); D-glyceric acid kinase (ambiguous); ATP: (R)-glycerate 3-phosphotransferase.

[0566] This enzyme belongs to the family of transferases, specifically those transferring phosphorus-containing groups (phosphotransferases) with an alcohol group as acceptor. This enzyme participates in 3 metabolic pathways: serine / glycine / threonine metabolism, glycerolipid metabolism, and glyoxylate-dicarboxylate metabolism.

[0567] In some embodiments, an enzyme having glycerate kinase activity catalyzes the conversion of 3-phosphoglycerate to glycerate. In other embodiments, an enzyme having glycerate kinase activity catalyzes the conversion of 2-phosphoglycerate to glycerate.

[0568] In some embodiments, the enzyme having glycerate kinase activity is a glycerate 3-kinase. In some embodiments, the enzyme having glycerate 3-kinase activity is encoded by an amino acid sequence having at least 70% sequence identity, having at least 80% sequence identity, or having at least 90% sequence identity to Arabidopsis thaliana GLYK. In some embodiments, the glycerate 3-kinase is Arabidopsis thaliana GLYK.

[0569] In some embodiments, the one or more nucleic acid molecules encoding the enzyme having glycerate 3-kinase activity is GLYK, or homolog thereof. In some embodiments, the one or more nucleic acid molecules encoding an enzyme having glycerate 3-kinase activity comprise an amino acid sequence set forth in SEQ ID NO: 248. In a further embodiment, the one or more nucleic acid molecule encoding an enzyme having glycerate 3-kinase activity is encoded by a nucleic acid sequence set forth in SEQ ID NO: 247.

[0570] In some embodiments, the enzyme having glycerate kinase activity is an enzyme having glycerate 2-kinase activity. In some embodiments, the enzyme having glycerate 2-kinase activity is encoded by an amino acid sequence having at least 70% sequence identity, having at least 80% sequence identity, or having at least 90% sequence identity to E. coli glxK. In some embodiments, the enzyme having glycerate 2-kinase activity is encoded by an amino acid sequence having at least 70% sequence identity, having at least 80% sequence identity, or having at least 90% sequence identity to E. coli gark. In other embodiments, the enzyme having glycerate 2-kinase activity is E. coli glxK. In some embodiments, the glycerate 2-kinase is E. coli garK.

[0571] In some embodiments, the one or more nucleic acid molecules encoding the enzyme having glycerate 2-kinase activity is glxK, or homolog thereof. In some embodiments, the one or more nucleic acid molecules encoding the enzyme having glycerate 2-kinase activity is gark, or homolog thereof. In some embodiments, the one or more nucleic acid molecules encoding an enzyme having glycerate 2-kinase activity comprise an amino acid sequence selected from SEQ ID NOs: 250 and 252. In a further embodiment, the one or more nucleic acid molecule encoding an enzyme having glycerate 2-kinase activity is encoded by a nucleic acid sequence selected from SEQ ID NOs: 249 and 251.Transferase that Transfers One-Carbon Group (EC 2.1.2.-)

[0572] The present disclosure describes enzymes that can catalyze the following reaction:M-THF+H2O↔THF+formaldehyde

[0573] Transferases such as the hydroxymethyl-, formyl- and related transferases may be used. Examples of hydroxymethyl-, formyl- and related transferases include glycine hydroxymethyltransferase, phosphoribosylglycinamide formyltransferase, phosphoribosylaminoimidazolecarboxamide formyltransferase, glycine formimidoyltransferase, glutamate formiminotransferase, D-alanine 2-hydroxymethyltransferase, deoxycytidylate 5-hydroxymethyltransferase, methionyl-tRNA formyltransferase, aminomethyltransferase, 3-methyl-2-oxobutanoate hydroxymethyltransferase and UDP-4-amino-4-deoxy-L-arabinose formyltransferase.Serine Hydroxymethyltransferase (EC 2.1.2.1)

[0574] The present disclosure describes enzymes that can catalyze the following reaction:L-serine+tetrahydrofolate (THF)↔Glycine+5,10-methylenetetrahydrofolate (M-THF)

[0575] Serine hydroxymethyltransferase (GlyA) converts serine to glycine, transferring a methyl group to tetrahydrofolate, thus forming 5,10-methylene-tetrahydrofolate (M-THF). M-THF is the major source of C1 units in the cell, making GlyA a key enzyme in the biosynthesis of purines, thymidine, methionine, choline and lipids.

[0576] The enzyme also catalyzes several side reactions including hydrolysis of 5,10-methenylTHF to 5-formylTHF and the reversible cleavage of 3-hydroxy amino acids (L-threonine, allothreonine, 3-phenylserine) to glycine and an aldehyde. D-alanine inactivates the enzyme by reacting with the pyridoxal phosphate prosthetic group to form pyridoxamine phosphate.

[0577] The Thr226 residue within a conserved region of the enzyme appears to be involved in substrate discrimination. The His228 residue plays a role in determining reaction specificity. Lys229 does not appear to play a catalytic role. Arg363 appears to be the binding site for the carboxyl group of the amino acid substrate. The hydroxyl group of Tyr65 may be involved in the conversion of the active site from a closed to an open conformation. Both Tyr55 and Arg235 are required for the transaldimination reaction.

[0578] Studies on refolding of the enzyme indicate that pyridoxal 5′-phosphate (PLP) only binds to the dimeric apoenzyme at the end of the folding pathway. The mechanism of PLP addition has been investigated further. At high concentrations of PLP, a second molecule of PLP can bind at Lys346. A conserved hydrophobic contact area is involved in stability of the PLP binding site. Tyr55 is required for correct positioning of the PLP cofactor.

[0579] Crystal structures of wild type and mutant serine hydroxymethyltransferase have been solved.

[0580] glyA mutants cannot use glycine as the sole source of nitrogen. A glyA mutant is auxotrophic for glycine; glyA was later shown to be essential for growth on glycerol minimal medium.

[0581] Sequences 3′ to the structural gene within the glyA mRNA are required for mRNA stability.

[0582] In some embodiments, the enzyme having serine hydroxymethyltransferase activity is encoded by an amino acid sequence having at least 70% sequence identity, having at least 80% sequence identity, or having at least 90% sequence identity to E. coli glyA. In some embodiments, the one or more nucleic acid molecule encoding an enzyme having serine hydroxymethyltransferase comprises an amino acid sequence set forth in UniProt ID P0A825. In a further embodiment, the one or more nucleic acid molecule encoding an enzyme having serine hydroxymethyltransferase is encoded by a nucleic acid sequence set forth in Gene ID 947022.Formaldehyde Dehydrogenase (EC 1.2.1.46 and EC 1.2.1.-)

[0583] The present disclosure describes enzymes that can catalyze the following reaction:Formaldehyde+NAD++H2O→formate+NADH+2H+

[0584] Formaldehyde dehydrogenase may also be known as NAD-linked formaldehyde dehydrogenase, NAD-dependent formaldehyde dehydrogenase or formaldehyde:NAD+ oxidoreductase.

[0585] Most of the formaldehyde dehydrogenases found in animals, plants and bacteria belong to a group called class III alcohol dehydrogenase group and require the addition of glutathione for activity. As a matter of fact, the true substrate for these enzymes was shown to be not formaldehyde, but S-hydroxymethylglutathione, which is formed nonenzymatically from formaldehyde and glutathione.

[0586] Unlike those enzymes, the enzyme isolated from Pseudomonas putida catalyzes the irreversible oxidation of formaldehyde to formate without the addition of glutathione. Since its substrate is formaldehyde, in an essence this is the “genuine” formaldehyde dehydrogenase. Like other formaldehyde dehydrogenases, the P. putida FDH is a zinc-containing metalloenzyme. It also requires NAD+ as the electron acceptor. However, unlike the enzymes that belong to the class III alcohol dehydrogenase group, it is sensitive to 4-methylpyrazole. In one embodiment, the formaldehyde dehydrogenase is from Pseudomonas putida. In some embodiments, the formaldehyde dehydrogenase is encoded by an amino acid sequence having at least 70% sequence identity, having at least 80% sequence identity, or having at least 90% sequence identity to P. putida fdhA. In some embodiments, the one or more nucleic acid molecule encoding a formaldehyde dehydrogenase comprises an amino acid sequence set forth in GenBank Accession BAA04743.1. In a further embodiment, the one or more nucleic acid molecule encoding a formaldehyde dehydrogenase is encoded by a nucleic acid sequence set forth in GenBank Accession D21201.1.

[0587] In the industrially important actinomycete Corynebacterium glutamicum ATCC 13032, evidence suggests that two enzymes contribute to the degradation of toxic formaldehyde, mycothiol-dependent formaldehyde dehydrogenase encoded by gene fadH, and to a lesser extent acetaldehyde dehydrogenase encoded by gene ald (acetaldehyde dehydrogenase). A mutant lacking both of these enzymes was unable to grow in formaldehyde-containing medium. It also did not grow in vanillate-containing medium because the oxidation of vanillate produces intracellular formaldehyde. Detoxification of formaldehyde is necessary when this soil bacterium encounters formaldehyde in its habitat, or when formaldehyde is generated during metabolism of environmental compounds such as vanillate. The formate produced by FadH can be further oxidized to CO2 by the formate dehydrogenase encoded by gene fdhF.

[0588] An ald mutant showed a reduction in formaldehyde degradation of about 30% as compared with wild-type. Inactivation of the chromosomal ald gene resulted in loss of acetaldehyde dehydrogenase activity and loss of the ability of this organism to grow on or utilize ethanol, suggesting a two step oxidation of ethanol to acetate. Expression of gene ald is dependent on the transcriptional regulator RamA, whereas RamB has a slightly negative effect on expression. In one embodiment, the formaldehyde dehydrogenase is from Corynebacterium glutamicum ATCC 13032. In some embodiments, the formaldehyde dehydrogenase is encoded by an amino acid sequence having at least 70% sequence identity, having at least 80% sequence identity, or having at least 90% sequence identity to Corynebacterium glutamicum ATCC 13032 ald. In some embodiments, the one or more nucleic acid molecule encoding a formaldehyde dehydrogenase comprises an amino acid sequence set forth in UniProt ID Q8NLZ0. In a further embodiment, the one or more nucleic acid molecule encoding a formaldehyde dehydrogenase is encoded by a nucleic acid sequence set forth in Gene ID 1020739.

[0589] In some embodiments, the enzyme having formaldehyde dehydrogenase activity is encoded by an amino acid sequence having at least 70% sequence identity, having at least 80% sequence identity, or having at least 90% sequence identity to Pseudomonas oleovorans alkH.

[0590] In Saccharomyces cerevisiae, two tandem-repeated genes ALD2 and ALD3 encode two cytoplasmic stress-inducible isoforms of aldehyde dehydrogenase. The expression of these isoforms is dependent on the general-stress transcription factors Msn2 and Msn4 but is independent of the HOG MAP kinase pathway. Both forms can use the cofactor NAD+ much more efficiently that NADP+, and are not activated by any cations. While ALD3 is induced by a variety of stresses, including osmotic shock, heat shock, glucose exhaustion, oxidative stress and drugs, ALD2 is only induced by osmotic stress and glucose exhaustion.

[0591] In some embodiments, the enzyme having formaldehyde dehydrogenase activity is encoded by an amino acid sequence having at least 70% sequence identity, having at least 80% sequence identity, or having at least 90% sequence identity to Saccharomyces cerevisiae ALD2. In other embodiments, the enzyme having formaldehyde dehydrogenase activity is encoded by an amino acid sequence having at least 70% sequence identity, having at least 80% sequence identity, or having at least 90% sequence identity to Saccharomyces cerevisiae ALD3. In some embodiments, the one or more nucleic acid molecule encoding an enzyme having formaldehyde dehydrogenase activity comprises an amino acid sequence selected from UniProt ID P47771 and UniProt ID P54114. In a further embodiment, the one or more nucleic acid molecule encoding an enzyme having formaldehyde dehydrogenase activity is encoded by a nucleic acid sequence selected from Gene ID 855206 and Gene ID 855205.

[0592] In some embodiments, the enzyme having formaldehyde dehydrogenase activity is encoded by an amino acid sequence having at least 70% sequence identity, having at least 80% sequence identity, or having at least 90% sequence identity to Homo sapiens ALDH3A2. In other embodiments, the enzyme having formaldehyde dehydrogenase activity is encoded by an amino acid sequence having at least 70% sequence identity, having at least 80% sequence identity, or having at least 90% sequence identity to Homo sapiens ALDH9A1. In some embodiments, the one or more nucleic acid molecule encoding an enzyme having formaldehyde dehydrogenase activity comprises an amino acid sequence selected from UniProt ID P51648 and UniProt ID P49189. In a further embodiment, the one or more nucleic acid molecule encoding an enzyme having formaldehyde dehydrogenase activity is encoded by a nucleic acid sequence selected from Gene ID 224 and Gene ID 223.Formate Dehydrogenase (EC 1.2.1.-)

[0593] The present disclosure describes enzymes that can catalyze the following reactions:formate+an oxidized electron acceptor+H+→CO2+a reduced electron acceptorformate+H+→CO2+H2 (catalyzed by complex)formate+an oxidized hydrogenase 3→CO2+a reduced hydrogenase 3Formate dehydrogenase-H is one of three membrane-associated formate dehydrogenase isoenzymes in E. coli. All are functional in the anaerobic metabolism of the organism.Formate dehydrogenase-H (FDH-H) is located in the cytoplasm and together with hydrogenase-3, FDH-H forms the formate-hydrogen lyase complex. The enzyme is oxygen sensitive and contains selenium as selenocysteine incorporated cotranslationally at the position of an in-frame UGA stop codon in the FdhF open reading frame. A crystal structure of FDH-H has been solved at 2.3 Å resolution, confirming the presence of a [4Fe-4S] cluster, coordination of the Mo cofactor by selenocysteine, and the position of the binding site for the inhibitor nitrate. Expression of fdhF is induced by formate and the absence of external electron acceptors, and is repressed by nitrate, nitrite, trimethylamine N-oxide, and oxygen. Formate can overcome repression by nitrate but not by oxygen. Inhibition of DNA gyrase enhances expression of fdhF.

[0596] fdnGHI encodes membrane bound formate dehydrogenase N (FDH-N)—a respiratory enzyme that catalyses the oxidation of formate to carbon dioxide, donating electrons to the quinone pool for the reduction of anaerobic respiratory substrates such as nitrate and trimethylamine N-oxide. FDH-N is a member of the complex iron sulfur molybdoenzyme (CISM) family. The oxidation of formate by FDH-N is electrogenic (H+ / e−=1); oxidation of formate in the periplasm is accompanied by menaquinone reduction at the cytoplasmic face of the inner membrane. Expression of formate dehydrogenase-N is induced by nitrate and anaerobiosis, mediated by NarL and Fnr, respectively. Purified FDH-N contains three subunits, designated α (FdnG), β (FdnH) and γ (FdnI). A crystal structure, resolved at 1.6 Å, indicates that this subcomplex is further organised into physiologically relevant trimers with the α and β subunits located towards the periplasmic face of the inner membrane and the γ subunits located towards the cytoplasm. Electrons are tranferred from the site of formate oxidation in the a subunit across the membrane to the site of menaquinone reduction in the γ subunit. Protons are taken up from the cytoplasm at the menaquinone reduction site.

[0597] fdoGHI encodes formate dehydrogenase O (FDH-O)—a respiratory molybdoenzyme that catalyses the oxidation of formate to carbon dioxide, donating electrons to the membrane soluble quinone pool for the reduction of nitrate. FDH-O and nitrate reductase Z participate in a formate to nitrate electron transport pathway that is active when cells are shifted from aerobic to anaerobic conditions. The pathway operates with either menaquinone or ubiquinone. FDH-O appears to be expressed constitutively; unlike formate dehydrogenase N (FDH-N), it is not regulated by Fnr or NarL. Expression of FDH-O is increased under aerobic conditions; under anaerobic conditions, nitrate stimulates expression slightly; the global regulators H-NS and CRP may play a role in regulation of FDH-O expression. FDH-O may contribute to the cells ability to rapidly adapt to anaerobiosis while levels of FDH-N are still insufficient. FDH-O is a heterotrimeric complex consisting of an α (FdoG), a β (FdoH) and a γ (Fdol) subunit—it shares extensive sequence similarity and immunological properties with the anaerobically expressed FDH-N.

[0598] Candida boidinii formate dehydrogenase FDH1 is an NAD-dependent enzyme that mediates the detoxification of formate and is strongly inhibited by Cu2+, Hg, p-chloromercuribenzoate, cyanide, azide, thiocyanate and cyanate. The inhibition of cyanide is reversible and competes with formate. Protein expression is induced by methanol and repressed by glucose. Since the enzymatic reaction catalyzed by this formate dehydrogenase can regenerate NADH, it has been cloned into E. coli to optimize NADH requiring engineered pathways.

[0599] In the industrially important actinomycete Corynebacterium glutamicum ATCC 13032 evidence suggests that a formate dehydrogenase catalyzes the oxidation of formate to CO2. Both formate and toxic formaldehyde are present in the environment and can be dissimilated by this soil bacterium via the oxidation of formaldehyde to formate. This can be accomplished via FadH and Ald. Formate is then converted to CO2 by FdhF. FdhF is a molybdenum cofactor-dependent formate dehydrogenase that is active under oxic conditions, and was speculated to be involved in the stress response. The exact electron acceptor used by FdhF has not been defined. Gene fdhF is part of a gene cluster containing related genes fdhD and cg0617 that were shown by mutant analysis to be required for formate dehydrogenase activity. The growth of Corynebacterium glutamicum ATCC 13032 is inhibited to some extent in the presence of formate and strains lacking formate dehydrogenase activity show increased inhibition. Radiotracer experiments showed that when Corynebacterium glutamicum ATCC 13032 was grown with glucose and 13C-formate, it was metabolized to 13C-carbon dioxide. An fdhF deletion mutant could not metabolize formate. Growth studies also demonstrated the requirement for Mo2+. Protein sequence analysis suggested that FdhF is not an integral membrane protein, but is likely either cytosolic or membrane-associated. Putative orthologs have been identified in a variety of other soil bacteria.

[0600] When Cupriavidus oxalaticus is grown on formate as the main carbon and energy source, NAD+-dependent formate dehydrogenase is the key enzyme that generates NADH and CO2. The latter enters the ribulose diphosphate carboxylase reaction. The enzyme has been purified to homogeneity from cells grown with formate. The enzym...

Examples

example 1

In Vitro Enzymatic Assay for PGM3 Protein

[1465]The enzymatic assay of a phosphoglucomutase, which is a phosphopentomutase, encoded by ScPGM3 (SEQ ID NO: 255 or SEQ ID NO: 258) (PGM3 from Saccharomyces cerevisiae) was measured on its natural substrate, ribose-1-phosphate and glucose-1-phosphate in the presence of glucose-1,6-biphosphate, by monitoring the reduction of NADP+ into NADPH at OD 340 nm for 10 minutes (FIG. 15). Both glucose molecules were purchased from Merck. The reaction mixture contained HEPES 60 mM, pH 7.5, KCl 60 mM, MgCl2 3 mM, purified PGM3 protein, NADP+ 0.5 mM, glucose-1,6-bisphosphate 5 μM, glucose-1-phosphate 8 mM, and commercially available Glucose-6-Phosphate dehydrogenase at 3 U / ml (from Merck).

[1466]The activity on pentose-5P substrates (ribulose-5P and xylulose-5) was determined according to the scheme in FIG. 16. The reaction mixture contained HEPES 60 mM, pH 7.5, KCl 60 mM, MgCl2 3 mM, NADH 0.25 mM, glucose-1,6-biphosphate 5 μM, pentose (ribulose or xylu...

example 2

In Vivo Enzymatic Assay for PGM3 Protein

[1467]To assess the feasibility of using PGM3 for glycolic acid (GA) production in vivo, an assay was developed based on the use of a screening strain with the genotype MG1655 ΔtktA-ΔtktB. As described in FIG. 17, such a strain cannot grow on xylose by itself, because of the deletion of transketolase genes tktA (GenBank Gene ID: 947420) and tktB (GenBank Gene ID: 945865). However, a strain expressing an active PGM3 protein could use pentoses phosphorylated on carbon 5 to produce pentose phosphorylated on carbon 1, and subsequently convert pentose-1P to glycolaldehyde and DHAP by aldolase activity. Glycolaldehyde and glyceraldehyde-3-phosphate can enter the glyoxylate shunt and glycolysis and support strain growth. Consequently, in vivo PGM3 activity in the screening strain is directly correlated with cell growth.

[1468]Screening strain PGM3 (MG1655 ΔtktA-ΔtktB) was transformed by electroporation with plasmid carrying both S. cerevisiae PGM3 and...

example 3

[1470]Enzymatic assay of D-xylulose-1-phosphate aldolase (aldoB) (Maylay A D, et al. (2002) Arch Biochem Biophys, 408:295-304) and D-ribulose-1-phosphate aldolase (FucA) (Elsinghorst E A, et al. (1994) J Bacteriol, 176:7223-7232) activities were tested according to the scheme in FIG. 18 on their natural substrates, xylulose-1P and ribulose-1P, respectively. The reaction mixture contained HEPES 60 mM, PH 7.5, KCl 60 mM, MgCl2 3 mM, NADH 0.25 mM, ATP 4 mM, purified kinase, and aldolase, GPDH at 2 U / mL. Furthermore, the kinases used to produce pentose-1P were fucK (SEQ ID NO: 257) (LeBlanc D J, et al. (1971) Metabolism of D-arabinose: origin of a D-ribulokinase activity in Escherichia coli. J Bacteriol, 106:82-89) for ribulose-1P, and khk-C(SEQ ID NO: 256) (Asipu A, et al. (2003) Properties of normal and mutant recombinant human ketohexokinases and implications for the pathogenesis of essential fructosuria. Diabetes, 52:2426-2432) for xyluolse-1P. Both proteins were tested as previousl...

Claims

1-71. (canceled)72. A recombinant microorganism that produces monoethylene glycol (MEG) or glycolic acid (GA) from one or more hexose feedstocks via D-xylulose-5-phosphate and / or D-ribulose-5-phosphate;wherein the recombinant microorganism comprises one or more overexpressed enzymes for the conversion of D-xylulose-5-phosphate and / or D-ribulose-5-phosphate to D-xylulose-1-phosphate and / or D-ribulose-1-phosphate,wherein the one or more overexpressed enzymes is one or more enzymes having arabitol phosphate dehydrogenase activity.

73. The recombinant microorganism of claim 72, wherein one or more co-products is co-produced with MEG or GA, wherein the one or more co-products is selected from the group consisting of acetone, isopropanol, propene, and isobutene.

74. The recombinant microorganism of claim 72, wherein the recombinant microorganism further comprises at least one overexpressed enzyme having transketolase activity.

75. The recombinant microorganism of claim 74, wherein the at least one overexpressed enzyme having transketolase activity comprises an amino acid sequence having at least 90% sequence identity to SEQ ID NO: 148 or SEQ ID NO: 150.

76. The recombinant microorganism of claim 72, wherein the recombinant microorganism further comprises at least one overexpressed enzyme having transaldolase activity, wherein the at least one overexpressed enzyme having transaldolase activity comprises an amino acid sequence having at least 90% sequence identity to SEQ ID NO: 152 or SEQ ID NO: 154.

77. The recombinant microorganism of claim 72, wherein the recombinant microorganism further comprises at least one overexpressed enzyme having ribulose-5-phosphate 3-epimerase activity, wherein the at least one overexpressed enzyme having ribulose-5-phosphate 3-epimerase activity comprises an amino acid sequence having at least 90% sequence identity to SEQ ID NO: 158.

78. The recombinant microorganism of claim 72, wherein the recombinant microorganism further comprises at least one overexpressed enzyme having ribose-5-phosphate isomerase activity, wherein the at least one overexpressed enzyme having ribose-5-phosphate isomerase activity comprises an amino acid sequence having at least 90% sequence identity to SEQ ID NO: 156 or SEQ ID NO: 253.

79. The recombinant microorganism of claim 72, wherein the recombinant microorganism further comprises a deleted or diminished activity in at least one endogenous enzyme selected from glyceraldehyde 3-phosphate dehydrogenase (gapA), phosphoglycerate kinase (pgk) and / or phosphoglycerate mutase (gpmA / gpmM).

80. The recombinant microorganism of claim 72, wherein the recombinant microorganism further comprises at least one overexpressed enzyme having fructose-6-phosphate phosphoketolase activity.

81. The recombinant microorganism of claim 80, wherein the at least one overexpressed enzyme having fructose-6-phosphate phosphoketolase activity comprises an amino acid sequence having at least 90% sequence identity to SEQ ID NO: 212, SEQ ID NO: 214, SEQ ID NO: 216, or SEQ ID NO: 21882. The recombinant microorganism of claim 80, wherein the recombinant microorganism further comprises at least one overexpressed enzyme having phosphate acetyltransferase activity, wherein the at least one enzyme having phosphate acetyltransferase activity comprises an amino acid sequence having at least 90% sequence identity to SEQ ID NO: 220 or SEQ ID NO: 222.

83. The recombinant microorganism of claim 72, wherein the recombinant microorganism further comprises a deleted or diminished activity in an endogenous 6-phosphofructokinase enzyme (pfkA / pfkB).

84. The recombinant microorganism of claim 72, wherein the recombinant microorganism further comprises a deleted or diminished activity in one or more endogenous enzymes selected from glucose 6-phosphate-1-dehydrogenase (zwf), 6-phosphogluconolactonase (pgl), or 6-phosphogluconate dehydrogenase (gnd).

85. The recombinant microorganism of claim 72, wherein the at least one enzyme having arabitol phosphate dehydrogenase activity catalyzes one or more of the following from (a) to (d):(a) a reversible conversion of D-xylulose-5-phosphate to D-arabitol-1-phosphate;(b) a reversible conversion of D-arabitol-1-phosphate from (a) to D-ribulose-1-phosphate;(c) a reversible conversion of D-ribulose-5-phosphate to D-arabitol-5-phosphate; and(d) a reversible conversion of D-arabitol-5-phosphate from (c) to D-xylulose-1-phosphate.

86. The recombinant microorganism of claim 72, wherein the at least one enzyme having arabitol phosphate dehydrogenase activity is selected from one or more of an enzyme having D-arabitol 1-phosphate 4-dehydrogenase activity, an enzyme having D-arabitol 5-phosphate 2-dehydrogenase activity, an enzyme having D-arabitol 1-phosphate 2-dehydrogenase activity, or an enzyme having D-arabitol 5-phosphate 4-dehydrogenase activity.

87. The recombinant microorganism of claim 72, wherein MEG or GA is produced through the conversion of glycolaldehyde in a C2 pathway and through the conversion of dihydroxyacetone phosphate (DHAP) or pyruvate in a C3 pathway.

88. The recombinant microorganism of claim 72, wherein MEG or GA is produced through the conversion of glycolaldehyde in a C2 pathway and one or more co-products is produced through the conversion of dihydroxyacetone phosphate (DHAP) or pyruvate in a C3 pathway.

89. A method of producing MEG or glycolic acid (GA) using a recombinant microorganism of claim 72, wherein the method comprises cultivating the recombinant microorganism in a culture medium containing one or more hexose feedstocks providing a carbon source until the MEG or GA is produced.

90. A method of producing a recombinant microorganism that produces or accumulates MEG or glycolic acid (GA) from one or more exogenous hexose feedstocks via D-xylulose-5-phosphate and / or D-ribulose-5-phosphate, comprising:expressing in the recombinant microorganism one or more enzymes for the conversion of the one or more hexose feedstocks to D-xylulose-5-phosphate and / or D-ribulose-5-phosphate;overexpressing in the recombinant microorganism one or more enzymes for the conversion of D-xylulose-5-phosphate and / or D-ribulose-5-phosphate to D-xylulose-1-phosphate or D-ribulose-1-phosphate, wherein the one or more overexpressed enzymes is one or more enzyme having arabitol phosphate dehydrogenase activity;expressing in the recombinant microorganism a C2 pathway comprising one or more enzymes for the production of MEG or GA from glycolaldehyde; andexpressing in the recombinant microorganism a C3 pathway comprising one or more enzymes for the production of MEG or GA derived from DHAP or pyruvate; andculturing the recombinant microorganism in a culture medium containing the one or more hexose feedstocks to produce or accumulate MEG or GA,wherein glycolaldehyde and DHAP (or pyruvate) are intermediates produced in the C2 pathway, and wherein MEG or GA is produced in both the C2 and C3 pathways.

91. A method of producing a recombinant microorganism that produces or accumulates MEG or glycolic acid (GA) and one or more co-products from one or more exogenous hexose feedstocks via D-xylulose-5-phosphate and / or D-ribulose-5-phosphate, comprising:expressing in the recombinant microorganism one or more enzymes for the conversion of the one or more hexose feedstocks to D-xylulose-5-phosphate and / or D-ribulose-5-phosphate;overexpressing in the recombinant microorganism one or more enzymes for the conversion of D-xylulose-5-phosphate and / or D-ribulose-5-phosphate to D-xylulose-1-phosphate or D-ribulose-1-phosphate, wherein the one or more overexpressed enzymes is one or more enzyme having arabitol phosphate dehydrogenase activity;expressing in the recombinant microorganism a C2 pathway comprising one or more enzymes for the production of MEG or GA from glycolaldehyde; andexpressing in the recombinant microorganism a C3 pathway comprising one or more enzymes for the production of one or more co-product derived from DHAP or pyruvate; andculturing the recombinant microorganism in a culture medium containing the one or more hexose feedstocks to produce or accumulate MEG or GA and one or more co-products, wherein glycolaldehyde and DHAP (or pyruvate) are intermediates produced in the C2 pathway, and wherein MEG or GA is produced in the C2 pathway and the one or more co-products is produced in the C3 pathway.